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Abstract
Adhesion, which includes cell-to-cell and cell-to-extracellular-matrix adhesion, plays
an important role in cancer invasion and metastasis. After undergoing morphologi-
cal changes malignant and invasive tumour cells, i.e., cancer cells, break away from
the primary tumour by loss of cell-cell adhesion, degrade their basement membrane
and migrate through the extracellular matrix by enhancement of cell-matrix adhesion.
These processes require interactions and signalling cross-talks between proteins and
cellular components facilitating the cell adhesion. Although such processes are very
complex, the necessity to fully understand the mechanism of cell adhesion is crucial
for cancer studies, which may contribute to improving cancer treatment strategies. We
consider mathematical models in an attempt to understand better the roles of cell ad-
hesion involved in cancer invasion. Using mathematical models and computational
simulations, the underlying complex biological processes can be better understood and
their properties can be predicted that might not be evident in laboratory experiments.
Cancer cell migration and invasion of the extracellular matrix involving adhesive in-
teractions between cells mediated by cadherins and between cell and matrix mediated
by integrins, are modelled by employing two types of mathematical models: a contin-
uum approach and an individual-based approach. In the continuum approach, we use
Partial Differential Equations in which cell adhesion is treated as non-local and formu-
lated by integral terms. In the individual-based approach, we first develop pathways
for cell-cell and cell-matrix adhesion using Ordinary Differential Equations and later
incorporate the pathways in a simulation environment for multiscale computational
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modelling. The computational simulation results from the two different mathematical
models show that we can predict invasive behaviour of cancer cells from cell adhesion
properties. Invasion occurs if we reduce cell-cell adhesion and increase cell-matrix
adhesion and vice versa. Changing the cell adhesion properties can affect the spatio-
temporal behaviour of cancer cell invasion. These results may lead to broadening our
understanding of cancer cell invasion and in the long term, contributing to methods of
patient treatment.
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”We will show them Our signs in the Universe and within themselves until it becomes
clear to them that it is the Truth. Is it not sufficient concerning your Lord that He is,
over all things, a Witness?”
(Qur’aan 41:53)
Chapter 1
Introduction
Computational models of complex biomedical phenomena, such as cancer develop-
ment and progression, now have become an integral part of building our understand-
ing of underlying cancer biology. Well-engineered models which are generated from
biological models and experiments, e.g., in vivo or in vitro, through observations in
real patients can help explain mechanisms in the complex phenomenon. When being
successful in predicting experimental results the models can be used to significantly
improve biomedical research throughput by allowing virtual, in silico modelling.
In healthy tissues, cells work in perfect order. They collaborate and follow the rules
governing normal tissue structure and maintenance, such as whether to divide, differ-
entiate, or to die. But in cancer, which starts from mutations at the genetic level, cells
acquire novel, often abnormal phenotypes which cause the cells to ignore the govern-
ing rules. The cells grow uncontrollably, they may invade surrounding tissue (which
is the topic of this thesis) and eventually spread throughout the body or metastasise.
When metastasis happens, cancer can cause the death of individuals. We discuss the
biology of cancer invasion, specifically cancer of epithelial tissue origin or carcinoma,
in Chapter 2.
Mathematical modelling of the various phases of cancer, in particular solid tumour
growth, has itself been developing and expanding over the years. Selected publications
1
2in the field of mathematical modelling of cancer invasion of tissue in connection with
the topic of this thesis is discussed in Chapter 3.
A common agreement between experimentalists and theoreticians recently is that
cancer progression involves processes that interact with one another and occur at mul-
tiple scales of time and space. The time scales involved vary from nanoseconds to
years: the signalling events in the cell typically occur over fractions of a second to a
few seconds, the transcriptional events may take hours, it takes days for cell division
and growth and tissue remodelling, months for tumour doubling times, and years for
tumour growth, etc. The spatial scales range from nanometres for protein-DNA inter-
actions to centimetres for tumour mass development, angiogenesis, tissue invasion, etc.
These scales are strongly linked with each other. A phenomenon cannot be considered
using a single scale, fully isolated, without taking into account what happens at other
smaller or larger scales.
In general when incorporating the temporal and spatial scales, there are three com-
monly used viewpoints: the subcellular level, the cellular level, and the tissue level. Or,
from a modelling point of view those levels can also be referred to as the microscopic
scale, the mesoscopic scale, and the macroscopic scale, respectively. Cancer usually
starts at the subcellular level marked by events that occur within the cell, such as ge-
netic mutations, transduction of chemical signals between proteins and a large number
of intracellular components that regulates activities at the cellular level such as uncon-
trolled cell division, cell detachment that leads to epithelial-mesenchymal transition
(EMT), etc. Interactions between tumour cells and host cells, intravasation and ex-
travasation processes are viewed from a larger scale, that is the mesoscopic scale. The
macroscopic scale concerns activities that occur at the tissue level such as cell migra-
tion, convection and diffusion of chemical factors, which are all typical for continuum
processes (Preziosi, 2003).
In modelling the various stages of cancer progression, certain computational and
3mathematical methodologies are more suitable than others. For example, in the case
of solid avascular tumour growth, simple continuum models are well-suited since they
capture bulk properties of tissues. Instead of explicitly treating individual cells, col-
lective properties of the tumour tissue are modelled, such as cell density and oxygen
concentration. An advantage of such an approach is that systems with a large number
of cells, on the order of 106 or higher, can be handled. We present continuum models
of cancer cell invasion of tissue that focus on the role of the urokinase plasminogen
activation (uPA) system in Chapter 4 and integrate the uPA system with cell adhesion
mechanisms in Chapter 5.
On the other hand, explicit representation of individual cells and their properties
(e.g., locations, radii, morphology, surface area, volume, etc.) can become computa-
tionally burdensome when trying to model systems on the order of 104 to 106 cells.
Nevertheless, such individual cell-based modelling approaches are capable of cap-
turing phenomena and behaviour in multicellular systems that continuum strategies
cannot capture. A multiscale individual cell-based approach focusing on the role of
intracellular proteins E-cadherin and β -catenin in mediating adhesion between cells is
presented in Chapter 6. A pathway model for interactions between cell and extracellu-
lar matrix and the mathematical model is proposed in Chapter 7.
The main aim of this thesis is to understand the roles of cell adhesion which include
cell-cell and cell-matrix adhesion in cancer invasion of tissue using two mathematical
approaches: a continuum approach and an individual cell-based approach.
For the continuum approach, first we look at a model of cancer invasion of tissue
developed by Chaplain and Lolas (2005), where the locomotion of cancer cells is gov-
erned by random motility, directional migration towards gradients of soluble chemoat-
tractants or chemotaxis, and directional movement up gradients of substratum-bound
extracellular matrix components or haptotaxis. We use this model as a basic model for
cancer cell invasion of surrounding tissue and extend the model by incorporating cell
4adhesion that accounts for cell motility, which is an important event in cancer invasion.
In summary, the key results of our continuum models in this thesis are: (i) com-
prehensive computational simulations of our mathematical model of cancer invasion
and the observation of interesting spatio-temporal irregular patterns; (ii) the linking of
these patterns to results of a linear stability analysis of unique positive uniform steady
states of the system, and, (iii) a comparison of the computational simulations with
experimental results and identification of weakness of the model for future work.
For the individual cell-based approach, we use a pathway developed by Ramis-
Conde et al. (2008) for multiscale modelling of cell detachment based on a cell-cell
adhesion mechanism for implementation in a lattice-based simulation methodology.
We present a case study on model cross-validation. We simulate, reproduce, and com-
pare the cancer invasion model described in Ramis-Conde et al. (2008) (which uses
off-lattice methodology) in a simulation environment CompuCell3D for cellular mod-
elling (using lattice-based methodology) and incorporate Bionetsolver for the intracel-
lular modelling.
Chapter 2
Biological Background of Cancer
Invasion
2.1 Introduction
About 90% of cancer-related illnesses and deaths are caused by malignant tumour
cells, i.e., cancer cells, that have left the primary tumour, spread to anatomically dis-
tant sites far from the locations in the body where their primary tumours first arose,
and formed secondary tumours at the new sites. Metastasis, the term given to this dis-
seminating process, depends on complex biochemical and biological changes in cancer
cells and in the associated stroma, and the interactions between them.
When cells have successfully undergone metastasis and established new colonies
at distant sites, they often produce considerable harm. Bone is the most common site
of recurrence of metastatic breast cancer cells, where they affect the spine, ribs, pelvis,
and proximal long bones. The breast cancer metastatic colonies in the bone can cause
localised erosion of bone tissue, resulting in severe pain and skeletal collapse. Breast
cancer cells also metastasise to vital organs such the lungs, liver, and to the brain,
posing life threatening effects (Weinberg, 2007).
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62.2 General Mechanisms of Invasion and Metastasis
Metastasis involves complex molecular cascades comprising many interconnected steps.
The steps are connected to each other through a series of adhesive interactions, inva-
sive processes, and responses to chemotactic stimuli. The major steps can be sum-
marised as follows: (1) the detachment of tumour cells from the primary tumour mass,
by down-regulation of cell-cell adhesion components such as cadherins and catenins;
(2) invasion of the basement membrane and the extracellular matrix (ECM) compo-
nents by over-expression of proteolytic enzymes such as matrix metalloproteinases
(MMPs) and urokinase-type plasminogen activator (uPA), and migration through the
ECM mediated by cell-matrix adhesion components such as integrins and fibronectin;
(3) intravasation of the tumour cells into the blood vessels and lymphatic vessels which
gives them access to the circulatory system to travel to distant anatomical sites; (4) ex-
travasation or escape from the circulatory system and penetration into the surrounding
tissue of new sites by adhesion of the circulating tumour cells to the endothelial cell
lining at the capillary bed of the target organ site; (5) invasion of the basement mem-
brane and target organ tissue; and (6) the growth of secondary tumours at the target
organ site (Guo and Giancotti, 2004; Brooks et al., 2010). Tumour-induced angiogen-
esis also provides a route for metastatic spread.
The metastatic cascade that we are mathematically investigating and modelling in
this thesis is the local invasion of normal or host tissues which involves steps (2) and
(3) as well as step (6) of the above mentioned complex sequence of steps critical for
metastasis. Typically for carcinomas (cancer of epithelial tissue origin) invasion indi-
cates penetration of cancer cells into the stromal compartment and their occupation.
Cancer cells invade beyond the constraints of the normal tissue where they originate.
Invasive cells acquire genetic and epigenetic changes that give rise to an aggressive
phenotype. Carcinoma cells must discard many of their epithelial phenotypes, de-
tach from epithelial sheets, and undergo a drastic alteration which is referred to as the
7epithelial-mesenchymal-transition (EMT). Two properties that are necessary for suc-
cessful invasion are increased cell motility through cell adhesion properties and the
ability to release proteolytic enzymes. These are associated with decreased cell-cell
adhesion, degradation of basement membranes and tissue, and enhanced cell-matrix
adhesion for migration across the tissue as well as enhanced local growth of tumour
cells. The process of invasion with cell detachment and migration (which may start
after angiogenesis takes place) is illustrated in plot (d) of Fig. 2.1.
2.3 Detachment
Many of the activities of mammalian cells in vivo, such as embryogenesis, mitosis,
morphogenesis, shape maintenance, cell orientation, survival, and motility depend on
the attachment of cells to their surroundings such as the extracellular matrix (ECM)
and other neighbouring cells. Most cells possess multiple mechanisms that enable
them to bind to other neighbouring cells (cell-cell adhesion) and to the extracellular
matrix (cell-matrix adhesion).
The maintenance, formation or disruption of cell-cell and cell-matrix adhesion are
particularly important cellular events in cancer invasion and metastasis. Cell-cell ad-
hesion functions to maintain a tumour’s compactness. Loss of cell-cell adhesion fa-
cilitates the detachment of tumour cells from the primary tumour mass. This event is
then followed by the formation of cell-matrix adhesion that mediate the migration of
tumour cells through the ECM (Guo and Giancotti, 2004).
Recent studies have shown that cell-cell and cell-matrix adhesion play a significant
role in the invasive and metastatic potential of many types of cancer, such as colorectal
cancer (Kirkland and Ying, 2008; Paschos et al., 2009), breast cancer (Kowalski et al.,
2003; Sloan et al., 2006; Havaki et al., 2007), cervical cancer (Maity et al., 2009),
ovarian cancer (Ahmed et al., 2005; Sawada et al., 2008), pancreatic cancer (Sawai
et al., 2006), lung cancer (Lee et al., 2002; Zhu et al., 2007), carcinomas (Schlippe
8et al., 2000; Brockbank et al., 2005; Heyder et al., 2005; Janes and Watt, 2006), and
melanomas (Kuphal et al., 2005).
Cell adhesion is mediated by cell adhesion molecules (CAMs) expressed on the cell
surface. Cell adhesion molecules (CAMs) are specialised membrane (glyco)proteins,
also called transmembrane receptors, that mediate chemical and mechanical interac-
tions between the intracellular and extracellular compartments. For these interaction
purposes, they all have cytoplasmic, transmembrane, and extracellular domains.
There are four major groups of cell adhesion molecules (CAMs) that have been
identified: the integrin family, the immunoglobulin superfamily, selectins, and cad-
herins. Two groups that are considered to be generally involved in cell adhesion of
epithelial tissue are cadherins and integrins.
Cadherins are the main adhesion molecules that are thought to be responsible for
the binding of a cell to neighbouring cells or cell-cell adhesion. Cadherins of one
cell bind to cadherins of adjacent cells in a calcium-dependent manner. Cadherins
mediate cell-cell adhesion mainly by homotypic interactions, although there are also
heterotypic bindings between different cadherin molecules. The cytoplasmic tail of
cadherins binds to the proteins of the catenin family to form cadherin/catenin com-
plexes mediating connection to the actin cytoskeleton that provides tensile strength for
the cell. The group of intracellular anchor proteins, catenins, consists of p120-catenin,
α-catenin, γ-catenin, and β -catenin (Jiang, 1996; Alberts et al., 2002). Classical cad-
herins are named based on the types of the main tissues where they are found, e.g.,
E-cadherin is found in epithelial tissues, N-cadherin is expressed predominantly in the
nervous system, and P-cadherin is present in cells in the placenta and epidermis, etc. Of
all types of cadherins, E-cadherin is the most well-studied cell-cell adhesion protein,
as it is thought to be a key molecule for cell-cell adhesion. Cells without E-cadherin
expression may not aggregate or adhere to each other.
9E-cadherin is mainly distributed at the cell membrane, particularly at cell-cell adhe-
sion areas. The function of E-cadherins is highly dependent on the functional activity
of catenins as a provider of mechanical linkage between E-cadherin and the cytoskele-
ton (Garrod, 1993; Tsutsui et al., 1996). After being synthesised, E-cadherin binds
to both β -catenin and γ-catenin in the cytoplasm, before being transported to the cell
membrane. α-catenin binds to E-cadherin or β -catenin-γ-catenin-E-cadherin com-
plexes at the cell membrane (Jiang, 1996). Cells with normal E-cadherin expression,
but lacking in catenins, are not able to adhere to each other.
Disruption of cell-cell adhesion is essential for the first step of local invasion of
cancer, in which malignant cells detach and break free from the primary tumour mass.
This mechanism is frequently associated with the abnormality of either E-cadherin
expression or function, the latter being related with loss of expression of α-catenin
(Shimoyama et al., 1992) or mutations in β -catenin (Kawanishi et al., 1995) that cause
disturbance in E-cadherin-catenin interaction. In vitro studies have suggested a linear
relation between disruption of E-cadherin-catenin complexes and the invasive phe-
notype (Wijnhoven et al., 2000; Aken et al., 2001). The loss of E-cadherin-catenin
complex bindings is followed by reduced expression of E-cadherin on the cell sur-
face, while catenins accumulate in the cell nucleus. Down-regulation of E-cadherin is
sometimes accompanied by up-regulation of N-cadherin, with which cancer cells form
homotypic interactions with various types of mesenchymal cells like fibroblasts and
endothelial cells that reside in the matrix/stroma (Weinberg, 2007).
It remains unclear whether the loss of E-cadherin-mediated cell adhesion is a pre-
requisite for cancer invasion or is a consequence of dedifferentiation during cancer
progression in vitro. However, Perl et al. (1998) demonstrated that the loss of E-
cadherin-mediated cell-cell adhesion is involved in the transition from adenoma to
invasive carcinoma. And there is also evidence that the up-regulation of N-cadherin
as exchange with down-regulation of E-cadherin occurs when melanocytes become
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transformed into melanoma cells (Weinberg, 2007).
Reduction of E-cadherin expression on the cell surface is accompanied by a marked
increase in proteolytic enzyme urokinase-type plasminogen activator (uPA). This in-
crease probably involves RNA and protein synthesis. E-cadherin is also associated
with the distribution of uPA from the perinuclear region to the cell surface (Jiang,
1996).
2.4 Degradation of the Extracellular Matrix
Extracellular matrix (ECM) has a dual role: as the substratum on which the cells move
and as the physical barrier that the cells have to surpass. One of the first steps in
cancer invasion is the remodelling of the matrix and a major part of this process in-
volves the over-expression of proteolytic enzymes, such as the urokinase-type plas-
minogen activator (uPA) and matrix metalloproteinases (MMPs), by the cancer cells
to degrade the physical obstacle by breaking down matrix proteins/components. The
inherent ability of cancer cells to invade because of the over-expression of uPA has
been experimentally demonstrated in several human cancers including breast cancer
(Duffy, 2002), prostate cancer (Webber and Waghray, 1995), murine lung carcinoma
(Henneke et al., 2010), pleural mesothelioma (cancer that develops in the lining of
the lungs) (Tucker et al., 2010), gastric carcinoma (Alpı´zar-Alpı´zar et al., 2010), pan-
creatic cancer (Gibbs et al., 2009), bladder, kidney, colorectal, stomach, brain, ovary,
endometrium and melanoma (Markus, 1988). High levels of uPA expression in cancer
are correlated with poor cancer prognosis.
The plasminogen activation system consists of two plasminogen activators, tissue-
type plasminogen activator (tPA) and urokinase-type plasminogen activator (uPA). tPA
mainly plays a role in the generation of plasmin for fibrinolysis in blood vessels, while
uPA is thought to play a more dominant role in tissue remodelling process specifically
in cancer.
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The serine protease uPA is implicated in the catalysis of the proteolytic conver-
sion of the inactive zymogen plasminogen to the active proteinase plasmin. Plasmin is
an important enzyme that catalyses degradation of major proteins in basement mem-
branes and extracellular matrix, facilitating cancer cell invasion of the surrounding
tissue. The activity of uPA to generate plasmin is inhibited by serpins plasminogen ac-
tivator inhibitor-1 or PAI-1 and the activity of plasmin is inhibited by α2-antiplasmin
(Andreasen et al., 1997, 2000; Duffy and Duggan, 2004; Danø et al., 2005).
uPA is secreted as a single polypeptide chain pro-enzyme, pro-uPA, which is inac-
tive and has a very low intrinsic proteolytic activity. Pro-uPA is activated to active uPA
by plasmin. Active uPA proteolytically converts the inactive zymogen plasminogen
to plasmin, which then degrades directly or indirectly matrix components, or activates
latent growth factors such as transforming growth factor 1 (TGF-1). Pro-uPA and uPA
bind with high affinity to a cell surface uPA receptor, uPAR, a multidomain glycopro-
tein tethered to the cell membrane with a glycosylphosphotidylinositol (GPI) anchor.
The binding of uPA by uPAR restricts plasminogen activation to the immediate vicinity
of the cell membrane (Andreasen et al., 1997, 2000; Duffy and Duggan, 2004; Danø
et al., 2005). The concerted action of these plasminogen activation system members
is more prevalent at the leading edge of migrating cells, contributing to the invasive
properties and metastatic potential of malignant tumour cells or cancer cells. In addi-
tion to matrix degradation, the migration of cancer cells requires cell attachment to the
matrix.
2.5 Cell Motility
After having been detached from the primary tumour mass followed by secretion of
proteolytic enzymes to degrade the barrier in front of them, invasive cancer cells now
are on their way to embark on their journey migrating across the tissue before gaining
access to any nearby blood or lymph vessel that transports them to distant sites. For
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the purpose of migration, invasive cells need adhesive interaction between them and
the matrix (components) or cell-matrix adhesion. It is a vital process in invasion of
the basement membrane and the tissue at primary site, and in penetration of the tis-
sue of the target organ at the secondary site, when metastasis has eventually formed.
In the interactions between cell and matrix, the intracellular compartment of a cell is
connected with the extracellular environment by binding of cell surface receptors with
proteins of the ECM. The major groups of proteins mediating cell-matrix adhesion are
a family of cell surface receptors known as integrins, named for their role in integrat-
ing the intracellular cytoskeleton with the ECM (Ojaniemi and Vuori, 1997). Aside
from migration, cell-matrix adhesion also plays an important role in cell survival and
proliferation.
Integrins are heterodimeric cell-surface receptors that consist of two transmem-
brane subunits, α and β , and each αβ combination has its own binding specificity
and signalling properties which form distinct integrin sub-types linking extracellular
matrix components, such as fibronectin, vitronectin, laminin and collagen, to the intra-
cellular actin cytoskeleton. The binding of integrins to the matrix components induces
discrete cell surface structures mediating direct interactions of cells with the extracel-
lular matrix (Giancotti and Ruoslahti, 1999; Berrier and Yamada, 2007).
There are many structural molecules involved that bind or link integrins to actin,
regulate signalling from integrins to the actin cytoskeleton, and also activate integrins.
The cytoplasmic tails of integrins are generally short and always devoid of enzy-
matic features. Hence, integrins transduce signals by associating with adapter proteins
that connect the integrin to the cytoskeleton, cytoplasmic kinases, and transmembrane
growth factor receptors (Giancotti and Ruoslahti, 1999).
Cancer cells spread within the tissues using similar migration mechanisms occur-
ring in normal, non-neoplastic cells during physiological processes such as embryonic
morphogenesis, wound healing and immune-cell trafficking. The principles of cancer
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cell migration show that they retain the same basic strategies as those initially inves-
tigated in non-neoplastic fibroblasts, keratinocytes and myoblasts (Friedl and Wolf,
2003). The mechanisms require multi-nodal control that ensure continuous, coor-
dinated assembly and disassembly of adhesions depending on the requirements of a
given situation (Webb et al., 2002; Vicente-Manzanares et al., 2005).
Cancer cells possess a broad spectrum of motility mechanisms, depending impor-
tantly on cell type and matrix structure. They can migrate as individual cells, referred
to as individual cell migration, or expand in solid cell strands, sheets, files or clusters,
called collective migration (Friedl and Wolf, 2003). Migration can be viewed as a
multiple cycle. The basic migratory cycle includes:
1. Extension of a protrusion → polymerization of the actin cytoskeletal network
drives the initial extension of the plasma membrane at the cell front.
2. Formation of stable attachments near the leading edge of the protrusion → the
interaction of the integrin family of transmembrane receptors with the ECM sta-
bilises the adhesions by recruiting signalling and cytoskeletal proteins.
3. Translocation of the cell body forward → these small, nascent adhesions may
transmit strong forces, and serve as traction points for the propulsive forces that
move the cell body forward.
4. Release of adhesions and retraction at the cell rear completes the migratory cycle
allowing net translocation of the cell in the direction of movement.
All the stages above are happening continuously as the cell moves on the matrix.
In connection with proteolysis, degradation of extracellular matrix occurs while the
advancing cell body gains volume towards the matrix scaffold. This is perhaps meant
to provide the space required for cell expansion and migration, leaving behind defects
in the matrix that look like tubes along the migration track.
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Figure 2.1: Illustration of typical growth and invasion of carcinomas from a layer of epithelial
cells sitting on a basement membrane (BM) that separates the epithelial layer from extracellular matrix
(ECM). (a) One cell (yellow) in a layer of epithelial cells undergoes the 1st mutation. (b) The mutated
cell divides uncontrollably replacing normal cells (blue), and new levels of mutations continue to occur
determined by the colours of the cells. Orange cells have undergone a second mutation, purple cells
with a third mutation, and the last mutation yielding more aggressive cells is faced by green cells. (c)
Tumour cells release Tumour Angiogenesis Factor (TAF) to stimulate new blood vessels for oxygen and
food supplies. (c) Angiogenesis takes place. (d) Invasion takes place. A group of cells E breach the
basement membrane, with some detaching from the primary tumour mass and secreting uPA. Cells C
and D have completely detached and perform individual migration on the matrix that has been degraded
by proteolysis through secretion of uPA. Cell B has reached the main blood vessel, invading endothelial
cells of blood vessel for intravasation. Cell A is travelling in the blood vessel. The invasive cells have
abnormally large nuclei (Weinberg, 2007).
Chapter 3
Mathematical Modelling of Cancer
Invasion
3.1 Introduction
Mathematical modelling of cancer growth and development in the 20th century dates
back at least as far as the 1950s, where Thomlinson and Gray (1955) carried out ex-
aminations of sections of human lung cancer and from it formulated a mathematical
model for diffusion and consumption of oxygen. The examined histological sections
were assumed to be in the shape of a cylinder and the model was based on a theory
developed by Hill (1928) for diffusion of oxygen into plane and cylindrical elements
of tissue. It was then followed by other mathematical models of cancer growth over
the next thirty years. During that period, research papers in cancer modelling appeared
slowly – on average about 2 research papers published per year in the 1970s and 1
paper per year in the 1980s.
With advances in computing technology since the 1990s until the present we have
witnessed the steady increase in the number of mathematical models everywhere in
cancer research. These models have diverse approaches. We could say that there has
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been a greater need for the cancer research field to embrace mathematics and computa-
tion. In this chapter we present a literature review of the progression of mathematical
models of cancer invasion of tissue as it is the focus of our research. We divide the re-
view into two sections: in section 3.2 we discuss the literature review of mathematical
models that use a continuum approach, while models based on a multiscale individual
cell-based approach are discussed in section 3.3.
3.2 Continuum Models
Mathematical modelling of the various phases of solid tumour growth has itself been
developing and expanding over the years. For comprehensive reviews of the modelling
in this area, see the books by Adam and Bellomo (1996); Preziosi (2003); Bellomo
et al. (2008). Early mathematical models of cancer focused on growth dynamics of
solid tumours. Some of these models were based on oxygen distribution and con-
sumption as factors that drive tumour growth, such as the models proposed by Burton
(1966); Greenspan (1972); McElwain and Ponzo (1977). It was not until the 1970s
after a series of experimental studies on metastasis by Liotta and co-workers (Araujo
and McElwain, 2004) that the modelling on tumour invasion started to appear, when
Saidel et al. (1976) developed a deterministic model of the metastatic process of a
solid tumour through blood vessels. They used a compartmental model that consisted
of tumour cells in the tumour mass, tumour vessels, tumour cells penetrating the ves-
sels, tumour cells arrested in the target organ, and metastatic foci in the target organ
as model variables. As their model aimed at providing a theoretical framework for
analysis and simulation, it was in good agreement with the general dynamics of the
process.
A myriad of experimental studies that have been performed since the 1970s and
are still ongoing up to date disclose that cancer progression is a very complex process
which involves many different subcellular or intracellular and extracellular phenomena
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that are related to each other. To unravel the complexities, it is necessary to dissect the
“black box” and study the components part by part. There are many aspects that have
been implicated in cancer progression and have been studied so far, such as angiogen-
esis, acidity-dependence, proteolysis, cell adhesion, modes of motility (based on tissue
rigidity), etc.
The transition of solid tumour growth from the avascular phase (which is rela-
tively harmless) to the invasive and malignant vascular phase depends upon the crucial
process of angiogenesis since it is necessary for the tumour to attain nutrients and dis-
pose of waste products (Folkman, 1974, 1976). To achieve vascularisation, tumour
cells secrete diffusible substances known as Tumour Angiogenesis Factors (TAF) into
the surrounding tissue (Folkman and Klagsbrun, 1987). This has the effect of stim-
ulating nearby capillary blood vessels to grow towards and penetrate the tumour, re-
supplying the tumour with vital nutrient, and then, the invasion and metastasis take
place. Several TAF substances have now been identified, such as members of the
fibroblast growth factor (FGF) family, vascular permeability factor/vascular endothe-
lial growth factor (VPF/VEGF), angiogenin, transforming growth factor alpha and beta
(TGF-α and TGF-β ), platelet-derived growth factor (PDGF), platelet-derived endothe-
lial cell growth factor (PDECGF), tumour necrosis factor alpha (TNF-α), interleukins,
chemokines, and angiopoietins (angs) (Ribatti et al., 2002). Mathematical modelling
of tumour-induced angiogenesis started in the early 1990s with a model of the diffusion
of TAF into surrounding tissue by Chaplain and Stuart (1991). It was expanded and
followed by other models of tumour-induced angiogenesis such as by Chaplain et al.
(1995); Maggelakis (1996); Orme and Chaplain (1996a,b); Chaplain (1996); Orme and
Chaplain (1997); McDougall et al. (2002); Plank and Sleeman (2003); Valenciano and
Chaplain (2003); Mantzaris et al. (2004); Plank et al. (2004); Zheng et al. (2005); Mc-
Dougall et al. (2006); Ste´phanou et al. (2006); Stamper et al. (2007); Macklin et al.
18
(2009). In particular mathematical models of tumour-induced angiogenesis for inva-
sion of tissue that include degradation/invasion of tissue or tissue components are those
proposed by Chaplain (2000); Zheng et al. (2005). A model of invasion in the lym-
phatic vascular system was proposed by Pepper and Lolas (2008). The model consists
of a coupled system of eight partial differential equations describing the evolution in
time and space of tumour cell density, LEC (lymphatic endothelial cells) density, extra-
cellular matrix protein density, urokinase plasminogen activator concentration (uPA)
secreted by LECs and by cancer cells, plasmin concentration activated by LECs and
by cancer cells, and vascular endothelial growth factor-C concentration (VEGF-C).
Human tumours have long been considered acidic. Measurement of pH in tissue
has shown that the microenvironment in tumours is generally more acidic (lower pH)
than in normal tissues. Tumour cells produce a high concentration of H+ ions that dif-
fuse along concentration gradients into the adjacent normal tissue, exposing the normal
tissue to an extracellular pH that is significantly lower than normal. This chronically
acidic environment causes normal cells to die due to the activation of p53-dependent
apoptosis pathways and loss of function of critical pH-sensitive genes. While normal
cells die, tumour cells exhibit maximum proliferation in the acidic medium. The pro-
gressive loss of normal tissue at the tumour-host interface then facilitates tumour inva-
sion (Gatenby and Gawlinski, 2003). Mathematical models of acid-mediated tumour
invasion have been proposed by Gatenby and Gawlinski (1996); Webb et al. (1999);
Smallbone et al. (2005). On their hypothesis that the alteration of microenvironmental
pH induced by tumour may provide a mechanism for cancer invasion, Gatenby and
Gawlinski (1996) developed an invasion model describing the interactions between tu-
mour tissue, normal tissue, and excess of H+ ion concentration. The model consists
of a system of reaction-diffusion equations of Lotka-Volterra type for the population
competition between normal and tumour tissue. Their model predicts a pH gradient
extending from the tumour-host interface, which is confirmed by reanalysis of their
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experimental data. Smallbone et al. (2005) develop an invasion model for multicellu-
lar tumour spheroid to examine the role of acidosis in the interaction between normal
and tumour cell populations. A model by Webb et al. (1999) proposed the involvement
of proteolytic activity (they considered matrix metalloproteinases or MMPs) in tumour
acidity and suggested that changes in MMP activity at low pH do not have significant
effects on the stimulation of a more metastatic phenotype or invasive behaviour.
During local invasion, the basement membrane and components of surrounding
extracellular matrix or tissue must be degraded through proteolytic activities of sev-
eral hydrolytic enzymes such as the urokinase-type plasminogen activator (uPA) and
matrix metalloproteinases (MMPs), released either by the tumour cells themselves or
by cells surrounding the tumour. Mathematical models by Perumpanani et al. (1996,
1998, 1999); Anderson et al. (2000); Marchant et al. (2001); Stewart et al. (2002);
Chaplain and Lolas (2005, 2006) emphasise the roles of proteolysis in cancer inva-
sion of tissue. Perumpanani et al. (1996) derived a model to describe the interactions
of invasive cells with normal cells, noninvasive tumour cells, ECM proteins, and pro-
teases. Their model also includes changes in cell adhesion that transform noninvasive
tumour cells into invasive tumour cells and changes in the protease-antiprotease axis
for excessive matrix degradation. The model suggests the occurrence of noninvasion
with high protease expression on the basis of chemotactic gradients that prevent inva-
sion. A model of human fibrosarcoma cell line HT1080 by Perumpanani et al. (1998)
shows that matrix metalloproteinase-2 (MMP-2)-digested fragments of fibronectin ex-
ert a chemotactic pull stronger than that of undigested fibronectin. In their other model,
Perumpanani et al. (1999) combine proteolysis and haptotaxis that can be produced by
contact with the extracellular matrix through the mediation of cell surface receptors
(integrins). Unlike the previous model (Perumpanani et al., 1998), diffusion terms for
cells and MMP-2 are absent in Perumpanani et al. (1999). In the continuum model
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proposed by Anderson et al. (2000), cancer invasion is described by interactions be-
tween tumour cell density, matrix degrading enzyme concentration, and extracellular
matrix density. A model by Marchant et al. (2001) looks at the influence of diffusion in
the invasion profiles, which stabilises the shock-like step at the invading front. Stew-
art et al. (2002) develop a model for the early stages of malignant tumour invasion
due to random motility, cellular proliferation, proteolysis and haptotaxis. Their model
demonstrates that invasion profiles asymptotically evolve to travelling wave solutions
and are also influenced by cell diffusion. Numerical simulations (in 1D) of the above
mentioned models produce results that behave like travelling wave solutions, which
suggest that the invading cancer cell density always maintains a uniform solution. Ex-
perimentally, invasive cancer cells that invade and penetrate the extracellular matrix
exhibit heterogeneity in their spatial patterns of spreading, as shown by experimental
data in Fig. 4.14 and studies by Nystro¨m et al. (2005). Models that particularly focus
on the role of specific proteolytic enzyme such as urokinase-type plasminogen activa-
tion system or uPA developed by Chaplain and Lolas (2005, 2006) produce rich and
dynamic heterogeneous spatio-temporal solution profiles of cancer cell invasion. Their
models describe the interactions between cancer cells, host tissue, and uPA (Chaplain
and Lolas, 2006) and additionally the inhibitor of uPA and plasmin (Chaplain and Lo-
las, 2005). Motility of cells is governed by cell random motion, chemotaxis in response
to gradients of diffusible uPA and PAI-1, and haptotaxis in response to gradients of ma-
trix density which is not diffusible. Mathematically, chemotaxis and haptotaxis take
the same form and it means that movement of cells is directed towards high concen-
trations of the substance in question. The chemotactic (and haptotactic) function that
was introduced by Patlak in 1953 and later by Keller and Segel (1970) has been char-
acterised experimentally and studied intensively from a theoretical standpoint since it
was first introduced. Mathematical models of chemotaxis have been developed in order
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to predict aggregation patterns of cells by establishing conditions leading to the insta-
bility of homogeneous or spatially uniform steady states (see for example, the books
by Murray (2003); Edelstein-Keshet (2005)). Studies have suggested that chemotaxis
in a system consisting of reaction-diffusion-taxis terms may destabilise spatially uni-
form steady states, resulting in some new state where spatial variations predominate.
We perform a linear stability analysis of the uPA system model by Chaplain and Lolas
(2005) in Chapter 4, and show that destabilisation of the spatially uniform steady state
in the uPA system is taxis-driven. The results obtained from computational simulations
carried out on the model equations produce dynamic heterogeneous spatio-temporal
solutions.
Another phenotypic alteration that must occur for the successful invasion of neigh-
bouring tissue is changes in cell adhesion. Although a model that implicitly includes
changes in cell adhesion has been implemented by Perumpanani et al. (1996), a con-
tinuum approach model that explicitly describes cell-cell adhesion leading to directed
cell movement due to adhesive forces was first developed by Armstrong et al. (2006).
The model consists of a term for the gradient of adhesive movement due to adhesive
force between cells. The cell adhesion term is nonlocal in space and was derived based
on cell sorting mechanisms. The adhesive force is considered to be the sum of local
forces between adjacent cells, hence depending on a so-called “cell sensing radius”
which gives the nonlocal term (integral term). This model has been extended for use
in cancer invasion models by (Gerisch and Chaplain, 2008; Painter et al., 2010) where
the cell adhesion term is expanded into interactions between cell-cell and cell-matrix
and can drive invasive behaviour. Invasion is controlled by reducing cell-cell adhesion
and enhancing cell-matrix adhesion, which is the hallmark for epithelial-mesenchymal
transition (EMT). Painter et al. (2010) show that the adhesive movement term alone
(without cell random motion term) could produce directed movement of cells driven
by low cell-cell adhesion and high cell-matrix adhesion. Gerisch and Chaplain (2008)
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show that in the limit of the sensing radius going to zero, the nonlocal model with in-
tegral term converges to a “standard” related system of reaction-diffusion-taxis equa-
tions. Convinced by the generality, simplicity, and convenient use of the cell adhesion
mechanism developed by Armstrong et al. (2006), we extend our uPA model in Chap-
ter 4 by incorporating cell adhesion in the equation for cancer cell density. This is
to complement the model of cancer invasion by covering more phenotypic alterations,
as discussed in Chapter 5. Using a volume filling effect as developed by Hillen and
Painter (2001); Painter and Hillen (2002); Gerisch and Chaplain (2008); Painter et al.
(2010), numerical solutions of our nonlocal model exhibit rich patterns of spatial het-
erogeneity by varying cell-cell and cell-matrix adhesion parameters. The boundedness
of solutions of the model by Armstrong et al. (2006) has been proven by Sherratt et al.
(2009) and the global existence has been proven by Szyman´ska et al. (2009).
Aside from what has been mentioned above, there are other aspects of invasion that
have been modelled, enriching the field of cancer research. Kim and Friedman (2009)
develop a model for the early development of transformed epithelial cells (TECs) in
the presence of fibroblasts in the tumour microenvironment. Their model is used to
generate several hypotheses on how to slow tumour growth and invasion. It also has
been revealed experimentally that cancer cells exhibit biphasic dependence of invasion
speed on matrix density, where the maximum speed of invasion is attained at an inter-
mediate level of the physical distribution of matrix proteins, density or adhesiveness
(Huttenlocher et al., 1996; Lauffenburger and Horwitz, 1996; Choquet et al., 1997;
Palecek et al., 1997; Stahl and Mueller, 1997; Maheshwari et al., 1999, 200; Cox et al.,
2001; Gobin and West, 2002; Hocking and Chang, 2003; Li et al., 2005; Peyton and
Putnam, 2005; Khatiwala et al., 2006; Zaman et al., 2006; Silvestre et al., 2009). A
mathematical model of malignant invasion that consists of equations for cancer cell
density, extracellular matrix (collagen) density, and protease by Marchant et al. (2006)
produces this biphasic dependence on the density of surrounding normal tissue. The
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biphasic behaviour that they explained using nonstandard phase plane analysis is sug-
gested to have appeared because of the inclusion of competition for space between the
collagen gel and the malignant cells. In our numerical simulations, we apply a bipha-
sic dependence of cell speed on matrix density and cell-matrix adhesion strength to
our nonlocal model by tuning the cell diffusion parameter (which governs cell speed
and movement) to be a maximum at intermediate matrix density and cell-matrix adhe-
sion strength. Proliferation and migration of brain tumour cells are mutually exclusive
phenotypes that do not occur at the same time (Giese et al., 1996). The exact cel-
lular mechanisms that dictate whether the cells either migrate or proliferate are not
known. Although Athale et al. (2005) have developed a deterministic approach for the
phenotypic switch by using epidermal growth factor receptor- or EGFR-mediated sig-
nalling pathway, their model involves a lot of signalling cascades within the network
of genes and proteins and is cumbersome to be implemented in our uPA and nonlocal
models. Fedotov and Iomin (2007) propose a two-component reaction-transport model
for the migration-proliferation dichotomy in the spreading of tumour cells which was
written as a system of integro-differential equations employing Laplace transform and
in which (Fedotov and Iomin, 2008) they propose a stochastic approach. Different
modes or strategies of tumour cell movement depending on extracellular matrix struc-
ture are also an interesting aspect to be modelled. Hillen (2006) develops mesoscopic
and macroscopic models for mesenchymal motion in a time-varying network tissue,
directed and undirected orientation tissue. Adding to mesenchymal motion, amoeboid
motion of cells with application to cancer invasion is also modelled by Painter (2009)
in various matrix density and orientation. With their reaction-diffusion model, Cristini
et al. (2005) manage to get simulations that result in heterogeneous cell proliferation
and migration of cells in a tumour mass in the presence of heterogeneous distribution
of oxygen and nutrients. The microenvironmental substrate gradients are thought to
drive morphologic instability with separation of cell clusters from the tumour edge and
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infiltration into the surrounding normal tissue.
Although the mathematical models presented in this thesis can be applied in gen-
eral for any type of cancer of epithelial origin, some mathematical models of cancer
invasion are dedicated to specific types of cancer, such as modelling of glioma invasion
by Swanson et al. (2000, 2003); Frieboes et al. (2006); Stein et al. (2007); Swanson
(2008) and breast cancer by Gavaghan et al. (2002); Enderling et al. (2007). Glioma is
a type of tumour that starts in the brain or spine, but is more common in the brain. The
tumour originates from glial cells. Unlike other types of tumours, human malignant
gliomas are exceedingly motile. Experiments showed that within 7 days of implanta-
tion, glioma cells can be identified throughout the central nervous system (CNS), see
Chicoine and Silbergeld (1995) and references therein. Swanson et al. (2000, 2003);
Swanson (2008) model the growth and invasion of a glioma in different parts of the
human CNS. To account for spatial heterogeneity of the brain tissue that consists of
white and grey matter, they employ nonlinear diffusion coefficient for tumour cells,
where the diffusion coefficient is a function of the spatial variable x and the different
regions of grey and white matter. This is to reflect experimental observations which
show that glioma cells exhibit higher motility in white matter than in grey matter. Sim-
ulations of Frieboes et al. (2006) show that tumour morphogenesis in vivo may be
a function of marginally stable environmental conditions caused by spatial variations
in cell nutrients, oxygen, and growth factors, while a mathematical model by Stein
et al. (2007) uses experimental data of U87 glioblastoma tumour spheroids in a three-
dimensional collagen gel. For breast cancer modelling, Enderling et al. (2007) develop
a mathematical model to simulate the stepwise development of breast cancer cells from
normal stem cells via mutations in two tumour suppressor genes (TSGs) and Gavaghan
et al. (2002) review mathematical models of cancer that can be used for modelling of
breast carcinoma to aid detection.
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3.3 Multiscale Individual Cell-based Models
Perhaps the earliest individual cell-based modelling was started in 1980 with a compu-
tational model of cancer invasion developed by Du¨chting and Dehl (1980a,b) to deter-
mine the spatial structure and temporal behaviour of tumour spread. They developed
an algorithm for the transformation of normal cells into tumour cells in 2D.
During the last decade or so many of approaches to multicell, multiscale modelling
of cancer evolution and treatment therapy that have been developed, have been driven
by a large number of computational advances and progresses in individual or single
cell-based modelling. Most of the multiscale models describe interactions between
variables that occur on the microscopic and mesoscopic scales, such as interactions
between cells that are driven by intracellular processes, interactions between cells and
extracellular matrix, interactions between cells and gradients of external stimuli (pro-
teolytic enzymes, oxygen, glucose, etc). Generally, individual cell-based models are
classified into lattice-based and off-lattice models. In the lattice-based modelling, each
biological cell is represented as either a single lattice site or a set of many contiguous
sites on a lattice through spatial discretisation. Models that fall into the category of
lattice-based modelling generally use approaches that include cellular automata mod-
els, some hybrid discrete-continuum or HDC (combination between continuum and
discrete cellular automata like) models, Glazier-Graner-Hogeweg or GGH models, and
the invariants and extensions of these models. On the other hand, in the off-lattice
modelling each biological cell is often treated as a unit of finite volume with arbitrary
locations whose motion is not restricted to lattice points and has shapes that are re-
stricted to spheres, ellipsoids, or Delaunay-decomposition-based shapes (or Voronoi
polygons or Thiessen polygons) (Galle et al., 2005; Kim et al., 2007). For off-lattice
modelling there are many approaches that have been developed, such as by Galle et al.
(2005); Kim et al. (2007); Ramis-Conde et al. (2008, 2009), models in Sections III and
IV of the book Anderson et al. (2007). Agent-based models by Athale et al. (2005);
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Athale and Deisboeck (2006); Zhang et al. (2007, 2009) belong to lattice-based cat-
egory, while other agent-based models (Bearer et al., 2009; Frieboes et al., 2010) are
categorised into off-lattice models. Here we only review selected articles related to the
multiscale modelling of cancer. The reader may refer to Drasdo (2003); Lowengrub
et al. (2010); Rejniak and Anderson (2010) for comprehensive reviews on these two
main types of individual cell-based models. van Leeuwen et al. (2007), in particular,
review a range of mathematical models of colorectal cancer (CRC) that provide insight
into different aspects of its development for potential multiscale modelling that could
advance our understanding of CRC. A review by Bellomo et al. (2003) provides a sur-
vey of mathematical models and methods dealing with the analysis and simulation of
tumour dynamics in competition with the immune system.
Cellular automata (CA) models have been proposed to describe avascular and vas-
cular growth of tumour invasion and angiogenesis. For more extensive reviews of CA
modelling of tumour growth in particular see Moreira and Deutsch (2002). Cellular
automata for multiscale modelling of tumour growth and invasion has been used to a
large extent, for example, in models by Alarco´n et al. (2004, 2005); Betteridge et al.
(2006); Byrne et al. (2006b,a); Deroulers et al. (2009). In their model Alarco´n et al.
(2004) couple cell growth to the (complex) environmental conditions and intracellular
processes. They used a hybrid cellular automaton as a basic theoretical framework to
combine and couple models from the tissue scale, such as vascular structural adap-
tation, to the intracellular scale, such as the cell cycle. Intercellular processes are
represented by ordinary differential equations, extracellular processes by partial dif-
ferential equations and cell processes by rules in a cellular automaton, as developed
earlier (Alarco´n et al., 2003). Their model predicts that inhomogeneity in the envi-
ronmental conditions may restrict the ability of malignant colonies to grow and invade
healthy tissue. Using the same methodology, in their other models more intracellular
processes (cell-cycle, VEGF production, and apoptosis) and tissue level phenomena
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(vascular structural, adaptation, and blood flow) were coupled into the model to inves-
tigate the effects of nutrient heterogeneity, growth and invasion of cancerous tissue,
and emergent growth laws (Alarco´n et al., 2005; Byrne et al., 2006b,a). In Betteridge
et al. (2006) the CA model incorporates cell movement, over-crowding, and dynamics
for haematocrit distribution. Computational simulations of all these CA models were
confined to 2-dimensional space.
The use of a lattice-based HDC technique for multiscale modelling of tumour
growth and progression has developed over the years. The technique used in mul-
tiscale models by Anderson (2005); Ayati et al. (2006); Anderson (2007); Anderson
et al. (2009) couples continuum equations that model the dynamics of diffusible ex-
ternal stimuli or chemical substances (such as glucose, matrix degrading enzymes,
oxygen concentration, etc) or non-diffusible substrates (such as extracellular matrix)
with a discrete cellular automaton-like model based on a biased random-walk tech-
nique that models discrete cell migration and interactions. These models use finite
difference approximations to discretise cell density (of a partial differential equation)
and then generate the probability of movement, based on a biased random-walk model
(Anderson, 2003). Anderson (2005) studies the importance of cell adhesion in cancer
invasion. However, we note that the model does not explicitly describe components of
adhesion (intracellular components for cell-cell adhesion and extracellular components
for cell-matrix adhesion) that significantly affect cellular phenotype.
Gerlee and Anderson (2007, 2008); Anderson et al. (2009) extend the HDC tech-
nique by modelling the regulatory pathways of each cancer cell with an artificial neu-
ral network, which they call an evolutionary hybrid cellular automata (EHCA) model.
Each cell is equipped with a genotype that determines the cell phenotype, that is they
provide each cell with a micro-environment response network that determines the be-
haviour of the cell based on the local environment. The network is modelled using a
feed-forward artificial neural network, that takes environmental variables as an input
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and from these determines the cellular behaviour as the output. The response network
is inherited by the daughter cells under mutations. Using this approach Gerlee and
Anderson (2007) model the impact of the tissue oxygen concentration on the growth
and evolutionary dynamics of the tumour and Gerlee and Anderson (2008) investigate
the influence of the tissue oxygen concentration and extracellular matrix density on the
growth dynamics of the tumour. Another variation of the cellular automata technique
that has been used for the modelling of tumour growth and invasion is the lattice-
gas cellular automata Dormann and Deutsch (2002); Ghaemi and Shahrokhi (2006);
Hatzikirou et al. (2010); de Franciscis et al. (2011).
Agent-based models are also widely used in multiscale cancer modelling. Athale
et al. (2005) develop a model to simulate the cellular decision-process for either the
proliferating or migrating phenotype based on a molecular interaction network of genes
and proteins. The model is based on a 2-dimensional spatial cellular automaton model
where each cell can only occupy one lattice site or grid point at a time. The network of
genes and proteins is modelled using ordinary differential equations. The same mod-
elling methodology is also used in Athale and Deisboeck (2006) to study the effects of
epidermal growth factor receptor (EGFR) density on tumour growth dynamics, both at
the sub- and the multi-cellular level.
Zhang et al. (2007) present a 3-dimensional multiscale agent-based model to simu-
late the cellular decision process to either proliferate or migrate in the context of brain
tumours. Each agent on cell is equipped with an EGFR gene-protein interaction net-
work module that is also connected to a simplified cell-cycle description. The same
cell modelling technique used in Athale et al. (2005) is adopted and each 3-dimensional
fixed grid point can be occupied by only one cell at each time step. The results show
that proliferative and migratory cell populations directly impact the spatio-temporal
expansion patterns of the cancer. This was later refined by Zhang et al. (2009) to
incorporate mutations representing a simplified tumour progression pathway.
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Another lattice-based modelling technique that is also one of the subjects of our
research is the GGH model, which is an extension of the large-q Potts model. The
large-q Potts model itself is an extension of the Ising model, a simple early model of
ferromagnetism based on the magnetic moments, or spins, of individual atoms and
their interaction energies. Spins interact via an energy minimisation function called a
Hamiltonian (Balter et al., 2007; Glazier et al., 2007). The GGH model is also known
as the Cellular Potts Model or CPM and was initially used to simulate the sorting of
a mixture of two cell types based on differential adhesion (Graner and Glazier, 1992;
Glazier and Graner, 1993). The technique gained popularity and has been widely used
in modelling systems based on individual cells. Glazier and co-workers implemented
the GGH model into a simulation environment called CompuCell3D or CC3D, which
is what we are using for our multiscale modelling in Chapter 6. CC3D implementations
are described using combination of CompuCell3D Markup Language (CC3DML) and
Python scripting. Such a combined approach allows us to build complex biomedical
models because CC3D contains description of objects (cells, ECM, diffusible external
stimulus), interactions (cell-cell adhesion, morphogen-dependent cell mitosis), initial
conditions (initial configuration of cells based on time-lapse microscopy image), and
the description of the time evolution of cell properties (concentration dynamics of in-
tracellular component of cells driving adhesive cell properties or rule-based cell type
differentiation). Each biological cell is represented by many lattice sites and the system
evolves in time through the Hamiltonian. For computational simulations we implement
the model in 3-dimensional space where one cell may contain between 300 to 400 cu-
bic lattice sites. The open source software CC3D is developed by collaborators at the
Biocomplexity Institute, Indiana University, Bloomington, Indiana, USA and it can be
downloaded from the CC3D website (http://www.compucell3d.org).
It is our aim to broaden the use of the GGH model implemented in the CC3D
30
simulation environment for multiscale modelling of cancer by incorporating the in-
tracellular programming library Bionetsolver developed by our collaborators at the
Computational Systems Biology/Sauro Lab, University of Washington, Seattle, Wash-
ington, USA. Bionetsolver is a C++ library with a high-level Python API. It makes
use of the SBML ODE Solver Library (SOSlib) to implement reaction-kinetic net-
work dynamics which can regulate the cell dynamics generated by the Hamiltonian.
Further details about Bionetsolver and the implementation with CC3D into multiscale
modelling is discussed in Chapter 6 of this thesis.
Jiang et al. (2005) use the extended large-q Potts model for their multiscale model
of avascular tumour growth that spans three scales, subcellular, cellular, and extra-
cellular level. They use a Boolean network for regulation of the expression of pro-
teins that control the cell cycle at the subcellular scale, a discrete lattice Monte Carlo
model for modelling cell growth, proliferation, death, and intracellular adhesion at
the cellular scale, and reaction-diffusion equations for modelling chemical dynamics
(nutrient, waste, growth promoter, and inhibitor concentrations) at the extracellular
scale. Rubenstein and Kaufman (2008) also employ the large-q Potts model for their
multiscale modelling of glioma invasion. The Potts model is used to model glioma
invasiveness from cell-cell adhesion and cell-matrix adhesion
It is also necessary to briefly review some off-lattice models that are used in multi-
scale modelling of cancer, particularly the model by Ramis-Conde et al. (2008), since
we are using it as our centre-based model for modelling cancer invasion driven by ki-
netics of intracellular components, discussed in Chapter 6. Ramis-Conde et al. (2008)
develop a pathway describing the interactions between E-cadherin, a family of cell
surface glycoproteins responsible for regulation cell-cell adhesion, and β -catenin, an
intracellular protein that is associated with E-cadherin. The pathway inside each in-
dividual cell is translated into a set of ordinary differential equations that model the
intracellular dynamics of E-cadherin and β -catenin depending on signalling, either for
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attachment or detachment. The dynamics or movement of the cells is described by
a stochastic equation of motion and each cell behaves as an elastic sphere. Cell-cell
interaction is approximated through cell-cell contact areas using the radii of neigh-
bouring cells and the distance between their centre. The technique used is similar to
that in Galle et al. (2005). The computational simulation results of this model are in
a good agreement with experiments by Brabletz et al. (2001) that show higher con-
centration of nuclear β -catenin in cells at the outer layer of the tumour mass due to
fewer binding neighbours as compared with the concentration of nuclear β -catenin in
cells inside the tumour mass. The same authors also developed a multiscale model of
cancer cell intravasation (Ramis-Conde et al., 2009) to study the influence of different
protein pathways in forming transendothelial migration (TEM), which is the disruption
of the VE-cadherin-mediated bonds between the endothelial cells forming the last cell
layer that a cancer cell needs to cross to reach the vasculature, blood or lymph ves-
sel. Aside from the same methods used for intracellular pathway and cell movement
in their previous work, the model in Ramis-Conde et al. (2009) uses a mathematical
force-based multiscale model for the biophysical properties of the cells and simplified
protein pathways involved in TEM.
Kim et al. (2007) have developed an off-lattice individual cell-based model com-
bined with a continuum model for multicellular tumour spheroid growth. They used
the technique developed by Dallon and Othmer (1997) where the cells are modelled
as deformable ellipses and the movement is modelled using an equation of motion.
The continuum model is used to describe nutrients (oxygen and glucose) and the me-
chanical response of the gel outside the tumour, and for the quiescent and necrotic
regions of the tumour. Agent-based off-lattice modelling is used to study nonlinear
tumour growth in 3-dimensional space (Frieboes et al., 2010) and to study how tumour
growth and invasion are governed by biophysical laws and regulated by heterogeneity
in phenotypic, genotypic, and microenvironmental parameters (Bearer et al., 2009). In
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these models the discrete cells are assumed to have zero size. In order for two cells
not occupy the same position in space, a circular random walk model that incorporates
chemotaxis, haptotaxis and volume exclusion is used.
In this chapter we have presented a review of the main models that have been de-
veloped to study cancer invasion. The list of papers is very long, and it is still growing,
particularly with advances of computer power enabling to reduce computational cost
as the numerical complexity and number of cells increase. Each approach has their
own advantage and limitation. Nevertheless they all enrich the field of cancer biology
modelling with the ultimate goal to be able to first of all replicate observations from in
vivo and/or in vitro experiments, and then eventually to contribute to cancer treatment
strategies.
Chapter 4
A Mathematical Model of Cancer
Invasion of Tissue Involving the uPA
System
4.1 Introduction
One of the first steps of invasion is the remodelling of the surrounding tissues or ex-
tracellular matrix or ECM and a major part of this process is the over-expression of
proteolytic enzymes, such as the urokinase-type plasminogen activator (uPA) and ma-
trix metalloproteinases (MMPs), by the cancer cells to break down matrix proteins.
Degradation of the matrix enables the cancer cells to migrate through the tissue and
subsequently to spread to distant anatomical sites in the body, a process known as
metastasis.
In order to understand the process of invasion of surrounding tissues by cancer
cells, we begin with an invasion model that describes the interactions between cancer
cells, the proteolytic enzymes and the host tissue. Because the phenomena that occur
in this model are typical of continuum systems, where the proteolytic enzymes are
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diffusible chemical substance and the movement of cancer cells can also be described
by random motility or diffusion, macroscopic scale modelling or continuum approach
is appropriate for this purpose.
In this chapter, we undertake an analysis of a mathematical model of cancer cell
invasion of tissue which focuses on the role of the urokinase plasminogen activation
(uPA) system for matrix degradation. We focus on the model that was first developed
by Chaplain and Lolas (2005) and discuss its role in tissue invasion, tumour hetero-
geneity and its biological and clinical implications.
In the model under consideration, the interactions of cancer cells and l chemicals
are described by a system of l+1 reaction-diffusion-taxis equations of the form
∂c
∂ t
= Dc∇2c−∇ ·
(
c
l
∑
j=1
p j(c,n)∇n j
)
+ f (c,n) , (4.1a)
(t,x) ∈ (0,T ]×Ω
∂n
∂ t
= D∇2n+g(c,n) , (4.1b)
where we denote the time (t) and space (x) dependent concentrations of the chemical
species by the vector valued function n(t,x) and the density of the cancer cells by
c(t,x),
c : [0,T ]× Ω¯→ R and n : [0,T ]× Ω¯→ Rl.
Here, Ω⊂ Rd , d = 1 or d = 2, is a bounded domain and [0,T ] is the time interval
of interest. Furthermore, the cancer cell random motility coefficient Dc ≥ 0 and the
diagonal matrix D ≥ 0 of chemical diffusion coefficients, the taxis functions p j, j =
1, . . . , l, associated with each chemical n j, as well as the reaction terms f and g are
given. The temporal derivative is denoted by
∂
∂ t
, the spatial gradient operator by ∇,
and the Laplace operator by ∇2. The partial differential equation (PDE) system (4.1)
is supplied with appropriate initial and boundary conditions.
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4.2 Cancer Invasion: the uPA System and its Role in
ECM Proteolysis
The prognosis of a cancer is primarily dependent on its ability to invade and metas-
tasise, and a crucial component of these processes is the degradation of extracellular
matrix. A major constituent of matrix are proteins and their directed degradation by
cellular enzymes (proteolytic enzymes or proteases for short) is called proteolysis.
Many steps that occur during tumour invasion and the formation of metastases (as
well as in a number of distinct physiological events in the healthy organism) require
the regulated turnover of matrix macromolecules. It is now widely believed that the
breakdown of these barriers is catalysed by proteases released from the invading cancer
cells. Most of these proteases belong to one of two general classes: matrix metallo-
proteases (MMPs) (Parsons et al., 1997; Pepper, 2001) or serine proteases (Andreasen
et al., 1997, 2000). Proteases give cancers their defining deadly characteristic—the
ability of malignant cells to break out of tissue compartments.
The enzymatic system we will focus on in this chapter is the urokinase plasminogen
activation system (uPA system) which consists of:
uPA, the urokinase plasminogen activator,
uPAR, the urokinase plasminogen activator receptor,
plasmin, the matrix degrading enzyme,
VN, the ECM protein vitronectin, and
PAI-1, the plasminogen activator inhibitor type-1.
A schematic diagram of the key interactions of the system is given in Fig. 4.1.
uPA is an extracellular serine protease. Cells secrete its enzymatically inactive
form pro-uPA into the extracellular space. pro-uPA is activated by plasmin to its ac-
tive form uPA. In the model below, we do not distinguish between pro-uPA and uPA,
which both bind to uPA receptors (uPAR) located on the cell membrane. Two major
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Figure 4.1: A schematic diagram of the uPA system showing its main components and their
interactions.
functional domains make up the uPA molecule: the protease domain and the growth
factor domain (not discussed here). The protease moiety in uPAR-bound uPA activates
the pro-enzyme plasminogen to its active form plasmin. Plasminogen is a ubiquitous
protein produced mainly in the liver and present in blood and the matrix. Plasmin it-
self is a broadly acting serine protease that, either directly or through the activation
of other proteases, catalyses the breakdown of many of the known extracellular ma-
trix and basement membrane molecules, such as vitronectin (VN), fibronectin, fibrin,
laminin, thrombospondin, and collagens. Therefore, to maintain tissue homeostasis
and to avoid unrestrained tissue damage, the process of plasminogen activation in a
healthy organism is strictly controlled through the availability of uPA, localised acti-
vation, and interaction with specific inhibitors (PAIs). One of these inhibitors, PAI-1,
is believed to be the most abundant fast-acting inhibitor of uPA in vivo (Andreasen
et al., 1997, 2000). In other words, for cells to protect themselves they must secrete a
surplus of inhibitors to guarantee restraint of pericellular proteolysis. Indeed secreted
uPA is often associated with PAI-1 and remains inactive. PAI-1 has a high affinity to
the matrix constituent VN and VN-bound PAI-1 remains in an active conformation for
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prolonged periods of time.
These facts suggest that the five molecules uPA, PAI-1, plasmin, uPAR and VN
constitute the core of an integrated dynamical system which allows spatial and tem-
poral rearrangements of its components at cell surfaces during cell migration and in-
vasion. Moreover, it has become clear that this system has a multi-functional role in
cancer biology. The system seems to function not only in cancer cell migration and
invasion, but also in remodelling of the tissue surrounding the cancer cells, which may
contribute decisively to the overall process of metastasis.
4.3 Mathematical Model
In this section we present the mathematical model of the uPA system and cancer cell
invasion of tissue. The model explicitly considers the production of plasmin and the
interactions between cancer cells (with uPAR located on their surface), uPA, PAI-1,
plasmin, and the extracellular matrix component VN. In the model we assume an un-
restricted supply of plasminogen. Furthermore, we assume a fixed average number
of uPARs located on each cancer cells surface. This implies that the concentration of
uPAR is proportional to the cancer cell density and we do not explicitly model the evo-
lution of uPAR. We denote the cancer cell density by c(t,x), the uPA concentration by
u(t,x), the PAI-1 concentration by p(t,x), the plasmin concentration by m(t,x), and
the VN concentration by v(t,x). We briefly describe the main interactions between all
the variables before writing the system of equations. A fuller description may be found
in Chaplain and Lolas (2005).
Cancer Cells The dominating factors governing cancer cell migration are ran-
dom motion, chemotaxis due to uPA and PAI-1 as well as haptotaxis due to VN and
other matrix components. Besides migration, cancer cell proliferation is also included
in the model in the form of a logistic growth law.
Extracellular Matrix It is known that extracellular matrix does not diffuse
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and therefore we omit any diffusion term (or other “migration” terms) from its model
equation. Furthermore, based on the experimental evidence that uPA activates plas-
minogen to its cancer cell-surface associated form plasmin, which in turn catalyses
the breakdown of VN (and other matrix molecules), we model the fact that plasmin
degrades VN upon contact at a (degradation) rate δ . The inhibitor PAI-1 also binds
to VN and in this way inhibits VN from binding to cell-surface receptors (such as
uPAR and/or integrins) and promoting its own production through the regulation of
cell-matrix-associated signal transduction pathways. This effect is accounted for by
the degradation term −φ22vp. Furthermore, it is assumed that the latter process is re-
versed by PAI-1 binding to uPA and the production term φ21up is added to the model.
Finally, a logistic growth term accounts for the remodelling of the extracellular ma-
trix by the cells present in the tissue such as fibroblasts. We assume the secretion of
extracellular matrix components by fibroblasts to be spatially limited, and therefore a
logistic growth term is considered to be appropriate to model this process.
Urokinase Plasminogen Activator The spatio-temporal evolution of the con-
centration of uPA is assumed to occur through diffusion, cancer cells acting as sources,
while its binding to PAI-1 and uPAR dominates its removal from the system.
Plasminogen Activator Inhibitor-1 The conservation equation for the con-
centration of PAI-1 is similar to that of uPA. Thus, we assume it diffuses, with its
production being a result of plasmin activation and its neutralisation in the system oc-
curs by its binding to VN and to uPA.
Plasmin In examining spatio-temporal evolution of the plasmin concentration,
we assume that it also diffuses. Furthermore, we assume that binding of uPA to uPAR
provides the cell surface with a potential proteolytic activity via activation and cell-
surface co-localisation of plasminogen and thus leads to plasmin formation. Addi-
tionally, the binding of PAI-1 to VN indirectly results in the binding of uPA to uPAR
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and therefore in enhanced plasmin formation. Finally, the term −φ54m models the de-
activation of plasmin either by degradation or by the action of the plasmin inhibitor
α2-antiplasmin.
The mathematical model depicting the interactions between all variables described
above, in its full dimensional form, is given by
∂c
∂ t
= D1∇2c︸ ︷︷ ︸
random motility
−∇ ·
[
ξuc∇u︸ ︷︷ ︸
uPA-chemo
+ ξpc∇p︸ ︷︷ ︸
PAI-1-chemo
+ ξcc∇v︸ ︷︷ ︸
VN-hapto
]
+σ1c(1− cc0 )︸ ︷︷ ︸
proliferation
, (4.2a)
∂v
∂ t
= − βvm︸︷︷︸
degradation
+ Φ21up︸ ︷︷ ︸
uPA/PAI-1
− Φ22vp︸ ︷︷ ︸
PAI-1/VN
+σ2v(1− vv0 )︸ ︷︷ ︸
remodelling
, (4.2b)
∂u
∂ t
= D3∇2u︸ ︷︷ ︸
diffusion
− Φ31 pu︸ ︷︷ ︸
uPA/PAI-1
− Φ33cu︸ ︷︷ ︸
uPA/uPAR
+ γ31c︸︷︷︸
production
, (4.2c)
∂ p
∂ t
= D4∇2 p︸ ︷︷ ︸
diffusion
− Φ41 pu︸ ︷︷ ︸
PAI-1/uPA
− Φ42 pv︸ ︷︷ ︸
PAI-1/VN
+ γ41m︸︷︷︸
production
, (4.2d)
∂m
∂ t
= D5∇2m︸ ︷︷ ︸
diffusion
+ Φ52 pv︸ ︷︷ ︸
PAI-1/VN
+ Φ53uc︸ ︷︷ ︸
uPA/uPAR
− Φ54m︸ ︷︷ ︸
degradation
. (4.2e)
These model equations coincide with those given in Chaplain and Lolas (2005)
(Equation (9)), except for some minor details. In this thesis we replace the degrada-
tion of plasmin term due to binding of uPA and PAI-1 in Chaplain and Lolas (2005)
(−Φ51 pu) with a natural degradation term −Φ54m. To nondimensionalise the system,
we rescale distance with the maximum distance of the cancer cells at this early stage of
invasion L := 0.1cm and time with τ := L2 D−1, where D := 10−6cm2 s−1 is a repre-
sentative chemical diffusion coefficient. The dependent variables v,u, p,m are rescaled
with appropriate reference concentration values v0,u0, p0,m0 in the nanomolar range,
1nM ≡ 10−9mol/l taken from Chaplain and Lolas (2005), while the reference cancer
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cell density n0 is taken from Gerisch and Chaplain (2008). The full set of scaling
parameters is given by
L = 0.1cm , τ =
L2
D
= 104s , c0 = 6.7×107cell cm−3 , v0 = 1nM ,
u0 = 1nM , p0 = 1nM , m0 = 0.1nM ,
from which the nondimensional variables are obtained,
x˜ =
x
L
, t˜ =
t
τ
or t˜ =
tD
L2
, c˜ =
c
c0
, v˜ =
v
v0
,
u˜ =
u
u0
, p˜ =
p
p0
, m˜ =
m
m0
,
as well as nondimensional parameters,
Dc =
D1
D
, χu = ξu
u0
D
, χp = ξp
p0
D
, χv = ξv
v0
D
, µ1 = σ1τ ,
δ = β
m0τ
v0
, φ21 =Φ21
u0 p0
v0
τ , φ22 =Φ21 p0τ , µ2 = σ2τ ,
Du =
D3
D
, φ31 =Φ31 p0τ , φ33 =Φ33c0τ , α31 = γ31
c0
u0
τ ,
Dp =
D4
D
, φ41 =Φ41u0τ , φ42 =Φ42v0τ , α41 = γ41
m0
p0
τ ,
Dm =
D5
D
, φ52 =Φ52
v0 p0
m0
τ , φ53 =Φ53
u0c0
m0
τ , φ54 =Φ54τ .
Inserting the nondimensional variables and parameters above into the system (4.2)
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we obtain the nondimensionalised form of the system of PDEs given by
∂c
∂ t
= Dc∇2c︸ ︷︷ ︸
random motility
−∇ ·
[
χuc∇u︸ ︷︷ ︸
uPA-chemo
+ χpc∇p︸ ︷︷ ︸
PAI-1-chemo
+ χcc∇v︸ ︷︷ ︸
VN-hapto
]
+µ1c(1− c)︸ ︷︷ ︸
proliferation
,(4.3a)
∂v
∂ t
= − δvm︸︷︷︸
degradation
+ φ21up︸ ︷︷ ︸
uPA/PAI-1
− φ22vp︸ ︷︷ ︸
PAI-1/VN
+µ2v(1− v)︸ ︷︷ ︸
remodelling
, (4.3b)
∂u
∂ t
= Du∇2u︸ ︷︷ ︸
diffusion
− φ31 pu︸ ︷︷ ︸
uPA/PAI-1
− φ33cu︸ ︷︷ ︸
uPA/uPAR
+ α31c︸︷︷︸
production
, (4.3c)
∂ p
∂ t
= Dp∇2 p︸ ︷︷ ︸
diffusion
− φ41 pu︸ ︷︷ ︸
PAI-1/uPA
− φ42 pv︸ ︷︷ ︸
PAI-1/VN
+ α41m︸ ︷︷ ︸
production
, (4.3d)
∂m
∂ t
= Dm∇2m︸ ︷︷ ︸
diffusion
+ φ52 pv︸ ︷︷ ︸
PAI-1/VN
+ φ53uc︸ ︷︷ ︸
uPA/uPAR
− φ54m︸︷︷︸
degradation
. (4.3e)
In this work we consider a default set of model parameters referred to as parameter
setP . The majority of the values of the parameters are taken from Chaplain and Lolas
(2005), except for the values of the new parameter φ54, and also for parameters µ1 and
µ2 which are cell proliferation and matrix remodelling terms, respectively. We consider
here the rate of matrix remodelling slower than cell proliferation (Perentes et al., 2009).
The values of the nondimensional parameter setP are given in Table 4.1.
Table 4.1: Parameter setP for the uPA model
Dc = 3.5 ·10−4 Du = 2.5 ·10−3 Dp = 3.5 ·10−3 Dm = 4.91 ·10−3
χu = 3.05 ·10−2 χp = 3.75 ·10−2 χv = 2.85 ·10−2 µ1 = 0.25
δ = 8.15 φ21 = 0.75 φ22 = 0.55 µ2 = 0.15
φ31 = 0.75 φ33 = 0.3 α31 = 0.215
φ41 = 0.75 φ42 = 0.55 α41 = 0.5
φ52 = 0.11 φ53 = 0.75 φ54 = 0.5
The above dimensionless parameters are taken from Chaplain and Lolas (2005).
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The dimensional values of the parameters can be recovered using the scalings detailed
above e.g. Dc (dimensional) = 3.5× 10−4× 10−6cm2s−1 = 3.5× 10−10cm2s−1. In
particular for the diffusion coefficient of the cancer cells, although based on in vivo
measurements of human colon adenocarcinomas diffusion coefficients range between
the order of 10−7 to 10−8cm2s−1 (Brown et al., 2004), we choose a small diffusion
coefficient because here our focus is on the motility of cancer cells due to chemo-
taxis by the components of the urokinase plasminogen activation system. Also, as will
be revealed in the computational simulation results in Section 4.5, smaller diffusion
coefficients give rise to heterogeneity of the solutions.
We consider system (4.3) to hold for times t ∈ (0,T ] and on a bounded spatial
domain Ω ⊂ Rd , for d = 1 or d = 2, representing a region of tissue. We use two
different cases of domains, each parameterised by a positive parameter M: the one-
dimensional domain Ω1 := (−M,M) ⊂ R and the two-dimensional square domain
Ω2 := (−M,M)× (−M,M) ⊂ R2. For reasons of symmetry, in our computational
simulations in Sect. 4.5 we take Ω1 := (0,M) ⊂ R for the one-dimensional domain
and Ω2 := (0,M)× (0,M)⊂ R2 for the two-dimensional square domain.
System (4.3) must be closed by appropriate initial and boundary conditions for
each of the dependent variables. For the two cases of domains we use different initial
conditions for cancer cell density and matrix/VN concentration. For the 1-dimensional
domain case we assume that initially there is a cluster of cancer cells already present at
x= 0 and that they have penetrated a short distance into the extracellular matrix, while
the remaining space is occupied by the matrix alone. Additionally, we assume that
the uPA protease as well as the PAI-1 inhibitor initial concentration are proportional
to the initial cancer cell density while the plasmin protease is not yet produced by
the cancer cells. Specifically, the initial conditions for system (4.3) in 1-dimensional
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spatial domain are taken to be
c(0,x) = exp(−|x|2 ε−1) ,
v(0,x) = 1− 1
2
exp(−|x|2 ε−1) ,
u(0,x) =
1
2
exp(−|x|2 ε−1) ,
p(0,x) =
1
20
exp(−|x|2 ε−1) ,
m(0,x) = 0 ,
for x ∈ Ω¯1 , (4.4)
where throughout this chapter we have taken ε = 0.01.
For the 2-dimensional square domain case, the cancer cells are initially placed to
form a strip along the top of the domain. The strip of cancer cells takes about 20% of
the domain and is at a uniform initial density of 1, while the matrix/VN concentration
uniformly occupies the rest of 80% of the domain also at initial concentration 1. The
uPA, PAI-1, and plasmin at t = 0 follow those in Eq. 4.4, i.e.,
u(0,x) = 0.5c(0,x) ,
p(0,x) = 0.05c(0,x) ,
m(0,x) = 0 .
for x ∈ Ω¯2 , (4.5)
We assume that cancer cells, and as a consequence uPA, PAI-1 and plasmin, remain
within the domain of tissue under consideration and therefore zero-flux boundary con-
ditions are imposed on ∂Ω, the boundary of Ω. For the matrix density, v(t,x) satisfies
an ordinary differential equation (ODE) and so no boundary conditions can be pre-
scribed.
4.4 Linear Stability Analysis
4.4.1 Positive, Spatially Uniform Steady States
We first write the solution components of the model (4.3) as a vector w(t,x)
w(t,x) := (c(t,x),v(t,x),u(t,x), p(t,x),m(t,x)) .
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We are interested in the existence of spatially uniform steady states w∗=(c∗,v∗,u∗, p∗,m∗)
of the system (4.3), where the values can be derived by setting the spatial and temporal
variations to zero
∂w
∂ t
=
∂w
∂x
= 0
to get
0 = µ1c∗(1− c∗) (4.6a)
0 = −δv∗m∗+φ21u∗p∗−φ22v∗p∗+µ2v∗(1− v∗) (4.6b)
0 = −φ31 p∗u∗−φ33c∗u∗+α31c∗ (4.6c)
0 = −φ41 p∗u∗−φ42 p∗v∗+α41m∗ (4.6d)
0 = φ52 p∗v∗+φ53u∗c∗−φ54m∗ (4.6e)
From Eq. 4.6a we infer that c∗ = 0 or c∗ = 1. The first case leads to non-positive
steady states and is not discussed. So in the following we investigate the case c∗ = 1.
Solving the steady state conditions for Eqs. (4.6c) to (4.6e) for u∗,m∗,v∗ results in
expressions for u∗,m∗,v∗ in terms of p∗. First, from solving Eq. 4.6c we get
u∗(p∗) =
α31
φ31 p∗+φ33
. (4.7)
Rearranging Eq. 4.6e into
p∗v∗ =
φ54
φ52
m∗− φ53
φ52
u∗ ,
and substituting it into Eq. 4.6d yields
m∗(p∗) =
(−φ41φ52 p∗+φ53φ42)u∗(p∗)
φ42φ54−α41φ52 . (4.8)
Further, substituting Eq. 4.8 into (4.6d) gives
v∗(p∗) =
(−φ41φ54 p∗+φ53α41)u∗(p∗)
p∗(φ42φ54−α41φ52) . (4.9)
Inserting the expressions (4.7), (4.8), and (4.9) into the steady state condition for
Eq. 4.6b results in a rational equation for p∗. Its denominator
p∗2(p∗φ31+φ33)2(φ42φ54−α41φ52)2 ,
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a polynomial of degree four, has no zeros p∗> 0. Its numerator, also of degree four, has
four different zeros. This leads to potentially four positive steady states w∗. However,
in all our tests we always have observed the existence of a unique positive, spatially
uniform steady state w∗ for a specific set of parameters. In the case of the parameter
setP as given in Table 4.1, the one positive and unique steady state w∗ is given by
w∗ := (c∗,v∗,u∗, p∗,m∗)≈ (1, 0.047, 0.222, 0.889, 0.343) . (4.10)
(Indeed, we note that for all parameter sets used in this chapter, it was verified using
both Mathematica and Maple that a unique positive steady state existed.) This steady
state is linearly stable which can be seen by evaluating the Jacobian matrix JR(w) of
the reaction terms, given by
JR(w) =

µ1(1−2c) 0 0 0 0
0 −δm−φ22 p+µ2(1−2v) φ21 p φ21u−φ22v −δv
−φ33u+α31 0 −φ31 p−φ33c −φ31u 0
0 −φ42 p −φ41 p −φ41u−φ42v α41
φ53u φ52 p φ53c φ52v −φ54

(4.11)
at w∗ and observing that its eigenvalues have a maximum real part of ≈−0.24.
4.4.2 Dispersion Curves and Taxis-driven Instability
Here we investigate the linear stability of system (4.3) in the vicinity of a spatially
uniform steady state w∗. To this end, we write the solutions w(t,x) of this system as
small perturbations of w∗,
w(t,x) := w∗+ εw˜(t,x) ,
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where ε > 0 is small and w˜(t,x) is bounded. We consider the PDE systems for x ∈
(−M,M)d with periodic boundary conditions and assume that the perturbations can be
written as d-dimensional Fourier series for all t ≥ 0, that is
w˜(t,x) = ∑
k∈Zd
ak(t)exp(ikpiM−1 ·x)
with coefficient functions ak : [0,T ]→ C5 for each k ∈ Zd . In the following we use
the notation k˜ ≡ kpiM−1. This allows for the visualisation of dispersion relations in-
dependent of the domain size parameter M.
Linearising system (4.3) around a spatially uniform steady state w∗ leads, upon
dropping terms of order ε2 or higher and dividing by ε , to
∂ w˜
∂ t
= JT (w∗)∇2w˜+ JR(w∗)w˜ . (4.12)
Here, the reaction Jacobian JR(w∗) is given by (4.11). Furthermore, the transport
Jacobian JT (w∗), accounting for diffusion and taxis, is
JT (w∗) =

Dc −χvc∗ −χuc∗ −χpc∗ 0
0 0 0 0 0
0 0 Du 0 0
0 0 0 Dp 0
0 0 0 0 Dm

. (4.13)
We arrive at these entries by observing, for the first row, that
Dc∇2c = Dc∇2(c∗+ ε c˜) = εDc∇2c˜
and accordingly for the diffusion terms in rows three, four, and five. The linearisation
of the taxis terms is as
−∇ · (χuc∇v) = −∇ · (χu(c∗+ ε c˜)∇(v∗+ ε v˜))
= −εχvc∗∇2v˜− ε2χv∇ · (c˜∇v˜)
47
which, upon dropping the ε2-term and dividing by ε leads to the entry in column 2 in
the first row of JT (w∗). The remaining entries in that first row follow accordingly.
Inserting the Fourier series representation of w˜ into (4.12) leads to
∑
k∈Zd
[
∂ak(t)
∂ t
+
(‖k˜‖22JT (w∗)− JR(w∗))ak(t)]exp(ik˜ ·x) = 0 . (4.15)
Furthermore, expanding the initial perturbation w˜(0,x) of the PDE system in a
Fourier series defines coefficients ak,0 via
w˜(0,x) = ∑
k∈Zd
ak,0 exp(ik˜ ·x) .
Both relations imply that the Fourier coefficients ak(t) satisfy the linear ODE sys-
tems
∂ak(t)
∂ t
=−(‖k˜‖22JT (w∗)− JR(w∗))ak(t) , ak(0) = ak,0 .
A growth of ak(t) then indicates a growth of the perturbation due to mode exp(ik˜ ·
x) whereas this perturbation is damped away with time if ak(t)→ 0 for t→ ∞. Which
type of behaviour takes place for a given perturbation mode is determined by the linear
stability of the zero steady state of the above ODE. In more detail, a perturbation due
to mode exp(ik˜ ·x) grows if
λk(w∗) := max{real part of the eigenvalues of JR(w∗)−‖k˜‖22JT (w∗)}> 0 .
If λk(w∗) < 0 then the perturbation is damped away. (The case λk(w∗) = 0 can be
treated as usual for linear ODE systems and leads to either growth or damping.)
We are interested in deciding whether there exist non-trivial perturbation modes
exp(ik˜ · x) which grow with time, i.e. destabilise the linearly stable fixed point w∗ of
the reaction system. To this end, we plot for the 1D case (d = 1, k˜ = k˜) and a given
spatially uniform steady state w∗ the quantity λk(w∗) against the (domain size scaled)
wave number k˜. This gives the so-called dispersion relation. For the parameter setP
and the variations of it, these dispersion relations for system (4.3) are given in Fig. 4.2.
For parameter setP (see the solid line in Fig. 4.2) we observe that there is a range of
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k˜-values for which λk(w∗) is positive and hence the corresponding perturbations are
growing in time. This means that the unique positive, spatially uniform steady state
w∗, which is linearly stable for the reaction system itself, is destabilised due to the
transport terms (diffusion and taxis).
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Figure 4.2: Plots of the dispersion relations for the unique positive, spatially uniform steady
state w∗ of system (4.3) with (i) parameter setP (solid line); (ii) with parameter setP but all
taxis coefficients set to zero (dashed line), and (iii) with parameter set P but the cell random
motility coefficient increased to Dc = 0.00425 (dash-dotted line).
Furthermore, setting all taxis coefficients in parameter set P to zero, there exist
no values k˜ ∈ [0,80] for which λk(w∗) > 0 (dashed line in Fig. 4.2). This observation
implies that the destabilisation of the steady state w∗ in system (4.3) is taxis-driven.
To see the effect of varying cell random motility coefficient, increasing Dc more than
ten times higher, that is to Dc = 0.00425, decreases the range of k˜-values for positive
λk(w∗) (dash-dotted line in Fig. 4.2). The influence of varying cell random motility
towards stability of the system is explained further in Fig. 4.3.
It is of interest to see how the range of k-values, for which perturbations grow,
changes if key parameters of the model are modified. One such parameter is the ran-
dom motility of the cancer cells, Dc. We again take the parameter set P but now
vary parameter Dc in the range [0,0.01]. For each value of Dc we compute the set
of k˜-values for which λk(w∗) > 0. The grey area in Fig. 4.3, top left, visualises this
49
set (with k˜ in the range [0,80]). We observe that up to a maximum value of Dc there
are always some values k˜ with λk(w∗) > 0. For decreasing cancer cell random motil-
ity Dc, the range of such k˜-values increases. This implies that increased cell random
motility has a smoothing effect and leads to damping of, in particular, high frequency
perturbations.
Figure 4.3: Dispersion relation of system (4.3) with parameters taken from set P and (i)
Dc varying in [0,0.01] (top left), (ii) µ1 varying in [0,1] (top right), (iii) φ53 varying in [0,2]
(bottom left), and (iv) φ53 varying in [0,2] with Dc = 0.00425 (bottom right) for their respective
unique positive, spatially uniform steady states. The grey area indicates the k˜-values for which
λk(w∗)> 0.
Besides the random motility coefficient Dc of the cancer cells, there are two other
key parameters in the model: the proliferation rate µ1 of cancer cells and the rate
φ53 of plasmin production due to uPA/uPAR binding. Varying µ1 ∈ [0,1] but keeping
parameter set P otherwise unchanged, leads to the dispersion relations as shown in
Fig. 4.3, top right plot. Here we observe that increasing cell proliferation leads to less
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and less amplified modes and hence eventually to the damping of all perturbations.
Varying φ53 ∈ [0,2] and keeping all other parameters as in setP gives no stability area
for k˜ within the range [15,70], (see bottom left Fig. 4.3). If the cancer cell random
motility is increased to Dc = 0.00425 and all other parameters as in set P , this leads
to the dispersion relations as shown in Fig. 4.3, bottom right plot. It tells us that at
lower values of φ53 with Dc = 0.00425, there are no k˜-values for which λk(w∗) > 0;
all perturbations are damped. But as φ53 is increased the grey area that determines
instability starts to appear and the range of frequency perturbations becomes bigger at
higher values of φ53.
k˜
λk(w
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Figure 4.4: Plots of the dispersion relations for the system (4.3) with parameter setP taking
(i) χu = 0 (dash-dotted red line); (ii) χp = 0 (dashed black line), and (iii) χv = 0 (dashed green
line). The blue solid line represents the dispersion relation with all parameter values as in
parameter setP .
In order to see which chemotactic term drives the instability, we plot the dispersion
relation by switching off one chemotactic term (or making the chemotactic parameter
equal to zero) at a time. Fig. 4.4 shows that taking χu = 0 (dash-dotted red line) signif-
icantly reduces the range of k˜-values for positive λk(w∗), while by taking either χv = 0
(dashed green line) or χp = 0 (dashed black line) the range of k˜-values for positive
eigenvalues remains large, almost the same as using the default values of parameter
setP . From these dispersion relations we can see that chemotaxis due to uPA mostly
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causes the instability to arise in the system.
4.5 Computational Simulation Results
In this section we present computational simulation results for the model (4.3), together
with the initial conditions and zero-flux boundary conditions, given in Sect. 4.3. The
parameters are taken from parameter setP unless otherwise stated. These simulations
firstly show the typical behaviour of the model solutions and, secondly, illustrate the
theoretical results on taxis-driven instability as obtained in Sect. 4.4. The majority of
the simulations presented are in a 1-dimensional spatial domain, Sub Sect. 4.5.2. How-
ever, we also perform 2-dimensional simulations, where the results are compared with
experimental data taken from an organotypic gel culture system quantifying squamous
cell carcinoma invasion. We begin with a few comments on the numerical method
employed in obtaining the simulation results.
4.5.1 Numerical Technique
All simulation results are obtained with a custom-made code for the numerical so-
lution of reaction-diffusion-taxis systems, see Gerisch and Chaplain (2006) and the
references therein. The code is based on the method of lines. The approach makes use
of a finite volumes discretisation in space which employs, for the taxis term, a higher-
order, upwind-biased discretisation with nonlinear limiter function. This dedicated
treatment of the taxis terms ensures, in general, second-order accuracy of the spatial
discretisation and leads to a large positive ODE system, the MOL-ODE system. Here
positive means that the exact and unique solution of the ODE system with arbitrary
non-negative initial data remains non-negative for all later times. Conditions which
ensure this property of an ODE system are, for instance, given in Horva´th (1998). We
note that negative solution values are often the result of unphysical oscillations near
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steep fronts in the solution when the taxis terms of the PDE problem are discretised
in a standard way, e.g., by central finite differences. These negative values feed back
into the reaction kinetics of the system which becomes unstable and we observe a
subsequent blow-up of the numerical solution within a short time. So the approach
taken here does not lead to negative solution values in the exact solution of the MOL-
ODE and all the problems which go with them. This particularly desirable property
is achieved automatically by the spatial discretisation by locally introducing just the
amount of numerical diffusion which is required to ensure the property of positivity.
No user intervention is needed. With these measures taken, the code also allows for
reliable computations also in the case of zero cell random motility, i.e., Dc = 0. The
code has been tested with a simple diffusion equation, linear advection, and a sim-
ple 2D taxis problem with exact solution. The validation of the code is shown by the
convergence of the simulation results as is explained in subsection 4.5.2 below.
After the discretisation in space a large ODE system is obtained which needs to
be solved numerically. In particular, simulations of 2D problems lead to a very large
dimension of the MOL-ODE system and suitable numerical schemes have to be em-
ployed. Due to the stiffness of the equations, the method selected must be implicit for
computational efficiency. We have opted here for using the linearly-implicit Runge–
Kutta method ROWMAP (Weiner et al., 1997). ROWMAP is designed for the efficient
numerical solution of stiff initial value problems of large ODE systems. One of its
particular strengths is that it requires a subroutine for the evaluation of the right-hand
side of the ODE only; no explicit subroutine for the evaluation of the Jacobian matrix
is required. The linear systems in the stages of the method are then solved using a mul-
tiple Arnoldi process (Weiner et al., 1997). The automatic time-step selection based
on a local error control further increases the efficiency and reliability of the method.
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4.5.2 Computational Simulation Results in 1D
The simulations in this section are obtained with the custom-made finite volume code,
see Sect. 4.5.1. We use an equidistant covering of the spatial domain with finite vol-
umes of length 1/50 or ∆x = 0.02. For the time integration we prescribe an absolute
and relative tolerance of 10−6 (variable time step sizes). Numerical convergence tests
have shown that these choices of discretisation parameters are appropriate for the prob-
lems at hand and give sufficiently accurate solutions. We ran all simulations up to a
final time t = 500 unless indicated otherwise. This corresponds to a real time span
of about 58 days. We have performed simulations on the domain Ω = (−10,10) with
zero-flux as well as with periodic boundary conditions. The results are qualitatively
and quantitatively similar and also similar to the results obtained with Ω= (0,10) and
zero-flux boundary conditions. In particular the same conclusions can be drawn. In the
interest of a clearer presentation we show simulation results obtained with Ω= (0,10)
(and Ω= (0,15) for certain simulations) and zero-flux boundary conditions only.
Fig. 4.5 captures the dynamic heterogeneity of cancer cell density that evolves over
time by interacting with components of the uPA system. The solution profile for the
cancer cell density, which is in the form of spikes, varies in height and reaches above
3 dimensionless units of density. Initially, at t = 0, we assume a cluster of cancer
cells are already present and they have penetrated a small area in the extracellular
matrix. By t = 75 (∼ 8.5days), several clusters of cancer cells that are composed of
the primary tumour occupied half of the domain. At t = 150 (∼ 17.5days) cancer cells
have invaded the remaining of the extracellular matrix. In order to see whether the
solutions converge, we performed numerical tests by using finer grids of grid spacings
∆x = 0.005 and ∆x = 0.0025. We measured the width of the spikes of cell density at
density height 1 at t = 500 and compared the results with the width of the spikes from
simulations using the default grid spacing of ∆x= 0.02. We can confirm that the width
of the spikes remains (approximately) constant at about 0.03−0.04 length units for all
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Figure 4.5: Sequence of profiles showing the spatio-temporal evolution of cancer cells c
(solid black line) invading the extracellular matrix v (dotted black line) along with the other
components of the model: uPA protease concentration u (dash-dotted black line), PAI-1 con-
centration p (dashed black line), and plasmin concentration m (dash-dotted grey thin line) for
model (4.3) with parameter setP at dimensionless times t = 0, t = 75, t = 150, and t = 500.
grid sizes, shown in Fig. 4.6
The spatio-temporal dynamic heterogeneity of the cancer cell density over time can
also be appreciated from the plot shown in Fig. 4.7. The solutions are as expected from
the linear stability analysis carried out in the previous section and also in line with the
results obtained by Chaplain and Lolas (2005). We note that for parameter set P the
spatially uniform, positive steady state w∗ is unstable (due to the taxis, as previously
shown). The initial data given by (4.4) allow the spread of the cancer cells into the
domain in a “wave-like” manner. Of course in this case (i.e. with parameter set P)
no travelling wave exists since the underlying steady state has been destabilised. We
note that these results show a spatio-temporal pattern that is very similar to previous
simulation results obtained by Wang and Hillen (2007) in a simpler chemotaxis system
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Figure 4.6: Convergence test for the simulation results using different grid spacings taken at
time t = 500, where (i) top figure is for a simulation with grid spacing ∆x = 0.02, (ii) middle
figure with ∆x = 0.005, and (iii) bottom figure with ∆x = 0.0025. The spikes of all simulations
have width 0.03−0.04 length units.
where a volume filling term was included in a Keller-Segel model. This approach
employed a “squeezing probability” with nonzero cell kinetics that resulted in merging
and emerging local peaks. More recently, Hillen and Painter (2009) also obtained
a similar pattern of merging and emerging peaks in one of their chemotaxis models
incorporating logistic growth for the cell kinetics.
Figure 4.7: Plots showing the spatio-temporal evolution of the cancer cell density c for
model (4.3) with parameter setP .
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It is useful to compare certain features of these simulations with other simulations
where a travelling wave does exist e.g., (furthest) distance travelled into the domain at
a given point in time - see, for example, Fig. 4.8. In the case of parameter set P we
note that any initial data that can be considered a perturbation of the steady state will
evolve into the observed spatio-temporal heterogeneity.
Effect of Varying the Parameter Dc
During the growth of a solid tumour, over time the cancer cells become more malignant
through increased mutations. One important phenotypic consequence of this is that the
cancer cells become more motile. This can be reflected in the model by increasing the
parameter Dc. In Fig. 4.8, we show the solution profiles of all five solution components
of model (4.3) at the fixed time point t = 70 for four different values of Dc. As can
be seen from the figure plots, increasing the cancer cell random motility parameter
Dc leads to smoother solution profiles with less steep “wave” fronts. The increased
speed of propagation of the leading edge of the invasive front with increasing Dc is
also obvious i.e. the higher the value of Dc, the faster into the tissue the cancer cells
penetrate.
In Fig. 4.9 we show the evolution of the cancer cell density c over time. In the top
and middle plot Dc has a value of 0.014 and 0.00425, respectively, i.e., increased with
respect to its base value in parameter set P . In the bottom plot, we have set the cell
random motility to zero. Recall that the corresponding plot for Dc as given in P is
shown in Fig. 4.7.
From the top plot in Fig. 4.9, i.e., with Dc = 0.014, we observe a travelling wave
like solution converging to the homogeneous steady state of the system. Decreasing
Dc to a value of 0.00425, we observe that the solution approaches a spatially hetero-
geneous steady state. When the value of Dc = 0.00035 is used, as given in parameter
set P , see Fig. 4.7, then a strong and persistent emerging and merging behaviour is
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Figure 4.8: Plots showing the profiles of all variables obtained from numerical solutions of
model (4.3) at time t = 70 with Neumann BCs with parameter setP but varying cell random
motility coefficient Dc. Shown are the cell density c (solid black line), the matrix density v
(dotted black line), the uPA concentration u (dash-dotted black line), the PAI-1 concentration
p (dashed black line), and the plasmin concentration m (dash-dotted grey thin line). With
increasing Dc, the profiles lose heterogeneity and eventually take on a travelling-wave-like
solution.
present and no steady state is attained. This type of behaviour is even more pronounced
for the case Dc = 0, as can be seen from the bottom plot of Fig. 4.9. We also note that
the speed of propagation of the ”invading wave” decreases with decreasing Dc.
Some insight into the range of spatio-temporal behaviour described above may
be provided by the stability/instability diagrams presented in Fig. 4.3 (top left). For
smaller Dc values more and more Fourier modes, in particular ones with higher fre-
quencies, are growing with time, i.e., are excited. More precisely, for Dc = 0.014
all perturbations of the corresponding spatially homogeneous steady state are damped
since this steady state is stable. According to the initial condition chosen, we obtain
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Figure 4.9: Plots showing the spatio-temporal evolution of the cancer cell density c for
model (4.3) with parameter set P and a cancer cell random motility coefficient of (i) Dc =
0.014 (top); (ii) Dc = 0.00425 (middle) and (iii) Dc = 0 (bottom). For Dc = 0.014, the solution
is shown up to a final time t = 300 when the spatially homogeneous steady state has been
reached and continues to persist. For Dc = 0.00425 and Dc = 0, the solution is shown up to a
final time t = 500.
a travelling wave solution leading to the stable homogeneous steady state of the sys-
tem. For Dc = 0.00425, we observe, for large times, a pattern of equally spaced peaks
in the domain (0,10). This is the case of the onset of instability, which is a transi-
tion from a heterogeneous solution to travelling wave solution. This transition case
is reminiscent of the cosine wave cos(20pi/10 · x). By examining the appropriate dis-
persion relation in Fig. 4.2, small dashed line, we note that the dominating mode is
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the one with k˜ ≈ 6.3, which corresponds, for M = 10, to k = 20 and hence nicely ex-
plains the observed behaviour, i.e., the initial data evolves to a spatially heterogeneous
steady state. For Dc = 0.00035, the dispersion relation given in Fig. 4.2, solid line,
shows a wide range of excited modes. We observe a much more heterogeneous solu-
tion and no steady state is reached. An analysis of the relation between the number
of excited modes and the observed heterogeneous solution has been provided by Aida
et al. (2006). Such a refined analysis has not been attempted for the model under study
in this chapter. Nevertheless, the numerical results strongly suggest that an increased
number of unstable modes leads to a stronger heterogeneity in the solution.
Effect of Varying the Parameter φ53
As was noted in the previous subsection, during the growth of a solid tumour, over
time, the cancer cells become more malignant through increased mutations. Another
important phenotypic consequence of this is that the cancer cells secrete more matrix
degrading enzymes. We reflect this here in our model by increasing the parameter φ53
of model (4.3) which prescribes the rate of plasmin production due to uPA/uPAR bind-
ing (a similar effect is achieved by varying the parameter α31). To avoid the numerical
effects of boundaries, we performed the simulations in the domain (0,15).
To see the effect of varying the parameter φ53 on the evolution of the cancer cell
density, initially, at t = 0, we set the value φ53 = 0.1. This low level of production
rate of plasmin is kept until just before t = 300, after which we increase the value of
φ53 smoothly to its default value 0.75 (via a smooth step-function) for the rest of the
simulation. The corresponding spatio-temporal evolution of the cell density is shown
in the top plot of Fig. 4.10. We note that the linear stability analysis carried out in
Sect. 4.4 (and corresponding dispersion relations) indicates the changes to be expected
by varying φ53 while keeping other parameters as in parameter set P and seen in the
bottom left plot of Fig. 4.3.
60
Figure 4.10: Plots showing the spatio-temporal evolution of the cancer cell density c for
model (4.3) with parameter set P in the domain (0,15). (i) Top plot, the parameter φ53 is
increased from 0.1 to 0.75 around t = 300. (ii) Bottom plot, the parameter φ53 is increased
from 0.1 to 0.75 around t = 150 and then decreased down to 0.1 again at around t = 250.
The cancer cell density evolves from the initial data and begins to invade the ex-
tracellular matrix. Between t = 100 and t = 200 we can see equally spaced peaks of
cancer cell density appearing in the wake of the invasive front (this corresponds with
the prediction of the dispersion relation from the linear stability analysis). At around
t = 300 (and all subsequent times) we note that the cancer cell density in the wake of
the invading front is now highly heterogeneous. Again this computational result con-
firms the prediction from the dispersion relation, since now φ53 = 0.75. We also note
a change in the speed of the invasive front when the value of φ53 is increased from low
(0.1) to high (0.75). At lower values of φ53 the speed of the invasive front is faster
than that at higher values of φ53. The change in the invasive speed occurs around the
switching time of t = 300 and can clearly be seen in the top plot of Fig. 4.10.
61
In the bottom plot of Fig. 4.10, the initial value of φ53 = 0.1 is increased smoothly
around t = 150 until it reaches the default value 0.75 (as prescribed by the parameter
setP). After t = 250 the value of φ53 is then smoothly reduced back to 0.1. The figure
shows the corresponding change in the nature of the cancer cell density profile. The
change of the speed of the invasive front from high to low and back to high again (for
the appropriate values of φ53) is also observed here.
To see the effects of higher cell random motility in varying φ53, we performed
simulations with Dc increased to 0.00425. The results are shown in Fig. 4.11. With
the smaller values of parameter φ53, in the top plot, we see an initial travelling wave
solution evolving. At around t = 40, we smoothly increase the value of φ53 to its
default value 0.75, where it stays for the remainder of the simulation. From the linear
stability analysis, we would expect the underlying spatially homogeneous steady-state
to be destabilised and this is indeed what is observed with eventually a final profile the
same as that shown in Fig. 4.9 (middle) being attained. This process is then reversed
Figure 4.11: Plots showing the spatio-temporal evolution of the cancer cell density c for
model (4.3) with parameter set P and Dc = 0.00425 in domain (0,15). In these plots, the
parameter φ53 is (i) increased from 0.01 to 0.75 around t = 40 (top) and (ii) then decreased
down to 0.01 again at around t = 180 (bottom).
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by reducing the value of φ53 smoothly back to 0.01 at around t = 180. The resulting
solution is visualised in Fig. 4.11 (bottom). From the linear stability analysis, we
would expect the spatially homogeneous steady state to have been re-stabilised and
this is indeed what we observe from the figure. In this case, locally in time and space
we see growing perturbations shortly after the switching time t = 40. These then decay
when φ53 is reduced again and have disappeared immediately after t = 180, leaving a
smooth travelling wave profile behind, which drives the solution to its steady state.
These simulations confirm the dispersal relation curve shown in the bottom right plot
of Fig. 4.3.
Effect of Varying the Parameter µ1
Similar computational experiments to the previous sub-section can be carried out by
varying the cell proliferation parameter µ1. An increase in the cancer cell prolifer-
ation rate is yet another important phenotypic consequence of increased malignancy.
In Fig. 4.12 we show the evolution of the cancer cell density c when µ1 is changed
with time (otherwise parameter set P is used). Initially, we use µ1 = 1.0, i.e. above
the threshold for the destabilisation of the steady state, see Fig. 4.3 (middle), and then
decrease its value smoothly to µ1 = 0.25, its default value, around t = 100. Accord-
ingly, we observe at first a travelling wave of cancer cells invading the domain. This is
followed, after t = 100, by the appearance of cancer cell density heterogeneity in the
wake of the wave front. The spatio-temporal structure of these solutions would per-
sist for increasing time (not shown) if µ1 were not changed again. Instead, at around
t = 180, the value of µ1 is increased to µ1 = 1.0 again, leading to a (re-)stabilisation
of the steady state. Correspondingly, we observe that the peaks in the cell density are
damped away quickly and the solution becomes homogeneous again.
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Figure 4.12: Plot showing the spatio-temporal evolution of the cancer cell density c for
model (4.3) with parameter set P . The parameter µ1 is decreased from 1.0 to 0.25 around
t = 100 and then increased back to 1.0 at around t = 180.
Simulation Results for Modified Proliferation Terms
The interactions between cancer cells and the extracellular matrix due to cell move-
ment and proliferation and matrix remodelling result in competition for physical space
between the cancer cells and matrix. Since it is considered more realistic biologically
and in order to take the effect into account, in this section we modify the proliferation
term of cancer cells and remodelling term of the extracellular matrix in (4.3) obeying
the spatial restrictions. The equations for cancer cells and the extracellular matrix now
become
∂c
∂ t
= Dc∇2c︸ ︷︷ ︸
random motility
− ∇ ·
[
χuc∇u︸ ︷︷ ︸
uPA-chemo
+ χpc∇p︸ ︷︷ ︸
PAI-1-chemo
+ χvc∇v︸ ︷︷ ︸
VN-hapto
]
+µ1c(1− c− v)︸ ︷︷ ︸
proliferation
, (4.16a)
∂v
∂ t
= − δvm︸︷︷︸
degradation
+ φ21up︸ ︷︷ ︸
uPA/PAI-1
− φ22vp︸ ︷︷ ︸
PAI-1/VN
+µ2(1− c− v)︸ ︷︷ ︸
remodelling
, (4.16b)
subject to the boundary and initial conditions given by (4.4). The modified prolifer-
ation terms model the competition for space between cancer cells and matrix. The
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cancer cells will grow as long as there is enough space available. The same effect ap-
plies to the extracellular matrix, where if the space is limited the extracellular matrix
then will remodel back to a normal, healthy level of density.
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Figure 4.13: Plots showing the spatio-temporal evolution of the cancer cell density c for
model (4.3) with modified proliferation and remodelling terms (4.16) on domain (0,10) with
Neumann BCs.
The use of these functional forms of carrying capacity for cell proliferation and
matrix remodelling specifically in cancer invasion modelling has been considered pre-
viously by Gerisch and Chaplain (2008). We note that the matrix remodelling term here
is slightly different to that used in Eq. (4.3b). However, both are qualitatively similar
in the sense that, in the absence of cancer cells (i.e. normal conditions), matrix will
tend to a steady-state value of 1. We have also carried out extensive simulations using
both remodelling terms and the precise form does not make any significant difference
to the results.
The simulations of the modified system is shown in Fig. 4.13. We observe similar
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dynamics as in the previous section. However, comparing solutions in Fig. 4.13 with
solutions in Fig. 4.5 we see, for example, that in Fig. 4.5, at t = 75 (∼ 8.5 days) the
cancer cells have already migrated through half of the domain, while in Fig. 4.13 they
have migrated appreciably less.
4.5.3 Computational Simulation Results in 2D
In this section we present computational simulation results of our model (4.3) with
parameter set P on a two-dimensional square domain with finite volumes of length
1/50 for each side of the domain. One of the reasons for doing this was to qualita-
tively compare our simulation results with experimental data obtained from an in vitro
organotypic culture model developed to examine the invasiveness of cancer cells into
a collagen:matrigel assay (Nystro¨m et al., 2005; Martins et al., 2009). Although our
model is formulated in terms of cancer cell invasion of matrix envisaged in vivo, it is
very difficult to obtain data from in vivo systems. Such in vitro experimental systems as
the collagen:matrigel assay provide an important first step at a qualitative comparison
with our model.
Fig. 4.14 shows the results of cancer cell invasion in vitro using such an organotypic
culture model. The figures show different penetration depths of the extracellular matrix
by cancer cells of varying grade. In the top left figure, we have the result using normal
cells. The remaining three figures (top right, bottom left and bottom right) show the
results using cells isolated from varying grade of tumour i.e., of increasing malignancy.
As can be seen from the figures, as the cancer cells increase in malignancy, the depth of
penetration into the extracellular matrix increases as does the extent of fragmentation
i.e., heterogeneity.
In Fig. 4.15, we present simulation results obtained using the finite volume code for
the model (4.3) on the square domain Ω = (0,5)2 with no-flux boundary conditions.
The two figures in the top plots show the initial conditions for the cancer cells and
66
Figure 4.14: Modelling tumour cell invasion in vitro using an organotypic culture model
reveals the varying extent of tumour mass fragmentation and extracellular matrix penetration.
The figures show the depth of penetration into the extracellular matrix and the degree of frag-
mentation (heterogeneity) of tumour cells of increasing malignancy. Normal cells (top left
figure) or cells isolated from varying grade of tumour (top right, bottom left and bottom right
figures respectively) were cultured in contact with an extracellular matrix populated with nor-
mal stromal cells over a 14 day period. The figures show H&E stained sections from the 3-
dimensional culture, highlighting epithelial cells (tumour and normal) forming a multi-layered
epithelia with or without extracellular matrix invasion.
matrix - a strip of cancer cells (at a uniform initial density of 1) is placed along the top
20% of the square domain (cf. Fig. 4.14) and the matrix takes up the remaining 80%
of the domain. The initial conditions for uPA, PAI-1 and plasmin are as given in (4.5)
of Sect. 4.3, i.e., u(0,x) = 0.5n(0,x), p(0,x) = 0.05n(0,x), and m(0,x) = 0.
The middle plots of Fig. 4.15 show the simulation results for the cancer cells and
matrix using parameter setP . The left hand plot shows the distribution of cancer cells
which have invaded most of the domain at t = 200 and are heterogeneously distributed
throughout i.e., a lot of fragmentation. Matrix distribution (right hand plot) is corre-
spondingly fragmented and heterogeneous. These results may be compared with the
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experimental data for the most malignant cancer cells shown in Fig. 4.14, bottom right
plot, where we observe a large degree of cancer cell invasion and extracellular matrix
degradation and heterogeneity.
Finally, the bottom plots of Fig. 4.15 show the simulation results for the cancer
cells and matrix using a modified parameter set, reflecting a less malignant cancer
cell population i.e., the diffusion coefficient Dc = 2.5 · 10−4, haptotactic coefficient
χv = 0.01425, cell proliferation rate µ1 = 0.1, matrix degradation rate δ = 4.15, and
production of plasmin φ53 = 0.45. The left hand plot shows the distribution of can-
cer cells at t = 200. In contrast with the middle plot, in this case the cancer cells
have penetrated the extracellular matrix to a lesser degree and there is less heterogene-
ity (fragmentation). Correspondingly the extracellular matrix is less degraded. Once
again, these results may be compared with the experimental data for the less malignant
cancer cells shown in Fig. 4.14, bottom left plot, where we observe lesser cancer cell
and matrix heterogeneity. Although our computational results qualitatively match the
experimental data, we cannot be certain objectively of the mechanism responsible for
the pattern. For example, a diffusion-driven instability may well play some role or
reduced cell-cell adhesion.
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Figure 4.15: Plots showing the distribution of the cancer cell density c(t,x,y) and matrix
density v(t,x,y) in a square domain Ω= (0,5)2. The top plots show the initial conditions, with
cancer cells taking up one fifth of the domain (top left) and matrix occupying the rest of the
domain (top right). The middle plots show the cancer cell (left) and matrix (right) densities
at t = 200 using parameter set P . The cancer cells have invaded the extracellular matrix in
a very heterogeneous (fragmented) manner and penetrated almost to the lower boundary. The
bottom plots show the cancer cell (left) and matrix (right) densities at t = 200 using a modified
parameter set reflecting a less aggressive cancer cell phenotype – Dc = 2.5 ·10−4, χv = 0.01425,
µ1 = 0.1, δ = 4.15, φ53 = 0.45 (all other parameters unchanged from parameter setP). In this
case, the cancer cells have penetrated the extracellular matrix to a lesser degree and there is less
heterogeneity (fragmentation). These simulations qualitatively mirror the experimental results
shown in Fig. 4.14.
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4.6 Discussion and Conclusions
In this chapter we have investigated, analytically and numerically, a mathematical
model of cancer cell invasion of tissue (extracellular matrix) first presented in Chap-
lain and Lolas (2005). The biological focus of the model is the urokinase plasminogen
activation (uPA) system but it is conceivable that similar results could be obtained by
focusing on alternative matrix/protease dependent remodelling systems such as those
associated with transforming growth factor-β activation (Jenkins, 2008). Our main
contribution and finding is the observation of a very rich (“dynamic”) spatio-temporal
heterogeneity of the solutions. The linear stability analysis and computational simula-
tions suggest that this may be due to a taxis-driven instability of the spatially homo-
geneous, positive steady state of the model, cf. (Keller and Segel, 1970; Pearce et al.,
2007) (although we have not proved this). This in turn, leads to a very interesting and
challenging open question to understand fully these “merging and emerging” dynam-
ics. Furthermore, in this chapter we have shown that by varying key parameters of the
model, the qualitative character of the solution—either of travelling-wave-like form or
heterogeneous dynamics—can be changed. The prevalent character of the solution for
a given parameter set can be predicted by examining dispersion relations (such as those
shown in this chapter) derived from a linear stability analysis of the system.
Examples of the two different “types” of invasion by cancer cells observed here
can be seen not only using laboratory based experimental models of cancer cell inva-
sion, but also directly in clinical samples and certainly have implications for cancer
treatment. In the case of “dynamic heterogeneity”, a surgical removal of the tumour
is made considerably more complicated and difficult due to the dissemination of small
and individual tumour cell clusters in the tissue space, i.e., a breakup of an initially
compact tumour mass. Here the danger is that surgery leaves some of those tumour
cell clusters behind which then are the starting point for a re-establishment of the dis-
ease or that this departure of cells from the primary tumour mass leads directly to
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metastasis (Lindemann et al., 1992; Izbicki et al., 1997).
In the second type of behaviour, the travelling-wave-like regime, the tumour mass
remains compact and can be more easily recognised as a whole and removed as such
by the surgeon. However, with the parameters considered here, the tumour is still
growing in this regime. We also note that in this case, although the tumour remains as
a compact mass, the distance penetrated into the tissue is greater (since the wave speed
is greater cf. Figure 4.8). One may draw the general conclusion that manipulation of
the tumour microenvironment (Sutherland, 1988; Anderson et al., 2006), for example
through the oxygen/nutrient supply to the tumour (and with a subsequent effect on can-
cer cell proliferation, migration, and enzyme production), may have a major impact on
invasion. Different tumour types may possess varying abilities to maintain growth in
the absence of oxygen/nutrient supply and different tumour types may evolve the abil-
ity to vascularise and re-supply the growing tumour mass. Rapid tumour growth either
in a dynamic heterogeneic or a traveling-wave-like manner has the potential to lead to
further evolution of the tumour but it is metastasis, not proliferation which results in
cancer mortality (Sporn, 1996). The act of cells breaking out and leaving the primary
tumour site remains the most deadly trait. The extent of invasion depth has long been
correlated with poor prognosis (Breslow, 1970) and laboratory modelling and mea-
surement of invasion tend to describe data more similar to the dynamic heterogeneic
regime of invasion as “more aggressive” (Nystro¨m et al., 2005) and Fig. 4.14.
In terms of future work and model development, we note that the model considered
in this chapter has some limitations. Future work will deal with these and now we
comment on these briefly.
In the original paper of Chaplain and Lolas (2005) an additional proliferation term
+φ13cu is present in the cancer cell equation of the model but is not considered here.
This term models additional cancer cell proliferation as a result of signal pathways
that are activated by uPA/uPAR binding. Such a dependence could be included in the
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model by allowing the cancer cell proliferation rate µ1 to depend on the uPA concen-
tration u. Other effects of the uPA system which are observed biologically will also
be considered for inclusion in the model. This critical review is expected to lead to
a more focused/streamlined model of the kinetics. Other extensions of the present
model would be to include explicitly an equation for oxygen/nutrient supply to the
cancer cells (Sherratt and Chaplain, 2001) and to account in detail for effects of both
cell-cell and cell-matrix adhesion. Although this effect has been modelled previously
using discrete techniques (Anderson, 2005; Turner and Sherratt, 2002), an interesting
approach using PDEs and continuum models has recently been developed by Gerisch
and Chaplain (2008) building on initial work of Armstrong et al. (2006). In this ap-
proach, nonlocal terms in the PDE system are used to model the cell-cell and cell-
matrix interactions, resulting in a system of integro-differential equations (Gerisch and
Chaplain, 2008; Painter et al., 2010).
Using this refined approach, coupled with accurate parameter estimation, it should
be possible to develop a mathematical model of cancer invasion that assesses invasion
objectively and provides a numerical “Invasion Index” (Nystro¨m et al., 2005; Martins
et al., 2009). The simulations presented in Fig. 4.15 show that such a mathemati-
cal model can provide information regarding both the depth and pattern of invasion,
two key features of cancer cell invasion. By varying parameter values, the mathe-
matical model is capable of indicating how various factors influence invasion. Future
work in this direction will require a careful estimate of parameter values in the colla-
gen:matrigel assay and a more detailed experimental investigation of the biochemical
processes involving the matrix degrading enzymes.
Finally, we note that since cancer is a progressive disease (Hanahan and Weinberg,
2000; MacSween, 2003), with the cancer becoming more malignant as the cancer cells
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undergo successive mutations, an interesting development of the model would be to re-
flect this important aspect by introducing a “mutation pathway” into the model at a phe-
notypic level, whereby different sub-populations of increasingly malignant cells appear
over time, Spremulli and Dexter (1983); Heppner (1984); Enderling et al. (2007). An
indication of how a model of this type with two cancer cell sub-populations, having
densities c1 and c2, respectively, might be implemented is given below:
∂c1
∂ t
= Dc1∇
2c1︸ ︷︷ ︸
random motility
−∇ ·
[
χu1c1∇u︸ ︷︷ ︸
uPA-chemo
+ χp1c1∇p︸ ︷︷ ︸
PAI-1-chemo
+χv1c1∇v︸ ︷︷ ︸
VN-hapto
]
+µ1,1c1(1− c)︸ ︷︷ ︸
proliferation
− λc1F(t,v)︸ ︷︷ ︸
conversion to c2
, (4.17a)
∂c2
∂ t
= Dc2∇
2c2︸ ︷︷ ︸
random motility
−∇ ·
[
χu2c2∇u︸ ︷︷ ︸
uPA-chemo
+ χp2c2∇p︸ ︷︷ ︸
PAI-1-chemo
+χv2c2∇v︸ ︷︷ ︸
VN-hapto
]
+µ1,2c2(1− c)︸ ︷︷ ︸
proliferation
+ λc1F(t,v)︸ ︷︷ ︸
conversion from c1
, (4.17b)
where c denotes the total cell density, c := c1+ c2, and the conversion function F is a
product of two Heaviside functions,
F(t,v) = H(t−50) ·H(v−0.3) . (4.18)
In the above model, we have assumed that the cancer cells of sub-population 1
are converted into cancer cells of sub-population 2 after t = 50 and only in regions
with sufficiently high matrix density v > 0.3. The differences between the two sub-
populations are (i) in the diffusion coefficients – cancer cells of sub-population 2 dif-
fuse faster than cancer cells of sub-population 1, i.e. Dc2 > Dc1 (ii) in the proliferation
rates – cells of sub-population 2 proliferate more rapidly than cells of sub-population
1, i.e. µ1,2 > µ1,1, (iii) in the chemotactic and haptotactic constants – more aggressive
cancer cells migrate more quickly i.e. χu2 > χu1, χup > χp1,χv2 > χv1. The other equa-
tions for the extracellular matrix, uPA, PAI-1, and plasmin remain unchanged from
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system (4.3).
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Figure 4.16: Plots showing the spatio-temporal evolution of the solution profiles of all
variables of our extended model with two sub-populations of cancer cells c1 and c2. Solution
profiles are shown for times t = 50,60,100, and 150 using parameter set P∗. The density
of cancer cells of sub-population 1 is denoted by the solid black line, the density of the more
aggressive cancer cells of sub-population 2 by the solid magenta line, the matrix density by
dotted black line, the uPA concentration by dash-dotted black line, PAI-1 concentration by
dashed black line, and plasmin concentration by dash-dotted grey thin line.
Fig. 4.16 shows the results of a computational simulation of the above 2 equa-
tions along with the uPA-system equations from model (4.3) using new values of the
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following parameters, we refer to as parameter setP∗
Dc1 = 3.5 ·10−4 , Dc2 = 2.5 ·10−4 ,
µ1,1 = 0.25 , µ1,2 = 0.75 ,
χu1 = 2.05 ·10−2 , χu2 = 3.05 ·10−2 ,
χp1 = 2.75 ·10−2 , χp2 = 3.75 ·10−2 ,
χv1 = 1.85 ·10−2 , χv2 = 2.85 ·10−2 ,
λ = 0.3 ,
and the rest of parameter values remains the same as parameter set P given in Ta-
ble 4.1.
As is to be expected, for t < 50 the solutions evolve as in Fig. 4.16, first plot. After
t = 50 there is some conversion from sub-population 1 to sub-population 2 at the lead-
ing edge of the invading front and so by t = 60 cancer cells of sub-population 2 are
visible (second plot). As time increases, the more aggressive sub-population 2 gradu-
ally replaces the less aggressive sub-population (third and fourth plots). Furthermore,
we observe an increase in the speed of invasion of the matrix by the more aggressive
sub-population 2.
The results of the proposed model extension shown above indicate the potential
for predicting the spatio-temporal evolution of an invasive cancer consisting of several
heterogeneous sub-populations that differ in many phenotypic characteristics. Clini-
cally, the different sub-populations within a primary tumour may give an impact on the
design of treatment protocols to predict individual chemotherapy for cancer patients
(Spremulli and Dexter, 1983).
Chapter 5
Modelling the Role of Cell Adhesion in
Cancer Invasion
5.1 Introduction
Intercellular adhesion has long been recognised to be a fundamental biological process
in many aspects of developmental biology. The binding and unbinding mechanisms
are also particularly important in cancer progression by which the malignant cells de-
tach from the primary tumour mass and spread throughout the surrounding tissues and
to anatomically distant parts of the body. There is growing evidence that cell adhesion
through cell adhesion proteins is implicated in cancer invasion and metastasis (Ya-
mada, 1983; Jiang, 1996; Pignatelli, 1998; Mizejewski, 1999; Hazan et al., 2000; Kase
et al., 2000; Aken et al., 2001; Irby and Yeatman, 2002; Kowalski et al., 2003; Cav-
allaro and Christofori, 2004; Heyder et al., 2005; Sawada et al., 2008; Paschos et al.,
2009; Schmalhofer et al., 2009; Brooks et al., 2010; Hsu et al., 2010; Huang et al.,
2010; Mao et al., 2010).
After undergoing genetic and epigenetic changes, malignant and invasive tumour
cells, i.e., cancer cells, break away from the primary tumour mass by losing adhesion
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with one another and dissociating from any adjacent cells. Cancer cells then need to,
(i) push their way through the basement membrane, which is a meshwork of protein
that creates a barrier for cell movement and, (ii) migrate through the ECM surrounding
the tumour epithelium. The degradation of the basement membrane and the ECM
is necessary for removing any physical obstacles in the direction of cell movement.
This process is performed by the activity of proteolytic enzymes, and the major one
responsible for ECM degradation (and remodelling) is the urokinase-type plasminogen
activator (uPA). Following ECM degradation, cancer cells are now able to migrate
through the extracellular matrix mediated by adhesion between other cells and matrix.
After analysing the model of cancer cell invasion tissue based on the uPA system
that we presented in the previous chapter (Chapter 4), here we discuss the incorporation
of cell-cell and cell-matrix adhesion processes in the uPA model. The extended model
consists of a system of partial differential equations with reaction-diffusion taxis terms
accounting for uPA system and new non-local (integral) terms for cell-cell and cell-
matrix adhesion.
5.2 Cell Adhesion in the uPA System
Molecular interactions are clinically proven to be critical in the metastatic cascade, de-
fined as the progression from a primary, single tumour to secondary tumours at anatom-
ically distant sites throughout the body. The interactions in the metastatic cascade con-
sist of several major steps: (1) the development of capillary blood vessels nearby a
primary tumour that crucially supply the tumour with vital nutrient and help to dispose
of waste product; (2) the detachment of tumour cells from the primary tumour mass;
(3) destruction of the basement membrane and invasion of the extracellular matrix
(ECM) components by over-expression of proteolytic enzymes such as urokinase-type
plasminogen activator (uPA), and migration through the matrix; (4) intravasation of
the tumour cells into the blood vessels and lymphatic vessels which gains them access
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to the circulatory system to travel to distant anatomical sites; (5) adhesion of the circu-
lating tumour cells to the endothelial cell lining at the capillary bed of the target organ
site; (6) invasion of the basement membrane and target organ tissue; and (7) the growth
of secondary tumours at the target organ site (Guo and Giancotti, 2004; Brooks et al.,
2010).
For cells of epithelial tissue origin, several steps in this cascade are dependent on
cell adhesion mechanisms and proteolytic activities for local invasion of malignant
cells of basement membrane and matrix around them. Tumour cells that have gained
invasive properties start to detach from the primary tumour mass triggered by loss of
cell-cell adhesion, particularly adhesion between cells at the edge or outer layer of the
tumour body. The next step for the cells is migration through the tissue before reach-
ing the vascular or lymphatic system for further circulation. To enable migration, the
matrix must be degraded, as well as be remodelled, and there must be attachment of
cells to the matrix. These processes requires pericellular proteolytic activities of matrix
components mainly carried out by uPA and enhancement of cell-matrix adhesion for
cell movement (Ellis et al., 1992). The association of uPAR with cell-matrix adhesion
components integrins has been studied by Xue et al. (1997) in connection with direc-
tional proteolysis for cancer cell migration in fibrosarcoma. Stahl and Mueller (1997)
studied the influence of the uPA and its receptor (uPAR) on melanoma cell adhesion to,
and migration on, the extracellular matrix protein vitronectin (VN). Their experimental
data showed the involvement of the components of the uPA system in direct regulation
of cell adhesion and migration, modulating the behaviour of malignant tumour cells.
5.3 Mathematical Model
Continuum mathematical models incorporating (in some way) cell adhesion that de-
scribe the interactions either between cells or between cells and extracellular matrix
have been proposed by Greenspan (1976); Bell et al. (1984); Evans (1985a,b); Bell
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and Torney (1985); Hammer and Lauffenburger (1987); DiMilla et al. (1991); Xiao
and Truskey (1996); Byrne and Chaplain (1996); Byrne (1997); Byrne and Chaplain
(1997); Palecek et al. (1999); Cristini et al. (2005); Zheng et al. (2005); Macklin and
Lowengrub (2007); Cristini et al. (2009); Macklin et al. (2009); Frieboes et al. (2010).
A comprehensive review of some of these papers may be found in Lowengrub et al.
(2010). However, in most of these models adhesion was incorporated via a boundary
condition as a surface tension-like force. A model that used a continuum approach
to model the role of adhesion in cell sorting behaviour was developed by Armstrong
et al. (2006). The model describes the movement of cells as a result of adhesive forces
generated due to binding and unbinding events of a cell to neighbouring cells. The
adhesive forces are presented in the partial differential equations themselves in a (non-
local) term explicitly describing cell adhesion. The idea was then used by Gerisch and
Chaplain (2008) to model cancer invasion of tissue incorporating cell-cell and cell-
matrix adhesion. Later Painter et al. (2010) used the model for modelling processes
such as cancer invasion and development on heterogeneous matrix, where the move-
ment is only driven by cell-cell and cell-matrix adhesion.
As it has been clear that cellular invasion depends on cooperation between adhesive
and proteolytic mechanisms, it is our aim here to account for cell adhesion in the cancer
cell invasion model, where cell motility is now also governed by movement due to cell
adhesion. We do this by replacing the haptotactic term in Eq. 4.2a of Chapter 4 with
a term that incorporates adhesive movement caused by forces that are generated when
there occurs binding or unbinding events between cell-cell and between cell-matrix.
The factors that drive cancer cell migration now consist of random motion, chemotaxis
due to uPA and PAI, and adhesive movement. The rate of change of cell density in full
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dimensional form is given by,
∂c
∂ t
= D1∇2c︸ ︷︷ ︸
random motility
−∇ · (cA {w(t, ·)})︸ ︷︷ ︸
adhesive movement
−∇ · (cξu(w)∇u)︸ ︷︷ ︸
uPA-chemotaxis
−∇ · (cξp(w)∇p)︸ ︷︷ ︸
PAI-1-chemotaxis
+ σ1c
(
1− c
c0
)
︸ ︷︷ ︸
proliferation
. (5.1)
The advection termA {w(t, ·)} represents the so-called adhesion velocity and is re-
ferred to as “nonlocal”. For our continuum approach we adapt the form forA {w(t, ·)}
introduced by Armstrong et al. (2006). This form has been studied and applied in var-
ious cancer models (Gerisch and Chaplain, 2008; Sherratt et al., 2009; Painter et al.,
2010), and is given by
A {w(t, ·)} := 1
R
∫
S
r
|r | g(w(t,x+ r))Ω(r)dr . (5.2)
The integrand consists of three components: (i) the direction of the force denoted
by the unit outer normal vector
r
|r| , (ii) the radial dependency function Ω(r), and (iii) a
function g(w(t,x+r)) that describes the nature of the forces and depends on the vector
concentration w.
For 1D spatial domains the forces generated through adhesive binding affect the
points in the right (
r
|r| = 1) or left (
r
|r| = −1) direction of the Cartesian coordinate
axis. In 2D domains the force is sensed by points within a circle or radius r, hence the
position vector r in polar coordinates r = r(cosθ ,sinθ)T and its magnitude |r|= r.
The function Ω(r) describes how strong the adhesion velocity A {w(t, ·)} is in-
fluenced by points of the sensing region at x depending on their distance r from x.
Adhesive bindings are strong nearer to x and become weaker at distances further away.
Therefore, in 1D Ω(r) should be an odd function of r with Ω(r) > 0 for r > 0 and
Ω(r)< 0 for r < 0 (Armstrong et al., 2006). The simplest form Ω(r) that can be con-
sidered is a step function describing a constant magnitude of the force sensed by cells,
either closer or further away from the force-generating cells within a sensing radius
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(Armstrong et al., 2006; Painter et al., 2010), i.e.,
Ω1(r) = 1 for −R < r < R , (5.3)
where R = max(r) is the sensing radius of the cells.
Gerisch and Chaplain (2008) consider normalised forms of Ω(r) in which its inte-
gral over the sensing region is one, i.e.,∫ R
0
2Ω(r)dr = 1 or
∫ R
0
2pirΩ(r)dr = 1 ,
for 1D and 2D, respectively. This leads to the constant form in 1D
Ω2(r) =
1
2R
, (5.4)
and for 2D
Ω2(r) =
1
piR2
. (5.5)
The second form of Ω(r) considered in Gerisch and Chaplain (2008) is a function
that linearly decreases to Ω(R) = 0 with increasing distance from the centre. For 1D
Ω3(r) =
1
R
(
1− r
R
)
, (5.6)
and for 2D is given by
Ω3(r) =
3
pi2R
(
1− r
R
)
. (5.7)
Since the adhesion involves forces between cancer cells (cell-cell adhesion) and be-
tween cancer cells and extracellular matrix (cell-matrix adhesion), we take g(w(t,x+
r)) as function of c and v. For convenience, we write g(c,v). At its simplest, it could
take a linear form,
g(c,v) = Sccc(x+ r)+Sscv(x+ r) , (5.8)
where Scc and Scv are constants that account for the strength of cell-cell and cell-matrix
adhesion, respectively. The linear forms imply continuous generation of stronger ad-
hesive force even at higher densities, eventually leading to movement of cells at very
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high density. This scenario cannot be supported from an experimental point of view,
as at high densities cells may form steady colonies or clusters that keep growing in
size rather than conducting migration (Zantek and Kinch, 2001). This suggests that at
high densities the cells are prevented from moving due to crowding and lack of space
for cells to perform orientation. Therefore we consider a form for g(c,v) that is more
realistic by including a spatial restriction, where the cells aggregate and move only if
there is space locally available. In our model the cells share the physical space with
other components like the ECM, uPA, PAI-1, and plasmin. We assume that the chemi-
cal substances uPA, PAI-1, and plasmin subsume into the space occupied by the ECM.
Now in one unit volume of the physical space there are cells that occupy a fraction ϑ1
of the space and the ECM that takes another fraction ϑ2,
fs ≈ ϑ1c+ϑ2v .
The total fraction fs should be positive and must not be higher than a threshold
density. An appropriate choice is 0 ≤ fs ≤ 1. If the space is densely occupied (either
by the cells or ECM or by both combined) with ϑ1c+ϑ2v≈ 1, the self-limiting process
should operate, giving
g(c,v) = (Sccc+Sscv) (1−ϑ1c−ϑ2v)+ , (5.9)
where the new form with a factor (1−ϑ1c−ϑ2v)+ :=max{0,(1−ϑ1c−ϑ2v)} ensures
that the force that is generated is limited by densities of cells and matrix.
In the basic cancer invasion model analysed in Chapter 4 we consider a constant
form for the chemotactic sensitivity coefficients ξu(w) = ξu and ξp(w) = ξp. The
chemotactic function was introduced by Patlak in 1953 and later by Keller and Segel
(1970) to describe the aggregation of slime mould amoebae towards high concentra-
tions of a chemical substance using two coupled parabolic equations. The model has
been intensively studied in mathematical biology since then. The constant form of ξu
means that the gradient of ∇u is multiplied by a linear instead of a nonlinear function.
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This is similar to the linear form of the function g(c,v) in Eq. 5.8. A feature of this
choice is the fact that it may lead to mathematically finite time blow-up or “overcrowd-
ing” scenarios, where the solutions become unbounded. Whether the blow-up situa-
tions occur or not typically depends on the initial conditions and the space dimension
d. The conditions for blow-up as well as the existence and uniqueness of solutions for
specific forms of chemotactic sensitivity coefficient ξ (·) have been derived by a large
number of authors, for example Ja¨ger and Luckhaus (1992); Herrero and Vela´zquez
(1996); Hortsmann and Wang (2001).
Although many have tried to interpret blow-up situations from a biological point of
view, the linear form can also pose difficulty for numerical simulations. Therefore we
opt for a form that includes assumptions for spatial restrictions, such as by limiting the
movement of cells at relatively high densities. One of the possibilities to achieve this is
by switching off the chemotactic response if the cell density becomes high, preventing
cells from moving into dense regions. Such a mechanism, also called “overcrowding
prevention” or “volume filling”, has been studied by Hillen and Painter (2001); Painter
and Hillen (2002) and references therein. This takes the same form as for the g(c,v)
function as in Eq. 5.9 and the chemotactic sensitivity coefficients ξu(w) and ξp(w) are
now given by:
ξu(w) = ξu(1−ϑ1c−ϑ2v) and ξp(w) = ξp(1−ϑ1c−ϑ2v) . (5.10)
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We write down the system of equations in full dimensional form as
∂c
∂ t
= D1∇2c︸ ︷︷ ︸
random motility
−∇ ·
(
c
R
∫
S
r
|r |(Sccc+Scvv)(1−ϑ1c−ϑ2v)Ω(r)dr
)
︸ ︷︷ ︸
adhesive movement
−∇ · (ξuc(1−ϑ1c−ϑ2v)∇u)︸ ︷︷ ︸
uPA-chemotaxis
−∇ · (ξpc(1−ϑ1c−ϑ2v)∇p)︸ ︷︷ ︸
PAI-1-chemotaxis
+σ1c
(
1− c
c0
)
︸ ︷︷ ︸
proliferation
, (5.11a)
∂v
∂ t
= − βvm︸︷︷︸
degradation
+ Φ21up︸ ︷︷ ︸
uPA/PAI-1
− Φ22vp︸ ︷︷ ︸
PAI-1/VN
+σ2v(1− vv0 )︸ ︷︷ ︸
remodelling
, (5.11b)
∂u
∂ t
= D3∇2u︸ ︷︷ ︸
diffusion
− Φ31 pu︸ ︷︷ ︸
uPA/PAI-1
− Φ33cu︸ ︷︷ ︸
uPA/uPAR
+ γ31c︸︷︷︸
production
, (5.11c)
∂ p
∂ t
= D4∇2 p︸ ︷︷ ︸
diffusion
− Φ41 pu︸ ︷︷ ︸
PAI-1/uPA
− Φ42 pv︸ ︷︷ ︸
PAI-1/VN
+ γ41m︸︷︷︸
production
, (5.11d)
∂m
∂ t
= D5∇2m︸ ︷︷ ︸
diffusion
+ Φ52 pv︸ ︷︷ ︸
PAI-1/VN
+ Φ53uc︸ ︷︷ ︸
uPA/uPAR
− Φ54m︸ ︷︷ ︸
degradation
. (5.11e)
We nondimensionalise the system of equations the same way as in Chapter 4. For
the additional nonlocal and nonlinear chemotactic terms we nondimensionalise with
the parameters ϑ1 := c−10 and ϑ2 := v
−1
0 , where ϑ1 is the space fraction per unit cancer
cell density (1.5× 10−8 cm3 cell−1) and ϑ2 is the space fraction per unit density of
ECM (10nM−1) (Gerisch and Chaplain, 2008), and we take
R˜ =
R
L
, r˜ =
r
L
, ˜Scc =
Sccc0
D
, ˜Scv =
Scvv0
D
.
The maximum size of cells (including protrusion or sensing radius) is approximately
in the range of 10−100µm, and so the dimensionless R˜≈ 0.01−0.1.
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Upon nondimensionalisation, combining the equation for cell density with the
equations for matrix density, uPA, PAI-1, and plasmin concentrations all together, the
mathematical model of cancer cell invasion of tissue incorporating cell adhesion in
nondimensional form, after dropping the tildes for notational convenience, is given by:
∂c
∂ t
= Dc∇2c︸ ︷︷ ︸
random motility
−∇ ·
(
c
R
∫
S
r
|r |(Sccc+Scvv)(1− c− v)Ω(r)dr
)
︸ ︷︷ ︸
adhesive movement
−∇ · (χuc(1− c− v)∇u)︸ ︷︷ ︸
uPA-chemotaxis
−∇ · (χpc(1− c− v)∇p)︸ ︷︷ ︸
PAI-1-chemotaxis
+µ1c(1− c)︸ ︷︷ ︸
proliferation
, (5.12a)
∂v
∂ t
= − δvm︸︷︷︸
degradation
+ φ21 pu︸ ︷︷ ︸
uPA/PAI-1
− φ22 pv︸ ︷︷ ︸
PAI-1/VN
+µ2v(1− v)︸ ︷︷ ︸
remodelling
, (5.12b)
∂u
∂ t
= Du∇2u︸ ︷︷ ︸
diffusion
− φ31 pu︸ ︷︷ ︸
uPA/PAI-1
− φ33cu︸ ︷︷ ︸
uPA/uPAR
+ α31c︸︷︷︸
production
, (5.12c)
∂ p
∂ t
= Dp∇2 p︸ ︷︷ ︸
diffusion
− φ41 pu︸ ︷︷ ︸
PAI-1/uPA
− φ42 pv︸ ︷︷ ︸
PAI-1/VN
+ α41m︸ ︷︷ ︸
production
, (5.12d)
∂m
∂ t
= Dm∇2m︸ ︷︷ ︸
diffusion
+ φ52 pv︸ ︷︷ ︸
PAI-1/VN
+ φ53cu︸ ︷︷ ︸
uPA/uPAR
− φ54m︸︷︷︸
degradation
. (5.12e)
The system (5.12) is closed with appropriate initial and boundary conditions. For
1D cases we use the spatial domain D1D := (0,M)⊂Rwhere M is a positive parameter
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for domain length. We choose the following initial conditions
c(0,x) =
(
1+ exp
(
x−a
ε
))−1
,
v(0,x) = 1− 1
2
(
1+ exp
(
x−a
ε
))−1
,
u(0,x) =
1
2
(
1+ exp
(
x−a
ε
))−1
,
p(0,x) =
1
20
(
1+ exp
(
x−a
ε
))−1
,
m(0,x) = 0 ,
for x ∈ D¯1D , (5.13)
in which we take ε = 0.1 and a = 1. We assume that initially there is already some
amount of cancer cells present in the domain in which they occupy
a
M
of the domain
length and the extracellular matrix takes the remaining domain. The initial conditions
that we use for the 1D simulations are smooth type of initial conditions. We have
observed that the initial conditions affect the speed of cancer cell movement of inva-
sion across the extracellular matrix – the smoother the initial conditions, the faster the
invasion process. For a 2D spatial domain D2D := (0,Mx)× (0,My) ⊂ R with posi-
tive parameters Mx (the length of domain in x-direction) and My (the length of domain
in y-direction), we choose the same 2D initial conditions as described in Chapter 4,
where the cancer cells of uniform initial density of 1 are placed to form a strip along
one side of the domain, that is along (0,My). The cell strip takes up about 25% of the
domain while the rest of the domain is taken up by the extracellular matrix. The initial
conditions for the other variables are
u(0,x) = 0.5c(0,x) ,
p(0,x) = 0.05c(0,x) ,
m(0,x) = 0 .
for x ∈ D¯2D . (5.14)
In this chapter we implement symmetry boundary conditions on one of the bound-
aries for the computational simulations. We assume that the x = 0 line is a (mirror)
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symmetry line for the solutions (and parameters) and hence we can consider the prob-
lem on a reduced domain, namely only for x> 0 values (as everything for x< 0 follows
from symmetry. For the opposite boundaries of x = 0, that is at x = M for the 1D do-
main and x = Mx for the 2D domain, we apply zero-flux boundary conditions. At the
other boundaries y = 0 and y = My for 2D we apply periodic boundary conditions.
These conditions are explained further in Section 5.5.2.
5.4 Linear Stability Analysis
Intuitively we would expect that using the volume filling mechanism would stabilise
the uniform steady state from some inhomogeneous perturbations, resulting in a homo-
geneous spatial pattern, or a pattern that evolves like a travelling wave. We carry out
a linear stability analysis to determine which parameters can be varied for the possi-
ble generation of instability of the spatially uniform steady state or close to instability
from system 5.12. We do this to highlight the key elements necessary for the system
to generate spatial patterns. We use the same approach in this chapter as the linear
stability analysis for the uPA system model presented in Chapter 4.
Since the reaction kinetics in (5.12) are similar to those in (4.3), in which c∗(1−
c∗) = 0 and we infer c∗ = 1, the spatially uniform steady state w∗ for the nonlocal
system by using parameter setP is the same as the steady state that has been calculated
in (4.10) given in section 4.4, which is,
w∗ := (c∗,v∗,u∗, p∗,m∗)≈ (1, 0.047, 0.222, 0.889, 0.343) . (5.15)
We linearise the system (5.12) about the spatially uniform steady state w∗ in the
usual way by setting
w(t,x) := w∗+ εw˜ ,
where 0 < ε  1. Substituting into (5.12) and after dropping the terms of order ε2 or
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higher and dividing by ε we get the linearised equations written in the vector form
∂ w˜
∂ t
= JT (w∗)∇2w˜+ JNL(w∗)∇ ·
(∫
w˜Ω(r)dr
)
+ JR(w∗)w˜ . (5.16)
The reaction Jacobian JR(w∗) has the same components as JR(w) given in (4.11),
which, upon evaluation around the steady state
JR(w∗)=

µ1(1−2c∗) 0 0 0 0
0 −δm∗−φ22 p∗+µ2(1−2v∗) φ21 p∗ φ21u∗−φ22v∗ −δv∗
−φ33u∗+α31 0 −φ31 p∗−φ33c∗ −φ31u∗ 0
0 −φ42 p∗ −φ41 p∗ −φ41u∗−φ42v∗ α41
φ53u∗ φ52 p∗ φ53c∗ φ52v∗ −φ54

(5.17)
The transport Jacobian JT (w∗) now becomes
JT (w∗) =

Dc 0 c∗χu(w∗) c∗χp(w∗) 0
0 0 0 0 0
0 0 Du 0 0
0 0 0 Dp 0
0 0 0 0 Dm

, (5.18)
where the forms for the linearised chemotactic terms χu(w∗) and χp(w∗) depend on
our choice of chemotactic linear sensitivity coefficients. Since here we use the form
that incorporates volume filling mechanism 1− c− v, which, from using 1− c∗ = 0,
χu(w∗) = χuv∗ and χp(w∗) = χpv∗ .
88
The nonlocal Jacobian is given by
JNL(w∗) =

g1(w∗) g2(w∗) 0 0 0
0 0 0 0 0
0 0 0 0 0
0 0 0 0 0
0 0 0 0 0

, (5.19)
where it consists of functions derived from adhesive force g1(w∗) and g2(w∗), where
for the form with volume filling:
g1(w∗) =
c∗
R
(Sccc∗+Scvv∗)+
c∗v∗Scc
R
, (5.20)
and
g2(w∗) =
c∗
R
(Sccc∗+Scvv∗)+
c∗v∗Scv
R
. (5.21)
Now we look for solutions of the perturbations (5.16) in the usual way by setting
w˜(t,x) = Wexp(σt+ ik˜ ·x) , (5.22)
where k˜ is the wavevector and W is a vector of constants. Substituting this form into
(5.16) we get
[
σ I+‖k˜‖22JT (w∗)− ik˜JNL(w∗)
∫
exp(ik˜r)Ω(r)dr− JR(w∗)
]
W = 0 . (5.23)
The nonlocal Jacobian has a factor
∫
exp(ik˜r)Ω(r)dr that depends on the choice
of Ω(r), where for 1D cases:
• if Ω(r) = 1 , ∫
exp(ik˜r)Ω(r)dr =
2(cos(k˜R)−1)
ik˜
,
• if Ω(r) = 1
2R
,
∫
exp(ik˜r)Ω(r)dr =
cos(k˜R)−1
ik˜R
, and
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• if Ω(r) = 1
R
(
1− r
R
)
,
∫
exp(ik˜r)Ω(r)dr =
2(cos(k˜R)−1)
ik˜R
+
2(1− cos(k˜R))
k˜2R2
.
We use the radial dependency function Ω(r) = 1/2R for 1D and Ω(r) = 1/piR2 for
2D, as have been used in Gerisch and Chaplain (2008).
Going back to the equation (5.23), it has nontrivial solutions if and only if the
determinant of the coefficient matrix equals zero, i.e.,
|σ I+‖k˜‖22JT (w∗)− ik˜JNL(w∗)
∫
exp(ik˜r)Ω(r)dr− JR(w∗)|= 0 . (5.24)
We are interested in the dispersion relation for the unique positive, spatially uni-
form steady state w∗ from the solutions of the matrix determinant above which give
the eigenvalues of the solutions σk˜(w
∗) as a function of k˜, where k˜= kpiM−1, for each
k ∈ Z and M is the domain size parameter. The characteristic polynomial equation
(5.24) cannot be solved analytically. Therefore we resort to use a numerical package,
such as Matlab, to find the eigenvalues.
In our base model of cancer invasion explained in Chapter 4, the dispersion relation
in Fig. 4.2 suggests that the use of the parameter set P may lead to a wide range of
unstable modes. This is generally true for the linear form of the terms that govern cell
motility, which, for system (4.3), are heavily driven by chemotaxis and diffusion. For
the extended model in system (5.12) the cell motility is also governed by a nonlocal
term that accounts for aggregation/movement due to adhesive force. As we have stated
before, we use volume filling form for all motility terms. In order to see the difference
between the linear form and volume filling, in Fig.. 5.1 we plot dispersion relations
for the largest of the eigenvalues of the solutions of (5.24) using parameter set P
listed in Table 4.1 given in Chapter 4. The solid line represents the largest of the
eigenvalues with linear form for χu(w) = χu, χp(w) = χp, and g(c,v) = Sccc+Scvv and
the dash-dotted line represents the largest of the eigenvalues with volume filling form
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for χu(w) = χu(1− c− v), χp(w) = χp(1− c− v), and g(c,v) = (Sccc+Scvv)(1− c−
v)+. Since the haptotactic term in (4.3a) is replaced by the adhesive movement term,
the haptotactic coefficient χv is replaced by cell-matrix adhesion coefficient Scv and its
value in the dispersion relations in Fig. 5.1 is set to 2.85 ·10−2, which is the value of χv.
Other nonlocal parameters such as the cell-cell adhesion coefficient is set to Scc = 0, the
sensing radius R = 0.1, and Ω(r) =
1
2R
. We see that the dispersion relation with linear
form of the system (5.12) in Fig. 5.1 is qualitatively and quantitatively comparable
with the dispersion relation of our base model (4.3), except that the dispersion relation
of the base model in Fig. 4.2 has slightly larger range of unstable modes.
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Figure 5.1: Plots of dispersion relations of the largest of the real part of eigenvalues σk˜(w∗)
from the system (5.12) where (i) solid line is for equations with linear forms of χu(w) = χu,
χp(w) = χp, and g(c,v) = Sccc+Scvv, resembling the dispersion relation in Fig. 4.2 (solid line)
of Chapter 4, and (ii) dash-dotted line is for equations with volume filling forms of χu(w) =
χu(1−c−v), χp(w) = χp(1−c−v), and g(c,v) = (Sccc+Scvv)(1−c−v), all using parameter
setP with additional Scc = 0, Scv = 2.85 ·10−2, sensing radius R = 0.1, and Ω(r) = 1/2R.
One important use of the dispersion relation is that it may tell us the possibility
of spatial pattern generation and the sizes of the patterns. We can expect from the
dispersion relation with linear form for motility terms (solid line) that the patterns
of the solutions for the system (5.12) using the parameter values stated will exhibit
heterogeneity with merging and emerging peaks, qualitatively similar to the patterns
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that have been shown and explained in full detail in Section 4.5. On the other hand,
using the nonlinear form or volume filling form for motility terms results in the real
part of eigenvalues σk˜(w
∗) that are negative for all k˜ (dash-dotted line), indicating
stability of the spatial uniform steady state to some inhomogeneous perturbations.
In order to see the influence of adhesive movement in our model, particularly the
effects of cell adhesion parameters, in the following we use non-zero cell-cell adhe-
sion. The appropriate choice of nonlocal parameter values that resemble an invasive
situation is when the cell-matrix adhesion coefficient Scv is higher than the cell-cell ad-
hesion coefficient Scc. Biologically this means that the cells increase their attachment
to matrix for movement across the matrix and reduce their attachment to other cells
in order to set them free for movement. We set Scv = 0.1 and Scc = 0.01, and keep
R = 0.1 and Ω(r) = 1/2R for the 1D domain.
For the linear stability analysis of the extended nonlocal model (5.12) we concen-
trate on how the dispersion relation varies with diffusion coefficients by ‘tuning’ the
values of all diffusion coefficients at the same ratio. As we decrease the diffusion
coefficient parameters for cells (Dc), uPA (Du), PAI-1 (Dp), and plasmin (Dm), the dis-
persion curve rises until it rises above the axis with a finite range of k˜. This is seen
in Fig. 5.2, where we plot the maximum eigenvalues using different ranges of diffu-
sion parameters: (i) D1 is the curve using all default diffusion coefficients as given
in parameter set P in Table 4.1; (ii) D2 is the curve with the values of all diffusion
coefficients 10 times lower than the values of of D1; (iii) D3 with the all diffusion coef-
ficients 100 times lower than D1, and (iv) D4 with 1000 times lower than D1. We have
verified that the dispersion relation for all diffusion coefficients set to zero also lies on
the same line as the dispersion relation curve D4.
In Fig. 5.2 we see there is a range of diffusion parameters that generates a small
band of unstable modes (60< k˜< 70) which grow into spatial patterns, that is with dis-
persion relation curve D4, where Dc = 3.5 ·10−7, Du = 2.5 ·10−6, Dp = 3.5 ·10−6, and
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Figure 5.2: Plots showing the dispersion relation for different set of diffusion coefficients:
(i) D1 with all default diffusion coefficient values as given in parameter setP in Table 4.1, (ii)
D2 = D1× 10−1, (iii) D3 = D1× 10−2, and (iv) D4 = D1× 10−3. All plots are with volume
filling forms of chemotactic sensitivity coefficients χu(w) = χu(1−c−v) and χp(w) = χp(1−
c− v), and nonlocal g(c,v) = (Sccc+Scvv)(1− c− v). The nonlocal parameters are Scv = 0.1,
Scc = 0.01, R = 0.1, and Ω(r) = 1/2R.
Dm = 4.91 ·10−6. These values of diffusion parameters are too small for our numerical
code, thus we use the next diffusion parameter set D3 that is 10 times higher. As we
have seen in Chapter 4 in Fig. 4.8 where diffusion could affect cell speed and hetero-
geneity, in this chapter we choose even smaller diffusion coefficient values because
we want to focus on the role of cell adhesion in the system that drives the movement
or invasion of cancer cells. By using smaller diffusion coefficients we mainly focus
on adhesion-driven movement and also to get heterogeneity in the solutions since the
volume filling mechanism incorporated in adhesive and chemotaxis movement terms
may keep stabilising the homogeneous steady state resulting in travelling wave-like
solutions. There are diverse patterns that emerge in the solutions if we vary cell-cell
adhesion and cell-matrix adhesion parameters, which is our aim in this chapter. It is
also observed that varying cell-cell and cell-matrix adhesion can affect the speed of
cell dispersion or invasion. This is supported by a hypothesis that adhesive properties
of cancer cells may influence the patterns of spread and growth (Fidler, 1978). The
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precise patterns that evolve are governed by the full nonlinear system, hence a nonlin-
ear stability analysis perhaps could give us insight into these effects. We do not carry
out a nonlinear analysis in this chapter, but leave it as future work.
In most of computational simulations in Chapter 5.5 we use the diffusion parameter
set D3 to see the spatial patterns that may emerge by varying nonlocal parameters,
such as cell-cell adhesion Scc and cell-matrix adhesion Scv, and chemotactic parameters
χu and χp. Thus we consider two new parameter sets to be used in the numerical
simulations presented in the next section. The first parameter set is PNL1 and the
parameter values are listed in Table 5.1. The other parameter set with varied values of
diffusion and chemotactic coefficients isPNL2 and the values are listed in Table 5.2
Note that we only list parameter values in Tables 5.1 and 5.2 for diffusion coeffi-
cients, chemotactic coefficients, and nonlocal parameters. All other parameter values
for reaction kinetics terms remain the same as in parameter set P listed in Table 4.1
in Chapter 4.
Table 5.1: Parameter setPNL1
Dc = 3.5 ·10−6 Du = 2.5 ·10−5 Dp = 3.5 ·10−5
Dm = 4.91 ·10−5 χu = 3.05 ·10−2 χp = 3.75 ·10−2
R = 0.1 Scv = 0.1 Scc = 0.01
Table 5.2: Parameter setPNL2
Dc = 1.3 ·10−5 Du = 5 ·10−5 Dp = 7 ·10−5
Dm = 9.82 ·10−5 χu = 3.05 ·10−3 χp = 3.75 ·10−3
R = 0.1 Scv = 0.1 Scc = 0.01
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5.5 Computational Simulation Results
Here we solve the nonlocal system (5.12) numerically using the initial conditions and
mixed boundary conditions as we have explained in section 5.3. The numerical simula-
tions were performed using the same numerical technique for simulations in Chapter 4
that has been explained in full detail in section 4.5.1 with an additional evaluation
for the integral terms. The numerical scheme follows the method of lines where, for
the discretisation in space, a second-order finite volume approach is used to make use
of flux-limiting for an accurate discretisation of the chemotaxis and nonlocal terms.
Particularly for the nonlocal term, the spatial discretisation is done by using the Fast
Fourier Transform (or FFT) technique. Full details of the numerical scheme are given
in Gerisch and Chaplain (2006, 2008). The parameters are taken from parameter sets
PNL1 listed in Table 5.1 andPNL2 listed in Table 5.2, unless otherwise stated.
5.5.1 Computational Simulation Results in 1D
For the 1-dimensional spatial domain, we performed the simulations on the domain
D1D = (0,10). Each unit length is discretised into 100 grid cells, or ∆x = 0.01. At
x = 0 we impose symmetry boundary conditions while zero-flux boundary conditions
are applied at x = 10. Initially we assume there are cancer cells with unit density
(c0 = 1) occupying 1/10 of the domain and penetrating into a half degraded matrix.
The initial uPA concentration is half of the magnitude of cell density, while the ini-
tial concentration of PAI-1 is 1/20 of cell density. There is no plasmin concentration
initially. This initial condition set up is illustrated in Fig. 5.3, where the solid line rep-
resents cancer cell density, the dotted line represents matrix density, the dash-dotted
line represents uPA, and the dashed line represents PAI-1. We performed the simula-
tions up to dimensionless time t = 300, before the front of cancer cell density reaches
the boundary. This way, we may notice the behaviour of cells without any potential
numerical effects of the boundaries.
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Figure 5.3: Initial condition setup for 1D numerical simulations.
Fig. 5.4 shows the progression of solutions using diffusion parameter set D1 which
has the same values of diffusion as in parameter setP (Dc = 3.5×10−4, Du = 2.5×
10−3, Dp = 3.5×10−3, and Dm = 4.91×10−3), taken at dimensionless times t = 10,
t = 100, t = 200, and t = 300. The solutions for cancer cell density are shown on the
left figures which depict the movement of cancer cell density in a travelling-wave like
manner, moving forward with a little hump at its invading front. We also see on the
right figure that the matrix density is degraded homogeneously. The dispersion relation
for the simulations is shown in Fig. 5.5.
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Figure 5.4: Sequence of profiles showing the spatio-temporal evolution of cancer cells c
(black, left figures) invading the ECM v (blue, right figures) for model (5.12) with diffusion
parameter set D1 where Dc = 3.5×10−4, Du = 2.5×10−3, Dp = 3.5×10−3, and Dm = 4.91×
10−3, and other parameters are the same as those given in parameter setPNL1 at dimensionless
times t = 10, t = 100, t = 200, and t = 300.
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Figure 5.5: Dispersion relation for simulations in Fig. 5.4 using default diffusion coefficient
values as given in parameter set P in Table 4.1. The nonlocal parameters are Scv = 0.1,
Scc = 0.01, R = 0.1, and Ω(r) = 1/2R.
Next decreasing diffusion, we use diffusion parameter set D2 (where Dc = 3.5×
10−5, Du = 2.5× 10−4, Dp = 3.5× 10−4, and Dm = 4.91× 10−4), and as we see in
Fig. 5.6 spatial patterns start to emerge, but to a small extent. The corresponding
dispersion relation is shown in Fig. 5.7.
The perturbations to the uniform wave-like solutions of cancer cell density in
Fig. 5.6 only affect the area near the invading front. The cancer cell density behind
the perturbed area is still dominated by a uniform solution with unit density (c = 1).
We notice that the speed of cell invasion is slightly reduced compared to the speed of
cell invasion in Fig. 5.4. As for the matrix density, it is homogeneously degraded in
the uniform area of cell and slightly fluctuated in the area with perturbed solution.
Patterns become more apparent if we use smaller values of diffusion parameters.
Fig. 5.8 shows the progression of solutions over time using parameter set PNL1. We
see here the perturbations now dominate the solution of cancer cell density in the form
of peaks close to each other and the average height of cell density is maintained at
c = 1, although there is a small peak of cell density at the invading front. We observe
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Figure 5.6: Plots showing solutions with diffusion parameter set D2 where Dc = 3.5×10−5,
Du = 2.5×10−4, Dp = 3.5×10−4, and Dm = 4.91×10−4. Other parameters are the same as
those given in parameter setPNL1.
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Figure 5.7: Dispersion relation for simulations in Fig. 5.6 using Dc = 3.5× 10−5, Du =
2.5×10−4, Dp = 3.5×10−4, and Dm = 4.91×10−4.
that the cancer cells invade the matrix with a constant speed in all solutions in Figs. 5.4,
5.6, and 5.8. In particular here, if we calculate the speed of invasion, it can be seen
in Fig. 5.8 that at dimensionless time t = 100 the invading front lies at x = 3.5, after
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another 100 time later (at t = 200) the invading front reaches x = 6 which is 2.5 units
away from the cell position at t = 100, and at t = 300 the invading front takes the
position at x = 2.5+ 6 or equal to x = 8.5. By taking ∆t = 100 and ∆s = 2.5, the
constant invasion speed is about ∆s/∆t = 0.025. Another thing that we can notice in
Fig. 5.8 is that cancer cells are more dense near the area of initial position and cancer
cells further away progress forward in peaks with a regular pattern and less dense.
The matrix now has been degraded in a less homogeneous manner compared to the
degradation with previous diffusion parameters, where here matrix degradation shows
more fluctuations in its degraded density.
The regular peaks of cell density in Fig. 5.8 are thought to be associated with cell
adhesion in the nonlocal term, where cell-matrix adhesion is 10 times higher than the
cell-cell adhesion coefficient. If we invert the values of cell adhesion parameters, by
increasing cell-cell adhesion to Scc = 0.1 and reducing cell-matrix adhesion to Scv =
0.01, the results are a pattern of cell density with irregular peaks, as we observe in
Fig. 5.9. The cell peaks are more densely packed at some area and sparse at other areas.
We see that the solution near the initial position is not affected by perturbations at all, as
there is no peaks in that area. Although the average cell density is maintained at c = 1,
some peaks are slightly higher and a few peaks are smaller than the uniform density
c = 1. The matrix is also degraded less homogeneously, showing small fluctuations in
the density of degraded matrix.
The simulations shown in Figs. 5.8 and 5.9 suggest that cell adhesion can play a
role in shaping spatial patterns that occur, particularly from using parameter setPNL1.
The corresponding dispersal relations for the simulations are shown in Fig. 5.10. It is
of interest to see the patterns that may emerge in 2-dimensional spatial domain if we
vary parameters such as cell-cell and cell-matrix adhesion as we discuss in the next
subsection.
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Figure 5.8: Sequence of profiles showing the spatio-temporal evolution of cancer cells c
(black, left figures) invading the ECM v (blue, right figures) for model (5.12) with parameter
setPNL1 at dimensionless times t = 10, t = 100, t = 200, and t = 300. Cancer cells invade the
ECM with a constant speed.
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Figure 5.9: Plots showing less regular invading cancer cells (black, left figures) and degraded
matrix (blue, right figures) are produced when cell-cell adhesion is higher than cell-matrix
adhesion, that is Scc = 0.1 and Scv = 0.01 at dimensionless time t = 100, t = 200, and t = 300.
All other parameters are as in parameter setPNL1.
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Figure 5.10: Dispersion relations for simulations in Fig. 5.8 (solid blue line) using Scv = 0.1,
Scc = 0.01 and Fig. 5.9 (dashed blue line) using Scv = 0.01, Scc = 0.1, all with Dc = 3.5×10−6,
Du = 2.5×10−5, Dp = 3.5×10−5, and Dm = 4.91×10−5.
5.5.2 Computational Simulation Results in 2D
The simulations for a 2-dimensional spatial domain were performed on a rectangular
domain D2D := (0,Mx)× (0,My) ⊂ R2 where in all simulations Mx = 4 and My =
2 in x and y directions, respectively, unless otherwise stated. Here mixed types of
boundary conditions are imposed on each side of the rectangular domain. Periodic
boundary conditions are applied at the opposite sides (at y = 0 and y = My) while
symmetry boundary conditions are applied at the left side where the cells initially
deposited (at x = 0), and the right side (at x =Mx) with zero-flux boundary conditions.
The schematic for the setup of boundary conditions for the 2D domain is shown in
Fig. 5.11.
Each unit size is discretised into 50 grid cells, in which ∆x= ∆y= 0.02. We ran the
simulations up to a maximum dimensionless time t = 500 or before the solutions reach
the right side boundary (Mx = 4) to avoid any numerical effects of the boundaries.
Initially at t = 0 we assume there is already a uniform cell density occupying 1/4 of
the area of the domain and the extracellular matrix takes up the rest of the domain.
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Figure 5.11: Boundary conditions setup for 2D computational simulations on a rectangular
domain D= (0,4)×(0,2). Periodic boundary conditions are imposed at y= 0 and y= 2, while
symmetric boundary conditions at x = 0 and zero-flux boundary conditions at x = 4.
These initial conditions are the same as the initial conditions for the 2-dimensional
domain of the base model given in Section 4.5 of Chapter 4.
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Figure 5.12: Plots showing the distribution of the cancer cell density c(t,x,y) (left figures)
and ECM density v(t,x,y) (right figures) in a rectangular domain Ω = (0,4)× (0,2) with pa-
rameter setPNL1 taken at dimensionless times t = 100, t = 200, t = 300, t = 400, and t = 500.
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In Fig. 5.12 we plot solutions of cancer cell density (left figures) and the extracel-
lular matrix (right figures) using parameter set PNL1 at dimensionless times t = 100,
t = 200, t = 300, t = 400, and t = 500 arranged from top to bottom. In this simu-
lation cell-matrix adhesion is set higher than cell-cell adhesion, taking Scv = 0.1 and
Scc = 0.01. We observe here that the cell density invades the matrix in an irregular
manner, with the cell density in the middle part advancing more than the cell density
near the top and bottom boundaries. Until t = 100 the cell density shows a “collec-
tive” cell movement. The effects of stronger cell-matrix adhesion is more evident after
t = 200 where the cell density spreads as “colonies” or “clusters”. Cells are no longer
tightly attached to the group, spreading across the domain with the invading front dom-
inated by cell density at the middle part. We also observe that the distribution of cell
density almost resembles the pattern in the 1-dimensional domain shown in Fig. 5.8,
where the cell density near the initial position is more compact than the cell density in
other areas. Stronger cell-matrix adhesion also causes erosion of the uniform cell den-
sity in the area of initial position. These results are comparable with the experimental
data for the most invasive cancer cells shown in Fig. 4.14, on the right bottom figure.
In Figs. 5.13 and 5.14 we increase the cell-cell adhesion to Scc = 0.5 but keep the
cell-matrix adhesion at Scv = 0.1. In Fig. 5.13 we plot the solutions from t = 10 to
t = 50 to have a closer look at the behaviour of solutions when cell-cell adhesion is
very strong and the pattern that the cells generate. At t = 10 the cell density imme-
diately aggregates, destabilising the uniform density and forming a pattern of stripes
of high densities. Soon afterwards the high cell densities start to reduce and at t = 30
deformation of the stripe pattern occurs. In Fig. 5.14 from t = 100 onwards the cell
density is reduced to values close to uniform and moves forward invading the matrix in
a way between collective and cluster motility. We also see some cell densities moving
in stripes. Because cell-cell adhesion is strong, the speed of invasion here is relatively
slower than in Fig. 5.12.
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Figure 5.13: Plots showing the distribution of the cancer cell density c(t,x,y) and matrix
density v(t,x,y) with parameter set PNL1 where we keep Scv = 0.1 but increasing cell-cell
adhesion Scc to 0.5. We observe the effects of strong cell-cell adhesion.
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Figure 5.14: Continued from Fig. 5.13 for t = 100 to t = 500.
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More interesting patterns emerge when cell-cell adhesion is increased to Scc = 0.1
and cell-matrix adhesion is reduced to Scv = 0.01. The solutions are shown in Fig. 5.15.
Other parameter values remain the same as in parameter set PNL1. At time t = 100
we observe a slow movement of cell density because cells maintain strong attachment
to other adjacent cells and less attachment to the extracellular matrix. Cells form high
density regions along the domain boundaries where periodic boundary conditions are
applied. The cell density along the boundaries moves faster than the cell density in the
middle part of domain. If we compare these with the solutions in Figs. 5.12, the cell
density in Fig. 5.15 progresses forward by keeping a tight connection within cells and
the solutions look like the opposite of the solutions in Figs. 5.12 where cell density in
the middle part refrain from moving forward fast. The strong cell-cell adhesion effects
are also seen in the cell density near the initial position, where the cell density in that
area is less deteriorated and it maintains its uniform steady state. In the matrix density
we see less homogeneous degradation with a few spots of high matrix densities in the
degraded area.
Different patterns emerge if cell-cell adhesion and cell-matrix adhesion are equally
strong or equally weak. When the cell-cell adhesion and cell-matrix adhesion param-
eters are set to be sufficiently equally weak, such as Scc = Scv = 0.01, we see less
pulling together and/or less spreading of cell density patterns as shown in Fig. 5.16.
Until time t = 100 there seems to be a reluctance in the movement of cells, with very
few advancing parts at the front observed. But at time t = 200 onwards we can see
coherent movement, where the cell density moves forward due to cell-matrix adhesion
and moves collectively due to cell-cell adhesion. The speed of invasion here is com-
parable with the simulations shown in Fig. 5.14. A uniform steady state cell density at
the area of initial position is maintained, even until time t = 500.
107
Figure 5.15: Plots showing the evolving of the cancer cell density c(t,x,y) and matrix density
v(t,x,y) patterns with parameter set PNL, but cell-cell adhesion is increased to Scc = 0.1 and
cell-matrix adhesion is decreased to Scv = 0.01.
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Figure 5.16: Plots showing the evolving patterns of the cancer cell density c(t,x,y) and
matrix density v(t,x,y) with parameter set PNL1 and equally weak cell-cell and cell-matrix
adhesion, Scc = Scv = 0.01.
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Setting cell-cell and cell adhesion to be almost equally strong, such as Scc = Scv =
0.1 we get a completely different pattern of cell density, as seen in Fig. 5.17. Strong
cell adhesion immediately destabilises the uniform steady state of cell density. Cells
spread faster and form an irregular pattern. We conjecture that the irregular pattern is
attributed to an intense competition between cell-cell and cell-matrix adhesion.
To classify how abnormal cancer cells look under a microscope and how quickly
the tumour is likely to grow and spread, a measure called histologic grade or differenti-
ation is used. Well-differentiated cells have tight junctions between cells as a result of
strong cell-cell adhesion. They move collectively or in an epithelial manner and move
at a slower rate. These cells resemble normal cells. Invasive cancer cells on the other
hand are poorly differentiated because of a lack of structure and function of normal
cells. They are less adherent due to lack of cell-cell adhesion and are moderately ad-
herent to matrix for movement/invasion. They move in small clusters or colonies and
spread faster. Varying parameters of cell-cell and cell-matrix adhesion has enabled us
to mimic the patterns of cell spreading that might be exhibited from well-differentiated
and poorly-differentiated cells.
In Fig. 5.18 we see the effects of decreasing chemotaxis and slightly increasing
diffusion to the nonlocal system, by using parameter setPNL2 listed in Table 5.2. The
chemotaxis due to uPA and PAI-1 is set to 10 times lower than the chemotaxis in the
previous simulations, where now χu = 3.05× 10−3 and χp = 3.75× 10−3. Diffusion
parameters are increased two times higher than the diffusion parameters of parameter
setPNL1, except for the diffusion parameter of cancer cell density where it was chosen
to be 1.3×10−5. Using these parameters and setting cell-matrix adhesion higher than
cell-cell adhesion results in a cell density solution that forms fingering-like pattern.
We observe that the cell density advances by forming extending parts that are almost
regular in shape and are expanding with the same length over time. The extending
parts also form tips at the invading fronts whose size is slightly larger than the width of
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the extending parts. It is also noticeable that the density of the tips is relatively high.
Intuitively, increasing diffusion parameters leads to the increase of the speed of
the invasion of cell density. This is observable in Fig. 5.18 where the cell density has
reached x = 3 at time t = 250 while it takes up to t = 500 for the cell density in the
previous simulations (in Figs. 5.12 and 5.15) to reach the position. We notice here that
chemotaxis plays less of a role in this simulation, because reducing the chemotactic
parameters does not reduce the speed of cell invasion.
The diffusion and chemotaxis parameters in parameter set PNL2 are sensitive to
the variation of cell adhesion parameters. If we reduce the cell-cell and cell-matrix
adhesion parameters to Scc = 0.001 and Scv = 0.01, respectively, the speed of invasion
also reduces where the invading fronts of cell density reach just before x= 3 at time t =
500. Also interesting here is that we observe a “mixed pattern” emerging as shown in
Fig. 5.19. The cell density forms patterns that are a mixture of uniform, heterogeneous,
and fingering-like patterns. Between the uniform pattern and fingering-like pattern,
there is a transition pattern which is irregular in shape. Unlike the extending parts in
the simulation of Fig. 5.18, there are no heads or tips that are larger than the width of
the extending parts at the invading fronts.
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Figure 5.17: Plots showing the evolving patterns of the cancer cell density c(t,x,y) and
matrix density v(t,x,y) with parameter set PNL1 and equally strong cell-cell and cell-matrix
adhesion, Scc = Scv = 0.1.
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Figure 5.18: Plots showing a pattern of fingering of the cancer cell density c(t,x,y) and the
matrix density v(t,x,y) with parameter setPNL2, where the diffusion parameters are increased
and the chemotactic parameters are decreased, cell-cell adhesion Scc = 0.01 and cell-matrix
adhesion Scv = 0.1. Plots are taken at t = 50, t = 100, t = 150, t = 200, and t = 250.
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Figure 5.19: Plots showing a “mixed pattern” of the cancer cell density c(t,x,y) and matrix
density v(t,x,y) with parameter set PNL2 and lowering cell adhesion parameters Scv to 0.01
and Scc to 0.001.
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Invasion in a Heterogeneous Matrix
The in vivo structure of extracellular matrix is composed of 3 major classes of biomolecules:
(1) structural proteins, such as collagen and elastin; (2) specialised proteins, such as
fibrillin, fibronectin, and laminin; and (3) proteoglycans, which are composed of a pro-
tein core to which is attached long chains of repeating disaccharide units termed gly-
cosaminoglycans (GAGs), forming extremely complex high molecular weight compo-
nents of the matrix. There are also other glycoproteins including proteolytic enzymes
involved in the degradation and remodelling of the extracellular matrix. These ma-
trix macromolecule components are secreted locally and assembled into an organised
meshwork. The relative amounts of the matrix molecules are varied and diverse, based
on functional requirements of the particular tissue. Matrix is also under constant re-
modelling by simultaneous degradation and synthesis of matrix components with dif-
ferent turn-over rates. All of these give rise to heterogeneity in matrix density (Alberts
et al., 2002).
Attempts to mathematically model the behaviour of cell movement in heteroge-
neous and anisotropic fibre networks using a continuum approach has been done pre-
viously, such as a model by Chauviere et al. (2007). In order to see the influence of
complex matrix composition, or heterogeneous matrix, on our nonlocal model, we use
two different types of heterogeneous matrix, as shown in Fig 5.20. The first type (left
plot) has clusters of uneven high densities, formulated as
v0 =
n
∑
i=1
ai exp
(
−
(
(x− xi)2+(y− yi)2
bi
))
, (5.25)
where we choose arbitrarily n= 21 points (xi,yi) each with different values of a and b.
The second type (right plot) consists of two stripes of high densities,
v0 = m0+m1 cos
(
2piky
(
y−0.5
Ly
))
(5.26)
where for the D2D := (0,4)× (0,2) domain we use m0 = 0.7,m1 = 0.3,ky = 2, and
Ly = 2.
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Figure 5.20: Plots showing the two types of heterogeneous matrix for simulations in
Figs. 5.21 and 5.22.
To maintain the shape of the heterogeneous matrix throughout the simulations, in
the following two simulations shown in Figs. 5.21 and 5.22 we reduce the value of
matrix proliferation rate to µ2 = 0.0001. Due to the nature of our model, if we use
the default value of µ2 = 0.15 the heterogeneous matrix composition will be deformed
and the matrix density immediately returns to the uniform state, as the initial condition
for matrix density in other previous simulations. The parameter values in parameter
setPNL1 are used in these two simulations.
By using a heterogeneous matrix, we observe that cells tend to move or invade
faster in regions of low matrix density although regions of high matrix density are
eventually degraded. We also see that the pattern of degraded matrix follows the pattern
of invading cells.
Since there are many regions of low matrix density, this enables cells to move faster
and reach the other side of the domain in less than t = 250. Therefore, we deduce that
the rate of invasion on heterogeneous matrix density is faster than that on homogeneous
matrix density (uniform matrix density, v = 1).
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Figure 5.21: Plots showing the patterns that evolve from simulations with a heterogeneous
matrix, where the initial condition of matrix is shown on the left figure of Fig. 5.20 at dimen-
sionless times t = 50, t = 100, t = 150, t = 200, and t = 250 using parameter setPNL1.
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Figure 5.22: Plots showing the patterns that evolve from simulations with a heterogeneous
matrix with two stripes as matrix initial condition as shown on the right figure of Fig. 5.20 at
dimensionless times t = 50, t = 100, t = 150, t = 200, and t = 250 using parameter setPNL1.
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Biphasic Dependence
There is a growing evidence that cell motility is regulated by the chemical and phys-
ical properties of extracellular matrix. The factors that govern whether cells migrate
or not on extracellular matrix, and also their speed, depend on several variables re-
lated to interactions between cell surface protein integrins and matrix proteins (such as
fibronectin), including integrin levels, surface density and distribution of matrix pro-
teins, and binding affinities between integrin-matrix proteins (Palecek et al., 1997).
Studies suggest that cell migration speed exhibits a biphasic dependence on the sur-
face density of matrix protein, where the maximum speed of migration is attained at an
intermediate level of physical distribution of matrix proteins, density or adhesiveness
(Huttenlocher et al., 1996; Lauffenburger and Horwitz, 1996; Choquet et al., 1997;
Palecek et al., 1997; Stahl and Mueller, 1997; Maheshwari et al., 1999, 200; Cox et al.,
2001; Gobin and West, 2002; Hocking and Chang, 2003; Li et al., 2005; Peyton and
Putnam, 2005; Khatiwala et al., 2006; Zaman et al., 2006; Silvestre et al., 2009). This
implies that a significant increase in matrix protein density surrounding cells would
lead to a drastic reduction of migration speed at a given level of motile force. The same
effect also applies for very low matrix protein density, that causes very low anchorage
for cells thus refraining from performing movement. Since the interactions between
cells (or cell surface proteins) with matrix protein density result in adhesiveness or
cell-matrix adhesion, it can also be stated that cell speed exhibits biphasic dependence
on adhesive strength between cell and extracellular matrix.
In the nonlocal model (5.12) there are two separate variables for matrix density
and cell-matrix adhesion. It is of interest to see the effects of biphasic dependence of
cell speed on both matrix component density and cell-matrix adhesion to the nonlo-
cal model, each applied independently. Plots of the biphasic manners are illustrated
Fig. 5.23, where cell random motility parameter Dc is dependent on matrix density v
(left plot) and on cell-matrix adhesion Scv (right plot). We use a smooth step function
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that models the biphasic manner, i.e.,
Dc(v) = Dc
(
exp
(
−(v−0.5)
2
0.05
))
. (5.27)
for Dc as a function of matrix density ranging from [0,1], and
Dc(Scv) = Dc
(
exp
(
−(Scv−0.1)
2
0.002
))
, (5.28)
for Dc as a function of cell-matrix adhesion within a range Scv = [0,0.2], where Dc is
the default diffusion parameter in parameter setPNL1.
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Figure 5.23: Plots illustrating the biphasic dependence of cell diffusion coefficient on matrix
density (left) and on cell-matrix adhesion (right).
By using parameter set PNL1, if we apply the diffusion coefficient dependence
on matrix density we get slightly slower movement for low and high matrix density
compared to intermediate matrix density, as shown in Fig. 5.24 where all plots are
taken at simulation time t = 400. The top plots show the dispersion of cells (left) on
a uniformly low matrix density (v = 0.2) and the bottom plots for simulations using
a high and uniform matrix density (v = 1). Both simulations exhibit relatively slower
movement of cells compared to the simulation with an intermediate uniform matrix
density (v = 0.5) which is shown in middle figures. All simulations generate patterns
that are similar to each other, although the shape of the invading fronts are slightly
different.
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Figure 5.24: Plot showing the simulation results with biphasic dependence of the cell dif-
fusion coefficient Dc on matrix density at time t = 400 using parameter setPNL1. Top figures
show results of simulation with uniformly low matrix density (v = 0.2), middle figures for
simulation with intermediate and uniform matrix density (v= 0.5), and bottom figures for sim-
ulation with high and uniform matrix density (v = 1).
A more significant difference in cell speed is seen in the simulations if the cell
diffusion is a function of cell-matrix adhesion, as shown in Fig. 5.25. Based on the
biphasic curve in Fig. 5.23 (right plot) where we randomly set the maximum cell-
matrix adhesion 0.2, cell density attains its maximum speed at the intermediate adhe-
sion Scv = 0.1, shown by the middle plots of Fig. 5.25. At low cell-matrix adhesion,
where we set Scv = 0.025, the movement of cells is very slow, as shown by the top
figures. It also occurs at high cell-matrix adhesion (Scv = 0.175), shown by the bottom
plots. All plots are taken at simulation time t = 500. Different patterns emerge here,
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for biphasic dependence on cell-matrix adhesion. Simulation with low cell-matrix ad-
hesion exhibits a pattern of cells that consists of uniform cell density (near the initial
position area) and regular dispersion of cell density that moves forward invading ma-
trix. The simulation with intermediate cell-matrix adhesion exhibits a combination of
uniform cell density, connective cell density movement, and dispersion of clusters of
cell density. While for high cell-matrix density we observe a pattern of cells that have
dispersed throughout (destabilising uniform density) but moving very slow. There are
also a few clusters of cell density forming at the invading front.
Figure 5.25: Plots showing the comparison of simulations with biphasic dependence of cell
diffusion coefficient Dc on cell-matrix adhesion at time t = 500. Top figures show results of
simulation with relatively low cell-matrix adhesion (Scv = 0.025), middle figures for simulation
with relatively intermediate cell-matrix adhesion (Scv = 0.1), and bottom figures for simulation
with relatively high cell-matrix adhesion (Scv = 0.175).
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Modified Cell Proliferation and Matrix Remodelling Terms
As it has been discussed in Chapter 4, in order to take into account the effect of space
competition between cells and matrix, all motility, cell proliferation, and matrix remod-
elling terms are expressed with a carrying capacity effect that incorporates the limited
spatial availability for competition between cells and matrix, where the equations for
cancer cells and the extracellular matrix now become
∂c
∂ t
= Dc∇2c︸ ︷︷ ︸
random motility
−∇ ·
(
c
R
∫ R
−R
(Sccc+Scvv)(1− c− v)Ω(r)dr
)
︸ ︷︷ ︸
adhesive movement
−∇ · (χuc(1− c− v)∇u)︸ ︷︷ ︸
uPA-chemotaxis
−∇ · (χpc(1− c− v)∇p)︸ ︷︷ ︸
PAI-1-chemotaxis
+µ1c(1− c− v)︸ ︷︷ ︸
proliferation
, (5.29a)
∂v
∂ t
= − δvm︸︷︷︸
degradation
+ φ21 pu︸ ︷︷ ︸
uPA/PAI-1
− φ22 pv︸ ︷︷ ︸
PAI-1/VN
+µ2v(1− c− v)︸ ︷︷ ︸
remodelling
, (5.29b)
subject to the given initial and boundary conditions given previously. Here we use
a slightly different form for matrix remodelling than that in (4.16b) where the re-
modelling term is given by µ2(1− c− v). Here in (5.29b) we propose a form of
µ2v(1− c− v) for matrix remodelling which takes the same form as cell proliferation.
Simulation results using the new form for cell proliferation and matrix remod-
elling using parameter set PNL1 exhibit cells whose uniform density pattern breaks
and progresses forward very little, as shown in Fig. 5.26. We notice that at dimension-
less times t = 500 and t = 1000 the cell density remains almost at the same position.
Assuming it is due to diffusion coefficients that are too small for the modified prolif-
eration and remodelling terms and hence prevent the cells from moving, we increased
the diffusion coefficients in PNL1 10 times higher, that is to Dc = 3.5× 10−5,Du =
2.5× 10−4,Dp = 3.5× 10−4, and Dm = 4.91× 10−4. Now the cell density exhibits
movement as shown in Fig. 5.27. The cells invade the matrix and spread as clusters.
Matrix that has been degraded shows darker area, indicating high matrix remodelling.
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Figure 5.26: Plots showing simulation results using a modified form of cell proliferation and
matrix remodelling as in (5.29) with parameter set PNL1 at dimensionless time t = 500 (top
figures) and t = 1000 (bottom figures). Left figures show cancer cell density and right figures
show matrix density.
That the modified cell proliferation and matrix remodelling terms slow down cancer
cell invasion is also shown in simulation results in Fig. 4.13 of Chapter 4.
5.6 Discussion and Conclusions
In this chapter we have presented an extensive mathematical model of cancer cell in-
vasion of tissue that combines the roles of proteolysis and cell adhesion. We used the
urokinase-type plasminogen activator (uPA) model that was presented and analysed in
Chapter 4 as a base model and extended it with adhesion properties by incorporating an
adhesive movement term in the equation for cancer cell density. The adhesive move-
ment term is nonlocal (in space) and it comprehensively accounts for adhesiveness
between cell and cell or cell-cell adhesion and adhesiveness between cell and extra-
cellular matrix or cell-matrix adhesion. This adhesive movement term (nonlocal term)
replaces the haptotactic term used in the uPA model for gradient movement of cells
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Figure 5.27: Plots showing simulation results using the modified cell proliferation and
matrix remodelling terms in (5.29) with increased diffusion coefficients, where here Dc = 3.5×
10−5,Du = 2.5×10−4,Dp = 3.5×10−4, and Dm = 4.91×10−4 at dimensionless times t = 500
(top figures) and t = 1000 (bottom figures). Left figures show cancer cell density and right
figures show matrix density.
toward matrix components. The extended model (or nonlocal model) is biologically
more realistic and it resembles local invasion of cancer cells of tissue where malig-
nant tumour cells or cancer cells must detach from the main tumour body, degrade
surrounding tissue and migrate through the tissue (Liotta, 1986).
In order to account for population pressure or increased crowding in cell and ma-
trix density we used a volume filling mechanism in the motility terms, i.e., the adhesive
movement and chemotaxis terms. With the volume filling term, aggregation is limited
by available space in which the movement should decrease with increasing total density
of cell and matrix. Although the use of volume filling may result in no heterogeneous
spatial patterns or only travelling-wave like patterns of the solutions, with linear stabil-
ity analysis it is possible to determine the parameters that drive the dispersion relation
to go to an unstable regime or at least close to instability. It was revealed by a linear
stability analysis that decreasing diffusion parameters may lead to a finite range of pos-
itive eigenvalues, which is the requirement for generation of spatial patterns. We chose
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the range of diffusion parameters between 3.5× 10−6 for cell diffusion to 2.5× 10−5
for uPA diffusion, which are 100 times lower than the diffusion parameters used in
Chapter 4. These diffusion parameters yield a dispersion relation curve that is close to
the “unstable ” dispersion relation curve shown in Fig 5.2. It is the aim of our future
work to carry out a nonlinear stability analysis of the nonlocal model.
We have seen in Chapter 5.5 the effects of cell adhesion in the uPA system, where
varying cell adhesion parameters in the nonlocal system (5.12) exhibits various pat-
terns of cell movement or dispersion, particularly for simulations on a 2-dimensional
spatial domain. Cell adhesion also influences the speed of movement. Experimentally
it has been proposed that aside from the cancer cell environment, properties of cancer
cells such as cell adhesion, may influence the patterns of spread and growth (Fidler,
1978). As we have discussed in Chapter 4, the depth and pattern of invasion are two
key features of cancer cell invasion. Using the nonlocal model, by tuning cell-cell and
cell-matrix adhesion parameters it is possible to obtain patterns that mimic invasion
behaviours in organotypic culture, such the experimental data in Fig. 4.14 and patterns
in Nystro¨m et al. (2005). There is also a degree of freedom in adjusting cell adhesion
parameters to generate proper invasion speed or invasion depth. These aspects may
lead to possible generation of a numerical “Invasion Index” based on a mathematical
model.
As has been discussed in section 4.6 of Chapter 4, by using different sub-populations
of cancer cells (cf. cancer as a progressive disease), here we present the “mutation
pathway” into the nonlocal model and the equations for cell densities c1 (less invasive)
and c2 (more invasive) are given by
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∂c1
∂ t
= Dc1∇
2c1︸ ︷︷ ︸
random motility
−∇ ·
(
c1
R
∫ R
−R
(Scc1c1+Scv1v)(1− c− v)Ω(r)dr
)
︸ ︷︷ ︸
adhesive movement
−∇ · (χu1c1(1− c− v)∇u)︸ ︷︷ ︸
uPA-chemotaxis
−∇ · (χp1c1(1− c− v)∇p)︸ ︷︷ ︸
PAI-1-chemotaxis
+µ11c1 (1− c− v)︸ ︷︷ ︸
proliferation
− λc1F(t,v)︸ ︷︷ ︸
conversion to c2
, (5.30a)
∂c2
∂ t
= Dc2∇
2c2︸ ︷︷ ︸
random motility
−∇ ·
(
c2
R
∫ R
−R
(Scc2c2+Scv2v)(1− c− v)Ω(r)dr
)
︸ ︷︷ ︸
adhesive movement
−∇ · (χu2c2(1− c− v)∇u)︸ ︷︷ ︸
uPA-chemotaxis
−∇ · (χp2c2(1− c− v)∇p)︸ ︷︷ ︸
PAI-1-chemotaxis
+µ12c2 (1− c− v)︸ ︷︷ ︸
proliferation
+ λc1F(t,v)︸ ︷︷ ︸
conversion from c1
, (5.30b)
where Dc1 , Scc1 , Scv1 , µ11 all have the values as in parameter set PNL1 and the pa-
rameters for more invasive cells c2 are: Dc2 = 4.5× 10−6, Scc2 = 0.005, Scv2 = 0.2,
µ12 = 0.5 with exception χu2 and χp2 which we set the same as the chemotactic pa-
rameters in parameter set PNL1. These parameters for more invasive cells represent
higher cell motility, reduced cell-cell adhesion and increased cell-matrix attachment
for more motile cells, and higher rate of proliferation. The cells are converted from
less invasive into more invasive with rate λ = 0.1. The conversion function F is given
by
F(t,v) = H(60 < t < 70) ·H(v−0.3) . (5.31)
The conversion function that we choose here is slightly different that in (4.18),
where in (5.31) the conversion time from less invasive cells c1 to more invasive/malignant
cells c2 is limited to occur only between t > 60 and t < 70. The results of the com-
putational simulations for the “mutation pathway” mechanism are shown in Fig. 5.28.
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The top figure shows the progression of the less invasive cell density c1, the middle
figure with the more invasive cell density c2, and the extracellular matrix density at
the bottom. At dimensionless time t = 500 cells of sub-population 2 (c2) which are
more invasive spread and invade the matrix faster and disperse more (less crowded)
than cells of sub-population 1 (c1).
Figure 5.28: Plots showing the simulation results using different sub-populations of cancer
cells as in (5.30), where cells of sub-population 2 (middle figure) are more invasive than cells
of sub-population 1 (top figure). Parameters for cells of sub-population 1 are as in parameter
set PNL1 and the parameters for more invasive cells are: Dc2 = 4.5× 10−6, Scc2 = 0.005,
Scv2 = 0.2, µ12 = 0.5.
With the results achieved in this chapter, we believe that the nonlocal model offers
a deeper understanding of the processes involved in cancer cell invasion, particularly
adhesion processes that are clinically and experimentally very complex but is crucial
to understand for cancer studies and improving cancer treatment strategies. Although
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the present model provides a suitable level of sophistication and complexity to discuss
important features of cancer cell invasion, there are still many other known processes
that we do not explicitly account for, such as genetic mutations and signal transduction
pathways. Incorporation of such intracellular and genetic events in a genuine multi-
scale model is the next big challenge appearing on the modelling horizon.
5.6.1 Comments on the Numerical Scheme and Validation of the
Simulation Results
In this final section, we would like to add some notes concerning the numerical validity
of the simulations presented in this chapter. It is necessary to examine the behaviour
of the numerical simulations as we use finer spatial grids to demonstrate whether the
numerical simulations we have presented are the products of genuine model behaviour
or whether there are numerical artefacts involved. For 1D simulations, as we have
mentioned in subsection 5.5.1, all simulations were performed using a grid spacing of
size ∆x = 0.01. Here we look at simulations results obtained by using grid spacings
of size ∆x = 0.005 and ∆x = 0.0025. For 2D simulations, the numerical validation is
performed by using a finer grid spacing of size ∆x = ∆y = 0.01 to compare with the
results in subsection 5.5.2 which used a grid spacing of size ∆x = ∆y = 0.02.
Fig. 5.29 shows the results of 1D simulation using a grid spacing of size ∆x= 0.005
for comparison with the results in Fig. 5.4 where the diffusion coefficients used are
Dc = 3.5×10−4, Du = 2.5×10−3, Dp = 3.5×10−3, and Dm = 4.91×10−3. For even
smaller grid spacings of size ∆x = 0.0025 the results are shown in Fig. 5.30. We can
see that the simulation results for finer grids with grid spacings of sizes ∆x = 0.005
and ∆x = 0.0025 behave the same as the results using grid spacings of size ∆x = 0.01.
The little hump at the invading front is suspected to be a genuine consequence of
the nonlocal expression, where Scv = 0.1 and Scc = 0.01. If we swap the values of Scv
and Scc, as shown in Figs. 5.31 and 5.32, where now Scv = 0.01 and Scc = 0.1, the
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invading front changes shape.
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Figure 5.29: Sequence of profiles showing the spatio-temporal evolution of cancer cells c
(black, left figures) invading the ECM v (blue, right figures). Here we use a grid spacing of size
∆x= 0.005 and diffusion coefficients Dc = 3.5×10−4, Du = 2.5×10−3, Dp = 3.5×10−3, and
Dm = 4.91×10−3, and Scv = 0.1 and Scc = 0.01.
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Figure 5.30: Sequence of profiles of cancer cells c (black, left figures) invade the ECM v
(blue, right figures) using a grid spacing of size ∆x= 0.0025 for comparison with Fig. 5.4. The
other parameters remain the same as in Fig. 5.4 and/or Fig. 5.29.
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Figure 5.31: Sequence of profiles showing the spatio-temporal evolution of cancer cells c
(black, left figures) invading the ECM v (blue, right figures) using Scv = 0.01 and Scc = 0.1 with
a grid spacing of size ∆x = 0.005 and diffusion coefficients Dc = 3.5×10−4, Du = 2.5×10−3,
Dp = 3.5×10−3, and Dm = 4.91×10−3.
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Figure 5.32: Sequence of profiles showing the spatio-temporal evolution of cancer cells c
(black, left figures) invading the ECM v (blue, right figures) using Scv = 0.01 and Scc = 0.1 with
a grid spacing of size ∆x = 0.0025 and other parameters used are the same as in simulations in
Fig. 5.31.
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Figure 5.33: Sequence of profiles showing the spatio-temporal evolution of cancer cells
c (black, left figures) invading the ECM v (blue, right figures) for comparison with Fig. 5.6
where here the grid spacing is size ∆x = 0.005 and diffusion coefficients Dc = 3.5× 10−5,
Du = 2.5×10−4, Dp = 3.5×10−4, and Dm = 4.91×10−4, and Scv = 0.1 and Scc = 0.01.
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Figure 5.34: Sequence of profiles showing the spatio-temporal evolution of cancer cells c
(black, left figures) invading the ECM v (blue, right figures) for comparison with Fig. 5.6 as a
numerical validation with a grid spacing of size ∆x = 0.0025. The other parameters remain the
same as in Fig. 5.6 and/or Fig. 5.33.
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The numerical simulations behave slightly differently for the simulation results
with smaller diffusion coefficients Dc = 3.5×10−5, Du = 2.5×10−4, Dp = 3.5×10−4,
and Dm = 4.91× 10−4 if we use finer grids with grid spacings of size ∆x = 0.005
and ∆x = 0.0025 as shown in Figs. 5.33 and 5.34, respectively, as compared with the
results using ∆x = 0.01 presented in Fig. 5.6. We observe in Figs. 5.33 and 5.34 that
the heterogeneity width at the invading front reduces significantly, more than half of
the width of the heterogeneity of the invading front in Fig. 5.6.
The slight change of behaviour also occurs for smaller diffusion coefficients listed
in parameter set PNL1. In Figs. 5.35 and 5.36 where the grid spacing sizes used are
∆x = 0.005 and ∆x = 0.0025, respectively, the spikes of cancer cell density tend to
become irregular as compared with the regular spikes observed in Fig. 5.8 where ∆x =
0.01. The heterogeneity in the extracellular matrix is also more visible in Figs. 5.35
and 5.36, which is a consequence of the irregular cell density. We can also confirm
here that the solutions converge since there are approximately about 3 grid cells within
each spike for all grid sizes.
The differences of the numerical simulation results arise by using different grid
spacing sizes may be due to numerical artefacts in the code, where the code may not be
able to cope with the highly nonlinear equations that we use. Despite these differences,
nevertheless, the results are qualitatively the same and a range of parameter values
gives rise to heterogeneity in the solutions.
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Figure 5.35: Sequence of profiles showing the spatio-temporal evolution of cancer cells
c (black, left figures) invading the ECM v (blue, right figures) for comparison with Fig. 5.8
where here the grid spacing is of size ∆x = 0.005 and diffusion coefficients Dc = 3.5× 10−6,
Du = 2.5×10−5, Dp = 3.5×10−5, and Dm = 4.91×10−5, and Scv = 0.1 and Scc = 0.01.
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Figure 5.36: Sequence of profiles of cancer cells c (black, left figures) invading the ECM v
(blue, right figures) for comparison with Fig. 5.8 as a numerical validation with a grid spacing
of size ∆x = 0.0025. The other parameters remain the same as in Fig. 5.6 and/or Fig. 5.33.
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For our 2D simulations, changes of behaviour are observed if we use finer grids,
as can be seen in Fig. 5.37 where the grid spacing size is ∆x = 0.02 (top figures) and
∆x= 0.01 (bottom figures). The speed of invasion is faster for simulations using a finer
grid of spacing ∆x = 0.01 where the breaking of symmetry also becomes less.
Figure 5.37: Sequence of profiles showing the spatio-temporal evolution of cancer cells c
(left figure) invading the ECM v (right figure) with grid spacing size of ∆x = 0.02 (top figures)
and ∆x = 0.01 (bottom figures) taken at t = 250. Parameters used are Dc = 3.5× 10−6,Du =
2.5×10−5,Dp = 3.5×10−5,Dm = 4.91×10−5,Scc = 0.01,Scv = 0.1, and R = 0.1.
We have investigated the potential influence of initial conditions on the solutions.
We performed this by using smooth initial conditions, the same initial conditions that
have been used for our 1D simulations, where now
c(0,x) =
(
1+ exp
(
x−1.0
0.1
))−1
,
v(0,x) = 1− c(0,x) ,
u(0,x) =
1
2
c(0,x) ,
p(0,x) =
1
20
c(0,x) ,
m(0,x) = 0 ,
for x ∈ D¯2D , (5.32)
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and the results are shown in Fig. 5.38. The top figures show the smooth initial condi-
tions for cancer cell density (left figure) and extracellular matrix (right figure). By us-
ing the smooth initial conditions, the patterns of solutions are now different than those
obtained by using step function initial conditions, compared with Fig. 5.12. There is
no breaking of symmetry of cancer cell density, either with grid spacing size ∆x= 0.02
(shown on the left middle figure of Fig. 5.38) or a finer grid spacing size ∆x = 0.01
(shown on the left bottom figure). The speed of cancer cell invasion is the same for
both grid spacings. Because of the differences in the results for validation than the re-
sults presented in Section 5.5, it is part of our future work to investigate the numerical
technique used in the code.
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Figure 5.38: Sequence of profiles showing the spatio-temporal evolution of cancer cells c
(left figure) invading the ECM v (right figure) at t = 100 using smooth initial conditions as
in Eq. (5.32) and shown in the top figures. The results with grid spacing size ∆x = 0.02 are
shown in the middle figures and the results with grid spacing size ∆x = 0.01 are shown in the
bottom figures. Parameters used are Dc = 3.5×10−6,Du = 2.5×10−5,Dp = 3.5×10−5,Dm =
4.91×10−5,Scc = 0.01,Scv = 0.1, and R = 0.1.
Finally, as we have seen in Fig. 4.4 of Chapter 4 where the uPA chemotactic term
caused destabilisation of homogeneous steady state, we plot the dispersion relation
in which we reduce the value of χu from 3.05× 10−2 to 3.05× 10−4. The result is
that with smaller values χu there is a range of k˜-values where λk(w∗) is positive as
shown in Fig. 5.39, which suggests that uPA chemotaxis may play role in creating the
observed heterogeneity. The 2D computational simulations result in (almost) similar
heterogeneous patterns and invasion speed for both grid sizes ∆x= 0.02 and ∆x= 0.01,
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as shown in Fig. 5.40.
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Figure 5.39: Dispersal relations with χu = 3.05×10−4 (blue line) and χu = 3.05×10−2 (red
line).
Figure 5.40: Sequence of profiles showing the spatio-temporal evolution of cancer cells c
(left figure) invading the ECM v (right figure) with grid spacing size ∆x= 0.02 (top figures) and
∆x = 0.01 (bottom figures) at t = 500, where now χu = 3.05×10−4 and the rest of parameters
take the same values as simulations in Fig. 5.38 (here we used step function initial conditions).
Chapter 6
A Multiscale Individual Cell-based
Model of Cancer Invasion
6.1 Introduction
Having seen the role of cell adhesion in cancer invasion modelling from a cell popu-
lation/density approach in the previous chapters, now we change scale and look into
the adhesion processes inside of the cell. In this chapter we present a multiscale,
individual-based simulation environment that integrates CompuCell3D for lattice-based
modelling on cellular level and Bionetsolver for intracellular modelling. Compu-
Cell3D or CC3D provides an implementation of the lattice-based Glazier-Graner-Hogeweg
or GGH model, an extension of Cellular Potts Model or CPM, and a Monte Carlo
method based on metropolis algorithm for system evolution. The integration of CC3D
for cellular and Bionetsolver for subcellular modelling mechanisms enables us to study
cells in action due to the dynamics inside of the cells, capturing aspects of cell be-
haviour and interactions that is not possible using continuum approaches. We then
apply this multiscale modelling technique to a model of cancer growth and invasion,
based on the work of Ramis-Conde et al. (2008) where individual cell behaviours are
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driven by a molecular network describing the dynamics of E-Cadherin and β -catenin.
In this centre based model an alternative individual-based modelling technique has
been used, namely, an off-lattice approach. In many respects, GGH methodology and
the centre based model have the same overall goal, that is to mimic behaviours and
interactions of individual biological cells. Although the mathematical foundations and
computational implementations of the two approaches are very different, the results of
the simulations we will present are compatible with each other suggesting that using
cell behaviours we can formulate a natural way of describing complex multicell, mul-
tiscale models. The ability to easily reproduce results of one modelling approach using
an alternative approach is essential from a model cross-validation stand point and also
helps to identify modelling artefacts specific to a given computational implementation.
Modelling methodologies that explicitly represent individual cells are particularly
appropriate for the modelling and simulation of cancer invasion. There are important
events and physical phenomena associated with cancer invasion on the single-cell level
that can only be suitably captured in simulations by accounting for individual cell
properties and important aspects of cell-cell interactions, such as changes in cell-cell
contact area.
In modelling the various stages of cancer progression, certain computational and
mathematical methodologies are more suitable than others. For example, in the case
of solid avascular tumour growth, simple continuum models are well-suited since they
capture bulk properties of tissues. Instead of explicitly treating individual cells, col-
lective properties of the tumour tissue are modelled, such as cell density and oxygen
concentration. An advantage of such an approach is that systems with large number of
cells, on the order of 106 or higher, can be handled. On the other hand, explicit repre-
sentation of individual cells and their properties, such as locations, radii, morphology,
surface area, volume, etc., can become computationally burdensome when trying to
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model on the order of 104 to 106 cells. Nevertheless, such individual cell-based mod-
elling approaches are capable of capturing phenomena and behaviour in multicellular
systems that continuum approaches cannot capture.
The aim of the work in this chapter is to present a case study on model cross-
validation. We simulate, reproduce, and compare the cancer invasion model described
in Ramis-Conde et al. (2008) with the equivalent CC3D-based implementation.
6.2 The CC3D-Bionetsolver Framework for Biomedi-
cal Multiscale Individual Cell-based Simulations
CompuCell3D or CC3D is an open source simulation environment that is based on the
Glazier-Graner-Hogeweg or GGH model to simulate cell behaviours, such as individ-
ual cells that can interact with each other or with a medium. The GGH model is an
extension of the large-q Potts model, while the large-q Potts model itself is an exten-
sion of the Ising model, a simple early model of ferromagnetism based on the magnetic
moments, or spins, of individual atoms and their interaction energies. The interaction
between a single pair of neighbouring spins is called a link or a bond, and the spins
interact via an energy function called a Hamiltonian (Glazier et al., 2007), which we
describe in this section.
Systematic building of a biomedical model can be divided into following distinct
stages: a) building a conceptual biomedical model; b) formal description of the model
based on agreed upon modelling language, such as Systems Biology Markup Language
or SBML; c) translating the formal language into a mathematical formalism, for ex-
ample, SBML is translated into a set of ordinary differential equations or ODEs; and
d) computational implementation of c).
“Traditional” biomedical model building skips intermediate stages and jumps from
conceptual model description directly into low-level code. This is often convenient
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from the perspective of the modeller but it greatly impedes model cross-validation,
reuse or sharing. Problem solving environments such as CC3D, Mason, or Flame
greatly reduce the amount of effort necessary to build a model which rigorously fol-
lows stages a)–d) and at the same time offers the same level of flexibility in model
construction as low-level programming languages.
A CC3D model contains a description of objects (e.g., cells, ECM, diffusible fields),
interactions (e.g., cell-cell adhesion, morphogen-dependent cell growth), initial condi-
tions (e.g., initial configuration of cells based on time-lapse microscopy image), and a
description of the time evolution of cell properties (e.g., β -catenin concentration dy-
namics driving adhesive cell properties or rule-based cell type differentiation).
CC3D models are described using a combination of CompuCell3D Markup Lan-
guage (CC3DML) and Python scripting. Such a combined approach allows one to
build complex biomedical models and does not require recompilation when running
them. In typical CC3D simulations “static” aspects of the model such as lattice size,
simulation runtime, list of cell types, initial conditions or cadherin affinities are usually
described using CC3DML. We can replace CC3DML with the equivalent Python syn-
tax. The “dynamic” part of the CC3D model is described using Python scripting. Since
Python is a full featured programming language, modellers have freedom to express
complex cell type differentiation rules, coupling of cell properties to concentration of
diffusive chemicals cell-cell signalling or parameterising cell adhesive properties in
terms of the underlying molecular or gene regulatory networks.
Several models of tumour growth and angiogenesis have already been simulated
using the CC3D environment, see for example articles by Poplawski et al. (2006, 2008,
2009); Shirinifard et al. (2009); Swat et al. (2009).
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6.2.1 GGH Methodology
The GGH model uses an effective-energy formalism. It facilitates multiscale simula-
tions by defining spatially extended generalised cells, which can represent clusters of
cells, single cells, subcompartments of single cells or small subdomains of non-cellular
materials. All GGH models include a list of objects, their interaction descriptions, their
dynamics, and appropriate initial conditions. Objects in a GGH model can be gener-
alised cells or fields. Generalised cells are spatially-extended objects which reside on
a single cell lattice and in the current model represents cancer cells (Balter et al., 2007;
Glazier et al., 2007). Generalised cells carry a set of state descriptors, e.g., the cell’s
target volumes and volumes at which mitosis occurs.
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Figure 6.1: Schematic diagram showing an example of a 2-dimensional GGH cell-lattice
configuration. The size of lattice is 21×17 pixels. Each colour domain represents the type of
generalised cells τ(σ(i)). Each generalised cell is composed of a set of pixels i with unit index
σ(i), here 1, 2, 3, and 4.
In a GGH model, a generalised cell is represented by a collection of lattice sites
with the same index. A lattice site or a pixel is denoted by a vector of integers i. A
unique index for each generalised cell σ(i) ∈ [1, ...,N] is defined at each lattice site
or pixel, where N is the maximum number of generalised cells, and cell type for each
cell is denoted by τ(σ(i)). Each generalised cell has a unique cell index and contains
many pixels. Many generalised cells may share the same cell type. As an example, in
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Fig. 6.1, in a 2-dimensional lattice of size 21×17 pixels there are 4 types of generalised
cells τ(σ(i)), each has index value σ(i): 1 (blue cell), 2 (orange cell), 3 (yellow cell),
and 4 (purple cell).
Fields are continuously-variable concentrations, each of which resides on its own
lattice. Fields can represent diffusible chemicals, non-diffusing extracellular matrix,
etc. Fields such as chemical attractant are used in our simulations for cancer cell
detachment from a layer of cells and a spheroid tumour, which is explained in detail in
Chapter 6.4.
The initial condition specifies the initial configurations of the cell lattice, fields, a
list of cells and their internal states related to auxiliary equations and any other infor-
mation required to completely describe the simulation.
Interaction descriptions and dynamics define how the various objects behave both
biologically and physically. For generalised cells, these behaviours and interactions
are embodied primarily in the effective energy which describes the behaviours and
interactions of a generalised cell, such as its shape, motility, adhesion, and also its
response to extracellular signals (Glazier et al., 2007). The effective energy mixes true
energies such as cell-cell adhesion with terms that mimic energies, e.g., the response
of a cell to a chemotactic gradient of a field. The effective energy, also called the
Hamiltonian H , is the core of the GGH model. Adhesion is one the most important
effective energy terms, due to its critical feature in biology.
To represent variations in energy due to adhesion between cells of different types,
a boundary energy, that depends on J(τ(σ(i)),τ(σ(j))) between two cells (σ ,σ ′) of
given cell types (τ(σ),τ(σ ′)) at a link (the interface between two neighboring pixels),
is defined as (Glazier et al., 2007)
Hboundary = ∑
(i,j)neighbours
J(τ(σ(i)),τ(σ(j)))(1−δ (σ(i),σ(j))) , (6.1)
where the sum is over all neighbouring pairs of lattice sites i and j (note that the neigh-
bour range may be greater than one), the boundary energy coefficients are symmetric,
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J(τ,τ ′) = J(τ ′,τ) , (6.2)
and
δ (x,y) =
 1 if x = y0 if x 6= y .
In addition to boundary energy, most simulations include multiple constraints on
cell behaviour. The use of constraints to describe behaviours comes from the physics
of classical mechanics. In the GGH context (based on Monte-Carlo dynamics) a con-
straint energy can be written in a general elastic form (Glazier et al., 2007)
Hconstraint = λ (value− target value)2 . (6.3)
This constraint is zero if “value = target value” and grows as “value” diverges from
“target value”. λ is the spring constant (a positive real number), which determines the
constraint strength. Smaller values of λ allow the pattern to deviate more from the
equilibrium condition (i.e., the condition satisfying the constraint).
For cell volume, most GGH simulations employ a volume constraint that restricts
volume variations of generalised cells from their target volumes (Glazier et al., 2007),
Hvolume =∑
σ
λvolume(τ(σ))(v(σ)−Vt(σ))2 (6.4)
where for cell σ , λvolume(τ(σ)) denotes the inverse compressibility of the cell, v(σ) is
the number of pixels in the cell (cell volume), and Vt(σ) is the cell’s target volume. One
useful result from the constraint formalism is that it defines P ≡ −2λ (v(σ)−Vt(σ))
as the pressure inside the cell. If v < Vt the cell has a positive internal pressure while
if v >Vt the cell has a negative pressure.
Because cells have nearly fixed amounts of cell membrane, a surface area constraint
can be defined
Hsurface =∑
σ
λsurface(τ(σ))(s(σ)−St(σ))2 (6.5)
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where s(σ) is the surface area of cell σ , St(σ) is cell’s target surface area, and λsurface(τ(σ))
is cell’s inverse membrane compressibility.
Now, the effective energy or the full Hamiltonian (Glazier et al., 2007) for our
simulations is formulated as the sum of the boundary energy (6.1), the volume con-
straint (6.4), and the surface area constraint (6.5):
HGGH = ∑
(i,j)neighbours
J(τ(σ(i)),τ(σ(j)))(1−δ (σ(i),σ(j)))
+ ∑
σ
λvolume(τ)(σ)(v(σ)−Vt(τ(σ)))2
+ ∑
σ
λsurface(τ(σ))(s(σ)−St(σ))2 . (6.6)
6.2.2 Bionetsolver Programming Library
Bionetsolver is a C++ library with a high-level Python API that permits easy defini-
tion of sophisticated models coupling reaction-kinetic models described in the SBML
with GGH objects for execution in CC3D. Bionetsolver makes use of the SBML ODE
Solver Library (SOSlib) to implement reaction-kinetic network dynamics which can
regulate the cell dynamics generated by the GGH core. For further reference on SOSlib
the reader may refer to the paper by Machne´ et al. (2006). SOSlib provides function-
ality both for reading SBML models and solving them as a system of ODEs. In addi-
tion to this functionality, there are three classes – BionetworkSBML, BionetworkTem-
plateLibrary and Bionetwork – that provide some additional convenience in storing and
manipulating SBML models as well as creating ODE integrators and time-stepping the
integrators. The Python API of Bionetsolver provides a set of 7 core functions that can
be called from within a CC3D Steppable. These 7 functions are used for the initialisa-
tion and manipulation of Bionetsolver objects from within the steppable. In this way,
the entire specification of a multiscale (cell-subcell-level) simulation can be written in
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Python and executed in the CC3D player.
The Bionetsolver API is imported and initialised in a typical CC3D steppable file,
at which point the API is made available within the steppable. SBML models are
loaded with a loadSBMLModel function and each SBML model can be added to one
or more template libraries using the function addSBMLModelToTemplateLibrary.
When loadSBMLModel is called, a string argument is required that signifies a name
for the SBML model. Similarly, when addSBMLModelToTemplateLibrary is called,
the user provides the SBML model name (specified when loadSBMLModel was called)
as well as a string argument that signifies the name of the template library. A single
SBML model may be added to several template libraries and each template library may
contain one or more SBML models.
In addition, a setBionetworkInitialCondition function can be used to spec-
ify initial conditions for parameters and state variables in any SBML model within a
template library. As arguments to this function, the user provides a template library
name, a variable or parameter name and the corresponding initial numerical value of
the variable or property. A set of SBML models stored within a template library can
be associated with a CC3D cell type by providing the cell type name as the name of
the template library. When the function initializeBionetworks is called, a sepa-
rate bionetwork object is created for each cell of the given cell type and the previously
specified initial conditions (specified using
setBionetworkInitialCondition) are set for each of the bionetworks. Any pa-
rameters or state variables for which setBionetworkInitialCondition was not
called are simply initialised, by default, to values specified in the original SBML mod-
els.
All of the functions mentioned above are initialisation functions and are called
within the start function of the CC3D steppable. In addition, there are three more
functions that are called within the step function of the CC3D steppable. These are (1)
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timestepBionetworks, for time-stepping the ODE integrators, (2) getBionetworkValue,
for retrieving SBML property and state variable values from the integrators, and (3)
setBionetworkValue, for setting SBML property values of the integrators. CC3D
cell-level properties can be retrieved using procedures described in the CC3D docu-
mentation and the CC3D demo simulations. Finally, SBML property values can be
set as a function of CC3D cell properties and, likewise, CC3D cell properties can be
set as a function of SBML state variable values. This is how mechanistic coupling
can be established between SBML (subcellular) and CC3D (cell-level) properties and
dynamics.
6.2.3 Comparison of Cell Center-model and GGH-model for Mul-
ticellular Simulation
Here we briefly discuss fundamental differences and some similarities between the
centre based model of Ramis-Conde et al. (2008) and our model based on the GGH
model. As indicated, CC3D is a software application that implements the GGH model,
allowing lattice-based simulation of multicellular systems. Each biological cell is rep-
resented as a set of contiguous sites on a lattice and the system evolves in time through
an energy minimization procedure. On the other hand, the centre based model repre-
sents each biological cell in terms of the location of its centre of mass and its radius.
This fundamental distinction between the two methodologies is illustrated in Fig. 6.2.
The cells of the centre model behave as elastic spheres and equations describing
their behaviour and interactions are derived on the basis of classical mechanical con-
cepts. It approximates cell-cell contact areas using the radii of neighbouring cells and
the distance between their centres. In the GGH model, the concept of cell neigh-
bour has an explicit representation, where two cells share one or more lattice edges
(for 2D simulations) or faces (3D simulations). These are the differences between
the two models. Each model has relative strengths and weaknesses with respect to
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Figure 6.2: Illustration of lattice-based representation of cells in the GGH model (left figure)
and lattice-free representation in the centre based model (right figure).
different biophysical processes and phenomena. In terms of biological and biophys-
ical concepts captured by the two approaches, the GGH and centre models also bear
many similarities. Both methodologies use continuum, reaction-diffusion equations to
model extracellular chemical fields and they both incorporate cell-cell adhesion and
mechanical constraints on cell shape. In each case, extracellular chemical fields can
both modify and be modified by cell behaviours or properties such as cell growth rates,
secretion, absorption and chemotaxis.
6.3 An Application to Multiscale Modelling of Cancer
Growth and Invasion
Recently Ramis-Conde et al. (2008) developed a multiscale model of cancer growth
and invasion incorporating important aspects of E-cadherin-β -catenin signaling and
its coupling to cell-level properties of intercellular contact and adhesion. This model
requires explicit representation (on a cell to cell basis) of localised and spatially het-
erogeneous changes in cell-cell adhesion strength and contact areas. It is at this level
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of “granularity” that invasive cancer cells sense and respond to their environment. In
terms of biological processes, the model of Ramis-Conde et al. (2008) captures cell-
contact-dependent recruitment of E-cadherin and β -catenin to the cell membrane and
reincorporation of both back into the cytoplasm. Computationally, the simulations in-
corporated: (1) time-varying changes in cell-cell adhesion as a function of a system
of ordinary differential equations (ODEs) for the intracellular reaction kinetic model
of E-cadherin-β -catenin signalling, and (2) changes in rate parameter values in the
reaction kinetic model as a function of changing contact areas between neighbouring
cells.
6.3.1 Biological Background
To maintain tissue structures and organisation, cells adhere to each other and to the
extracellular matrix through families of cell surface glycoproteins called cell adhesion
molecules (CAMs). One group of CAMs that is responsible for cell to cell adhesion
is called the cadherins, transmembrane glycoproteins that are dependent on calcium
(Ca2+) ions to function. Classical cadherins are named based on the types of the
main tissues where they are found, e.g., E-cadherins are found in epithelial tissues,
N-cadherins are expressed predominantly in the nervous system, and P-cadherins are
present on cells in the placenta and epidermis, etc. Of all the types of cadherins, E-
cadherins are the most well-studied cell-cell adhesion proteins. After their translation
from mRNA, E-cadherins are transported to the cell membrane where they anchor and
function as transmembrane proteins with distinct cytoplasmic and extracellular do-
mains. The extracellular domain is responsible for cadherin’s ability to link adjacent
cells by interacting with the extracellular domain of neighbouring cells in a calcium de-
pendent manner. The cytoplasmic domain is connected indirectly with actin filaments
mediated by a group of intracellular anchor proteins called catenins, e.g., p120-catenin,
α-catenin, γ-catenin, and β -catenin (Jiang, 1996; Alberts et al., 2002). These catenins
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offer mechanical linkage between E-cadherin and cytoskeleton, hence the function of
E-cadherins is highly dependent on the functional activity of catenins (Garrod, 1993;
Tsutsui et al., 1996).
In vitro and in vivo analyses showed that newly synthesised E-cadherin may bind
to β -catenins before being translocated to the cell membrane. α-catenin then binds
to E-cadherin-β -catenin complexes at the cell membrane (Jiang, 1996). When a cell
adheres to another cell, a high expression of E-cadherin-catenin complexes appears in
the area of adhesion. In cancer, if cells proliferate while maintaining tight cell-cell ad-
hesion, their expansive growth will be similar to that of a benign tumour, and hence the
tumour can be contained. Disruption of the E-cadherin-catenin complexes is associated
with invasive and metastatic behaviour of tumour cells, particularly those of epithelial
origin. This mechanism leads to the formation of mesenchymal cells from epithelial
cell lines, or epithelial-mesenchymal transition (EMT), which are dominant in many
types of carcinomas (Thiery, 2002) and life threatening for cancer patients. Due to
this, the E-cadherin-catenin complex is considered as a tumour invasion suppressor.
6.3.2 Kinetics of E-cadherin and β -catenin
In Ramis-Conde et al. (2008), the kinetic interactions between E-cadherin and β -
catenin in a cell are conceptually modelled as follows. After being synthesised, E-
cadherin is released to the cytoplasm as free E-cadherin (the concentration is denoted
by [Ec]). Free β -catenin (concentration [β ]) is assumed to be distributed in the cy-
toplasm and near the cell membrane. When there is signalling for cell-cell contact,
free E-cadherin in the cytoplasm ([Ec]) is transported to the cell membrane (concentra-
tion [Em]) where its cytoplasmic domain binds to free β -catenin to form E-cadherin-
β -catenin complex (concentration [E/β ]) and the extracellular domain binds to the
151
E-cadherin-β -catenin complex of adjacent cells. If cell detachment occurs, the E-
cadherin-β -catenin complex dissociates, releasing free β -catenin and sequestering E-
cadherin into the cytoplasm by endocytosis. The free β -catenin is then degraded and
downregulated after binding with proteasome. These intracellular interactions are sum-
marised in a schematic diagram shown in Fig. 6.3 and can be described by the chemical
reactions
[Ec]
ci(t)
GGGGGGGGA
{contact}
[Em] , (6.7)
[β ]+ [Em]−−−−→ν [E/β ] , (6.8)
[E/β ]
di(t)
GGGGGGGGGA
{detachment}
[Ec]+ [β ] , (6.9)
where ν is the rate of binding of E-cadherin and β -catenin. Applying mass conserva-
tion for the total concentration of E-cadherin ET gives
ET = [Ec]+ [Em]+ [E/β ] , (6.10)
where ET is constant.
Free β -catenin from a ruptured E-cadherin-β -catenin complex due to cell detach-
ment then forms a complex with a proteasome (concentration [P]). This complex (con-
centration denoted by [C]) is eventually degraded by the proteasome system as follows:
[β ]+ [P]
k+
GGGGGGBF GG
k−
[C] −−−−−→
k2
[P]+ω , (6.11)
where ω is the final product of the degradation process, k+ and k− are the rates of
association and disassociation of the β -catenin-proteasome complex, respectively, and
k2 is the β -catenin degradation rate in the proteasome system. The total concentra-
tion of proteasome consists of the concentration of proteasome and its complex and is
considered to be constant [PT ], hence
PT = [C]+ [P] . (6.12)
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Figure 6.3: A schematic diagram of the E-cadherin interactions with β -catenin.
Invoking the law of mass action we write the system of ODEs for the concentration
of E-cadherin in the cytoplasm [Ec], the concentration of the E-cadherin-β -catenin
complex [E/β ], the concentration of free β -catenin [β ], and the concentration of the
β -catenin-proteasome complex [C] for each individual cell i as
d[Ec]
dt
= −ci(t)[Ec]+di(t)[E/β ] , (6.13a)
d[E/β ]
dt
= A1−di(t)[E/β ] , (6.13b)
d[β ]
dt
= A2+di(t)[E/β ]− k+[β ] (PT − [C])+ k−[C]+ km , (6.13c)
d[C]
dt
= k+[β ] (PT − [C])− k−[C]− k2[C] , (6.13d)
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where, depending on signalling,
A1 =

ν (ET − [Ec]− [E/β ]) [β ] , for attachment ,
−α[E/β ] , for detachment ,
(6.14)
and
A2 =

−ν (ET − [Ec]− [E/β ]) [β ] , for attachment ,
α[E/β ] , for detachment ,
(6.15)
The parameter km is the rate of production of β -catenin, ci(t) is a time-dependent
function that measures the amount of cadherins stimulated to form bonds for cell-cell
contact, di(t) is a function that measures the amount of cadherins resulting from broken
bonds during cell detachment, and α is the rate of dissociation of E-cadherin-β -catenin
complex once the migration decision has been made. These functions (ci(t) and di(t))
depend on the area of contact between adjacent cells that changes over time, and are
defined as
ci(t) = ∑
new contacts
ac, j(t)ρc , (6.16)
and
di(t) = ∑
new detachments
ad, j(t)ρd , (6.17)
where ρc and ρd are the rates of E-cadherin translocation between the cell membrane
and the cytoplasm. When there is signalling for cell-cell contact ρc measures how fast
the E-cadherin is transported from the cytoplasm to the cell membrane and ρd mea-
sures the reverse action (from the membrane to the cytoplasm) for cell detachment.
In Ramis-Conde et al. (2008), ac, j(t) and ad, j(t) are time-dependent functions, to de-
termine enhancement of the area of contact (when E-cadherin is transported from the
cytoplasm to the membrane) and loss of area of contact (when E-cadherin is brought
back from the membrane to the cytoplasm), respectively. These functions are defined
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as
ac, j(t) =

∂
∂ t
aˆ(t) j , if
∂
∂ t
aˆ(t) j > 0 ,
0 , otherwise ,
and
ad, j(t) =

‖ ∂
∂ t
aˆ(t) j‖ , if ∂∂ t aˆ(t) j < 0 ,
0 , otherwise ,
where aˆ(t) j is the approximated contact area between cells i and j at time t divided by
the surface area of cell i.
Studies suggested that the loss of E-cadherin expression freed cells from tight cell-
cell association and provided them with malignant properties (Shimoyama et al., 1992).
Therefore we may propose that the condition for attachment is assumed valid as long
as the concentration of free β -catenin [β ] is below a threshold cT . For detachment to
occur, the amount of free β -catenin in the cytoplasm must be large enough, with an ad-
ditional increase from broken E-cadherin-β -catenin complex, or [β ]> cT . This claim
is based on several studies that have found upregulation of β -catenin in the cytoplasm
(or termed nuclear β -catenin) at the invasive front of colorectal carcinomas (Brabletz
et al., 2001; Suzuki et al., 2008), invasive breast cancer (Uchino et al., 2010), fibrosar-
coma, clear cell sarcoma and carcinosarcoma (Ng et al., 2005). Nuclear accumulation
of β -catenin initiates the loss of epithelial differentiation and gain of mesenchyme-like
capabilities of the tumour cells at the invasive front. In the central areas of the primary
tumours, nuclear β -catenin was found to be localised at the cell membrane. Nuclear
accumulation of β -catenin has been the most powerful predictor of liver metastasis
in colorectal cancer. This may be an important marker for adjuvant therapy or other
treatment modalities.
In order to obtain a nondimensional system of equations, we nondimensionalise
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Eqs. 6.13a-6.13d in the usual way by setting the following dimensionless variables:
Ec∗ =
Ec
E
, E/β ∗ =
E/β
E
, β ∗ =
β
E
, C∗ =
C
E
, t∗ =
t
T
where E is a reference concentration of E-cadherin and T is an appropriate reference
time, from which we obtain dimensionless parameters:
c∗i (t) = ci(t)T , d
∗
i (t) = di(t)T , k
−∗ = k−T , k∗2 = k2T ,
k+∗ = k+T E , ν∗ = νT E , α∗ = αT , k∗m = km
T
E
Inserting the dimensionless variables and parameters into the system (6.13) and af-
ter dropping the asterix signs for notational convenience, we obtain the dimensionless
system of equations
d[Ec]
dt
= −ci(t)[Ec]+di(t)[E/β ] , (6.18a)
d[E/β ]
dt
= A1−di(t)[E/β ] , (6.18b)
d[β ]
dt
= A2+di(t)[E/β ]− k+[β ] (PT − [C])+ k−[C]+ km , (6.18c)
d[C]
dt
= k+[β ] (PT − [C])− k−[C]− k2[C] . (6.18d)
The dimensionless parameter values used in the simulations of this chapter can be
found in Table 6.1. The dimensionless values are based on the parameters used in
Ramis-Conde et al. (2008).
Using the parameter values given in Table 6.1, we solve the underlying ODEs
given above to see the dynamics of the concentrations of β -catenin, E-cadherin-β -
catenin complex, and β -catenin-proteasome complex at attachment and when there is
signalling for detachment, as shown in Fig. 6.4.
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Table 6.1: Dimensionless intracellular parameter values for the cell detachment simu-
lations
Parameter Definition Value Reference
ν E-cadherin-β -catenin binding rate 100 Ramis-Conde et al. (2008)
k+ β -catenin-proteasome downregulated binding rate 1.5 Estimated
k− β -catenin-proteasome dissociation rate 19 Ramis-Conde et al. (2008)
k2 β -catenin degradation rate in proteasome 1 Ramis-Conde et al. (2008)∗
km β -catenin production rate 14 Ramis-Conde et al. (2008)∗
α E-cadherin-β -catenin dissociation rate 2 Ramis-Conde et al. (2008)
cT β -catenin threshold value 50 Ramis-Conde et al. (2008)
ρc E-cadherin cytoplasm-surface translocation rate 200 Ramis-Conde et al. (2008)
ρd E-cadherin surface-cytoplasm translocation rate 200 Ramis-Conde et al. (2008)
PT Proteasome total concentration 21 Ramis-Conde et al. (2008)∗
ET E-cadherin total concentration 100 Ramis-Conde et al. (2008)
∗ appears in the paper’s correction.
6.3.3 Implementation of CC3D in the Model
Cellular behaviours, such as motion, interactions, mechanics, etc., are described as
energy terms in the overall system Hamiltonian. In our simulations we use three major
terms to describe cell-cell adhesiveness, cell volume elastic constraint, and cell surface
elastic constraint. The simulation itself consists of a series of random attempts of cells
to extend their boundaries by copying the value of a pixel σ(i) to neighbouring site,
see Fig. 6.5. Since each cell in the GGH model is represented as a collection of pixels
i, at each step we randomly select a pixel i as a target pixel and randomly select one of
its fourth-order neighbouring pixel i′ as a source pixel. Then we attempt to change its
index from σ(i) to the index σ ′ = σ(i′). If they belong to the same generalised cell,
σ(i) = σ(i′), we do not need to copy the index. A successful index copy increases the
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Figure 6.4: Dynamics of β -catenin, E-cadherin-β -catenin complex, and β -catenin-
proteasome complex at attachment and detachment conditions based on the underlying ODEs
using parameters in Table 6.1.
volume of the source cell and decreases the volume of the target cell by one pixel. At
each pixel copy attempt we calculate the change in the system energy ∆E and accept
pixel reassignment with probability P(∆E)
P(∆E) =

1 , for ∆E ≤ 0 ,
exp(−∆ETm ) , for ∆E > 0 ,
(6.19)
where Tm is a parameter representing the effective cell motility.
Energy dependent pixel copy probability and Hamiltonian terms constitute the
essence of the GGH models. Although ∆E denotes change of the overall system en-
ergy, in practice contributions to ∆E are almost always “local” i.e., in our calculations
we only have to examine a small neighbourhood of pixels involved in the pixel-copy.
The simulation is subdivided in the so-called Monte Carlo Steps (MCS) which corre-
spond to a unit of physical time. By convention, each MCS consists of one index-copy
attempt for each pixel in the cell lattice. The conversion between MCS and physical
time depends on model parameters. In a simple case for example, in Bionetsolver we
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set timestepBionetwork to 0.03 and if Bionetsolver gets called every MCS then 1
MCS corresponds to 0.03 hours. In this chapter we do not specifically set a relationship
between MCS and the physical time because in the computational simulations we also
incorporate cell mitosis or cell division which in the process itself also requires another
time convention. In the mitosis process we do not apply any intracellular pathway, but
instead we use a built-in mitosis function provided by CompuCell3D. The physical
distance is recovered by converting pixels into unit of length. This conversion is more
straightforward than time conversion and in our simulations we set 1 pixel corresponds
to 2 µm.
Unlike models where cellular behaviours are put by hand by specifying various
parameters of the Hamiltonian, in our model the most critical parameters (i.e., concen-
trations of E-cadherins, β -catenins, and E-cadherin-β -catenin complexes) are linked to
the molecular pathways running inside each individual cell. This approach allows us to
represent more faithfully the multiscale nature of tumour invasion. Biological cells (or
tumour cells) change their phenotypic properties due to the dynamic events explained
in the previous subsection which occur inside the cell, in the nucleus or cytoplasm, and
on the cell membrane. We try to mimic the biology as closely as possible by linking
phenomena occurring at the intracellular scales (E-cadherin/β -catenin dynamics) to
processes which operate at the cell/multicell level (cellular adhesion).
To build the CC3D-Bionetsolver implementation, we provide four files and do
the following. The pathway of E-cadherin and β -catenin interactions is written in an
SBML file using JarnacLite (http://www.sys-bio.org/sbwWiki/sbw/jarnaclite).
The setup of Potts dimension, related CC3D plugins, and initial configuration are listed
in an XML file. In addition to plugins, there are also modules called steppables which
run either repeatedly after a defined intervals of Monte Carlo Steps or once at the be-
ginning or the end of the simulation. Steppables typically define initial conditions,
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alter cell states, update fields or output intermediate results. The Bionetsolver func-
tions are called from within CC3D steppables. The CC3D steppables and Bionetsolver
functions are written in a Python file. The main file that is called from the CC3D player
to run the simulation is written in Python and it lists the core CC3D simulation objects
and required steppables.
Figure 6.5: Schematic diagram showing the GGH representation of an index-copy attempt for
two cells on a 2-dimensional square lattice. The “white” pixel (source) attempts to replace the
“grey” pixel (target). The probability of accepting the index copy is given by equation (6.19).
For the boundary energy (Hboundary) of the Hamiltonian (6.6) we use the
ContactLocalProduct plugin that calculates the boundary energy based on the lev-
els of E-cadherin expression per cell. We set two types of cells, namely “LowBeta-
Cat” for cells having concentration of β -catenin below the threshold cT and “High-
BetaCat” for cells with β -catenin higher than cT . The values of contact/boundary
energy between the two types of cells, between the cells and the medium are spec-
ified in the ContactLocalProduct plugin. The medium is the non-cell area. The
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VolumeLocalFlex and SurfaceLocalFlex plugins are used for the volume con-
straint (Hvolume) and the surface constraintHsurface), respectively. We use these plug-
ins in the XML file to allow the target volume and the target surface to vary individu-
ally for each cell during the simulation without having to explicitly specify the values
of λvolume, Vt , λsurface, and St . For initialisation, in the steppable file we assign their
dimensionless parameter values as listed in Table 6.2.
Table 6.2: CC3D parameter values
Parameter Definition Dimensionless Value
λvolume Cell’s inverse compressibility 0.5
Vt Cell’s target volume 1.2×cell volume
λsurface Cell’s inverse membrane compressibility 1.5
St Cell’s target surface area 400
The integration of CC3D and Bionetsolver in the model is illustrated in the flow
chart, see Fig. 6.6. The simulations are started by adjusting cell shape and for simula-
tions that require cell division we invoke the cell mitosis function, which is a built-in
function of CC3D. After a certain time (denoted by T 1), we start the Bionetsolver for
the numerical integration of the differential equations. To change the concentration of
β -catenin at time T 2, we switch the values of k2 and k+, where if the concentration of
β -catenin inside each cell ([β ]) is higher than the concentration of β -catenin threshold
(cT ) the cell then detaches from the main tumour mass.
6.4 Computational Simulation Results
We modelled three different scenarios as follows: (1) detachment waves of β -catenin
on a thin layer of epithelial cells, described in subsection 6.4.1; (2) tumour growth and
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Figure 6.6: Flow chart of the integration of CC3D and Bionetsolver in the model.
detachment of cells from a layer of epithelial cells; and (3) tumour growth and detach-
ment of cells in a multicellular tumour spheroid, both described in subsection 6.4.2.
6.4.1 Detachment Waves of Epithelial Layer Simulations
To simulate detachment waves of β -catenin on a thin layer of epithelial cells, we per-
formed the simulation on a domain or a lattice of 264×224×60 pixels in x, y, and z
directions, respectively, with the z-axis being perpendicular to the page. In the lattice
we placed a sheet of cells with an arrangement of 30 cells along the x-axis (horizontal),
25 cells along the y-axis (vertical), and 1 cell in the z-axis. Initially each cell occupies
a cube of dimension 7×7×7 pixels and we insert a gap of 1 pixel between each cell,
as can be seen in the top left plot of Fig. 6.7. The initial target volume for cells is
set to 1.2 times the cell volume, making the average volume of each cell about 410
pixels. We set 1 pixel equivalent to 2 µm. Therefore one tumour cell has a volume
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of about 3280 µm3, and the sheet represents a thin layer of tissue with a volume of
0.48×0.408×0.014 mm3 = 2.74×10−3 mm3.
From time 0 MCS (Monte Carlo Steps) to 20 MCS we let the cells grow, where cell
volume increases, followed by increasing cell surface area, and eventually the cells be-
come more spherical. During this period of the simulations, cell-cell contact areas un-
dergo an equilibrating transient that does not reflect natural phenomena. Thus, we did
not start the numerical integration of the differential equations (corresponding to the
subcellular biochemical networks) until 20 MCS. Keeping in mind that the subcellu-
lar model is sensitive to changes in intercellular contact areas, if numerical integration
occurred during the initial cell shape changes, unrealistic subcellular dynamics could
occur as an artefact of these changes. Starting the integration at 20 MCS helped avoid
this. This is done to all simulations. All parameter values used in the computational
simulations are listed in Tables 6.1 and 6.2, unless stated otherwise. In the intracellular
model, summarised in Eqs. 6.18a-6.18d, disruption of cell-cell adhesion occurs when
there is an increase in the concentration of free β -catenin in the cytoplasm, that is the
β -catenin concentration exceeds a specified threshold value as a result of disassoci-
ation of the E-cadherin-β -catenin complex at the cell membrane. The threshold we
specified for our simulations is 50.0. As explained previously, for cell detachment to
occur nuclear β -catenin must exceed this threshold value and the terms A1 and A2 in
Eqs. 6.14 and 6.15 change accordingly. This essentially amounts to setting ν equal to 0
in Eqs. 6.14 and 6.15, and replacingA1 by−α[E/β ] andA2 by α[E/β ] in Eqs. 6.18b
and 6.18c, respectively. In the SBML implementation of our subcellular model, we
actually do not implement two separate sets of equations for attachment and detach-
ment. Instead, the equations, as implemented in the SBML model, are equivalent to
Eqs. 6.18a-6.18d with A1 and A2 as for attachment condition, but with all instances
of components ofA1 andA2 are swapped. In our CC3D-Bionetsolver implementation
(i.e., our Python script), the increase of β -catenin concentration above the threshold
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is deliberately done by decreasing the value of k+ at a specified time, that is from
k+ = 1.5 to k+ = 1.0 at = 70 MCS. This parameter influences the association rate of
β -catenin with the proteasome. When k+ = 1.5, the β -catenin-proteasome complex
formation is sufficiently rapid to keep the β -catenin concentration of all cells well be-
low the threshold of cT = 50.0. However, when k+ is decreased to a value of 1.0,
β -catenin accumulates in the cytoplasm as a result of decreased proteasomal degrada-
tion.
We check the β -catenin concentration for every cell at each MCS. If the β -catenin
concentration for a cell of type “LowBetaCat” increases above a threshold value of
50.0, the cell type is changed to “HighBetaCat”, ν is set to 0.0 instead of 100.0 and
α is set to 2.0 instead of 0.0. Similarly, when the β -catenin concentration of a “High-
BetaCat” cell decreases below the threshold, the value of ν for that cell is set to 100.0
and α is set to 0.0.
In the case of an EMT event (i.e., a cell type change from “LowBetaCat” to “High-
BetaCat”), changing the values of ν and α as described is equivalent to swapping the
components of the terms A1 and A2, between attachment and detachment. Physi-
cally, this corresponds to (1) a cessation of E-cadherin-β -catenin complex formation
in the membrane (ν = 0.0) and (2) an accelerated dissociation of E-cadherin-β -catenin
complex (i.e., the dissociation rate parameter di(t), is increased by α = 2.0) to form
cytoplasmic (free) E-cadherin and free β -catenin. Together, the effects of these two
changes are: (1) an increased concentration of β -catenin in the cytoplasm; and (2)
a significantly reduced adhesion strength between the transformed cell and its neigh-
bouring cells (due to the loss of the E-cadherin-β -catenin complex in the membrane).
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Figure 6.7: Plots showing a sequence of the disruption of a layer of epithelial cells due to
an increase in the β -catenin concentration inside the cells. After all cells have been detached
from the layer of cells or from each other showing EMT, low concentration of β -catenin causes
cells that are close to each other to perform re-attachment and regain MET while some cells
that are not close remain as mesenchymal cells. Colours of the cells represent concentration of
β -catenin, shown by the bar on the left.
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In Fig. 6.7 an increase of β -catenin concentration above threshold is triggered by
several cells. When one cell is induced with a high β -catenin concentration above the
threshold cT , the cell becomes vulnerable to the loss of cell-cell attachment leading
to EMT. The event propagates away, affecting neighbouring cells and subsequently
the cells in the neighbourhood of the affected neighbouring cells and so on, where the
concentration of β -catenin of the neighbouring cells also exceeds the threshold and
the neighbouring cells also become vulnerable to EMT. We observe a small group of
cells at 130 MCS start to detach and at 200 MCS the detachment waves have spread
affecting more adjacent cells. As time evolves, some cells at other positions also show
detachment waves independently. Eventually at around 500 MCS all cells in the layer
have been affected and are detached from each other, which is the hallmark of EMT
events. There is an alteration of the configuration of the epithelial layer of cells, where
the cells are displaced from their original position, remaining detached near the initial
configuration of the epithelial layer since we do not apply any chemoattractant in this
simulation. By letting the simulation run for a longer time, that is up to 5000 MCS, we
observe that the concentration of β -catenin of all the detached cells decreases and some
cells even have near zero concentration of β -catenin. The colour of cells in all figures
indicates the concentration of β -catenin. Low concentration of β -catenin causes cells
that are close to each other to perform re-attachment and this subsequently causes an
increase of β -catenin concentration. The cells recover the formation of epithelial cell
lines, or a mesenchymal-epithelial transition (MET), with irregular configuration of
the cell layer. The results we report here are consistent with those of Ramis-Conde
et al. (2008). We also observe from the simulation results that after the first EMT event
there are a few of cells that are dragged relatively far away from the other cells. As a
consequence of the big gaps between them, these cells cannot re-attach with the other
cells and remain as “mesenchymal” cells.
In order to see how the concentration of the proteins inside each individual cell vary
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Figure 6.8: Plots of β -catenin, E-cadherin-β -catenin complex, and proteasome-β -catenin
concentrations for a scenario of a cell that underwent an epithelial-mesenchymal transition
(EMT), and then regained mesenchymal-epithelial transition (MET) by reattaching with adja-
cent cells. The cycle of detachment and re-attachment continues for about 3 times until 5000
MCS.
over time, in our CC3D-Bionetsolver codes we recorded and saved data of all concen-
trations at every MCS. In Fig. 6.8 we plot the typical concentrations of β -catenin, E-
cadherin-β -catenin complex, and β -catenin-proteasome complex for cells that undergo
EMT and gain MET from the simulation shown in Fig. 6.7. Because of the stochastic
nature of the GGH model, the concentrations vary in response to fluctuations in contact
area between cells. We can verify that when the concentration of β -catenin increases
significantly (due to loss of contact area between cells) and immediately decreases af-
terwards, the transition curve becomes smooth showing no fluctuations. After the cell
regain contacts with other cells, the curve fluctuates again. By running the simulation
up to 5000 MCS, from Fig. 6.8 we can see that there are three cycles of detachment and
attachment as can be seen from the repeated cycles of the high and low concentration
of β -catenin (yellowish-green line).
As for cells that cannot re-attach after the first detachment because they have been
displaced relatively far away from other cells and remain mesenchymal (cannot re-
cover MET), the concentrations of the subcellular proteins immediately reach their
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own steady states, as shown by plots of data in Fig. 6.9.
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Figure 6.9: Plots of β -catenin, E-cadherin-β -catenin complex, and proteasome-β -catenin
concentrations for a scenario of a cell that underwent an epithelial-mesenchymal transition.
6.4.2 Tumour Growth and Invasion
For simulations involving tumour growth, the GGH target volume is incremented each
MCS during growth phases, at a constant rate of 0.02 times the current cell volume
and the GGH target surface area is also incremented at a constant rate of 0.02 times
the current cell surface area. This results in a doubling of cell number approximately
every 40 MCS. Cell division was set to occur when the volume of a cell exceeded 2
times its initial volume. This rate of growth was not necessarily intended to reflect in
vivo rates of tumour cell growth. Rather, the purpose in our simulations is simply to
let the tumour grow to a specified size so that we can then initiate EMT events and
observe the subsequent dynamics of cell detachment and migration.
Tumour from a Layer of Cells
To simulate the growth of a tumour from a layer of cells, a common occurrence for
tumours of epithelial tissue origin, we use a bigger 3-dimensional lattice or a cubic
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lattice of size 120× 120× 120 pixels in the x, y, and z directions. Initially we placed
one layer of cells, which consists of 10× 10 cells, at one face/side of the cube, or at
x = 120 as shown by the configuration of the top left plot in Fig. 6.10. All cells are
cubic in shape with size 7×7×7 pixels with a 1 pixel gap between each of them. Here
we apply a gradient of some chemoattractant linearly in the direction of the x-axis to
generate cell migration into the tissue space.
From a single thin layer, the tumour grows and becomes a bulky layer as a result
of cell division. In the implementation of CC3D-Bionetsolver it is possible to let the
tumour grow infinitely, but in this type of simulation we limit the cell division until
the number of cells in the tumour mass reaches a maximum of 500 cells. After 200
MCS we initiate an increase of free β -catenin concentration by reducing the value of
k+ from 1.5 to 1.0. Some random cells at the outer layer show a high concentration of
free β -catenin at 500 MCS and these cells eventually break away from the primary tu-
mour mass and migrate toward the region of high concentration of the chemoattractant,
which we apply at x = 0. As the EMT events propagate, over time as some cells at the
outer layer have detached, the cells that were underneath the detached cells fill in the
gap left by the detached cells. Subsequently these cells have reduced attachment with
neighbouring cells which causes an increase in the concentration of β -catenin above
the threshold, and eventually these cells detach.
To see the distribution of free β -catenin inside the cells that remain and are still
attached to the primary tumour mass, we plot a cross sectional view of the tumour mass
along the yz plane, as shown in Fig. 6.11. Cells of blueish colour that are bound to other
cells inside the tumour have a concentration of free β -catenin lower than the threshold
cT . Cells that have fewer binding sites, which lie at the outer layer, show a higher
concentration of free β -catenin above cT (shown in Fig. 6.11 by colours ranging from
yellowish green to dark orange). These results are qualitatively in good agreement
with the simulation results of Ramis-Conde et al. (2008) and the experimental data of
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Figure 6.10: Plots showing tumour growth and local invasion (detachment) from a layer of
cells. After the tumour reaches a certain size (by limiting the number of maximum cells in
the tumour mass), the cells at the outer layer lose cell-cell attachment due to the disruption of
E-cadherin-β -catenin complex. The EMT events then take place. A gradient of chemoattrac-
tant that is applied linearly in the direction of the x-axis causes the detached cells to perform
chemotactic migration into the tissue space. Colours in the cells represent the concentration of
β -catenin.
Brabletz et al. (2001). We may assume that the concentration of nuclear β -catenin is
represented by the concentration of free β -catenin inside the cytoplasm, because our
current mathematical model does not specify or distinguish between the two types of
β -catenin.
To study the dependency of the multiscale dynamics on the β -catenin degradation
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Figure 6.11: Plot of a cross sectional view showing the spatial distribution of β -catenin con-
centration inside cells from the simulation of tumour growth from a layer of cells. Cells in the
centre of the tumour mass have a large number of binding neighbours, hence the concentration
of β -catenin is lower than the cells at the outer layer of tumour mass that have fewer binding
neighbours and a high concentration of free β -catenin.
rate k2, Ramis-Conde et al. (2008) performed simulations by varying k2 that resemble
different degradation of rates of invasion assays which have been used in vitro as a
measure of invasive potential. If k2 is small enough, this leads to a high concentration
of free β -catenin. If it reaches a value above the threshold, then the cells are suscep-
tible to the loss of cell-cell detachment and become invasive by breaking away from
the primary tumour mass. In other words, a sufficiently small k2 can be a marker for
malignant or invasive tumour cells. Ramis-Conde et al. (2008) varied the β -catenin
degradation rate from k2 = 10 min−1 which represents an invasion assay with a fast
degradation rate, k2 = 1 min−1 for an invasion assay with a medium degradation rate,
and k2 = 0 min−1 to represent no degradation. Our CC3D-Bionetsolver implementa-
tion is sensitive to the variations of k2 and we only varied from k2 = 0.95 for the very
low degradation rate, k2 = 1 for medium degradation rate, and k2 = 1.05 for invasion
assay with fast degradation rate. The computational simulation results are shown in
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Fig. 6.12, where the number of cells that have reached a certain distance is plotted
over time. In the simulation, we remove the cells from the domain that have reached
a certain distance from the tumour. We chose a distance of 70 pixels away from the
initial position of cells (the position of the single layer of cells at the start of simula-
tions) as the position where a cell is counted. In Fig. 6.12 we have plotted the number
of cells removed from the domain over time, up to the maximum permitted number of
500 which we imposed as an upper threshold. The simulation results with k2 = 0.95
show a curve that quickly increases exponentially in a small time (purple line), while
the simulation results with k2 = 1.0 show a linear increase of the number of cells that
has been removed over time (blue line), and finally with the fast degradation rate of
invasion assay k2 = 1.05 there is only a very small number of cells that have been
removed beyond the distance of 70 pixels (green line).
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Figure 6.12: Number of cells removed from simulations of tumour growth from a layer of
cells by varying k2.
Multicellular Spheroid Growth
It is also of interest to see how our CC3D-Bionetsolver can mimic the growth and
invasion of multicellular spheroids which are spherical aggregations of (malignant)
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cells that can be grown in vitro. Multicellular spheroids are particularly used in cancer
research for studying multicellular resistance or chemo- or radiotherapy assays (Oudar,
2000). They can be used to study cell-cell and cell-matrix adhesion in vitro and also
the influence of the environment on many cellular functions such as differentiation,
cell death, apoptosis, gene expression and regulation of proliferation.
As in the simulations for tumour growth from a layer of cells, here we also use
a cubic lattice with size 240× 240× 240 pixels in the x, y, and z directions. Once
again the initial cell has a cubic shape with size 7×7×7 pixels. The simulations are
started with one cell placed at the centre of the cubic lattice. As the cells divide, to
maintain tumour compactness and prevent any undesirable effects before we trigger
detachment, we set the threshold value of β -catenin concentration, cT , high enough,
i.e., cT = 70. We let the tumour grow and become spherical in shape, as shown by the
top right plot in Fig. 6.13. At time 400 MCS, the value of k+ is decreased from 1.5 to
1.0 and we observe at time 500 MCS, cells at the surface of the tumour spheroid start
to show a high concentration of free β -catenin. In this type of simulation we apply a
radially symmetric concentration field of chemoattractant. After having lost cell-cell
adhesion with neighbouring cells due to the high concentration of free β -catenin above
the threshold, the detached cells migrate radially outwards in response to the applied
chemoattractant field.
An interesting result from these simulations is that it gives an indication of the size
of the tumour at which invasion begins. In Fig. 6.14 we plot the graphs of cell position
over time for simulations with different values of k2. All plots in Fig. 6.14 were taken
from the cell of ID1, which is the cell that we set at initial configuration, at time 0
MCS. The red line represents the case with k2 = 0.95, the blue line represents the case
with k2 = 1.0, and the black line is for the case with k2 = 1.02. At each k2 value,
the cell detaches from the primary tumour mass at a different “invasion time”. The
most invasive cell is the one that detaches the earliest, that is with k2 = 0.95. The least
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Figure 6.13: Plots showing the computational simulation results of multicellular tumour
spheroid growth. The tumour grows from a single cell placed in the middle of cubic lattice.
At a certain stage in its growth, cells may detach and invade into the external tissue driven
by chemotactic migration which has overcome the cell-cell adhesion. The colours of the cells
indicate the concentration of β -catenin.
invasive cell, with k2 = 1.05, detaches the latest. The reason we chose cell of ID1 is
because the cell started at the centre of the domain and as the simulation goes it moves
along the way to the boundary of the tumour mass before it detaches itself from the
tumour mass whereas other cells that came out of cell division started their position
not at the centre of the domain. Hence tracking the position of cell of ID1 is the best
choice for determining tumour radius or diameter.
After having been detached, the cells migrate radially away from the tumour mass
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Figure 6.14: Position of cell ID1 from the centre of cubic lattice of size 240× 240× 240
pixels from simulations of multicellular spheroid when parameter k2 is varied from k2 = 0.95,
k2 = 1, and to k2 = 1.02. Tumour radius is determined from a position of cell which is on a
horizontal curve for a period of time, here at pixel 40. Invasive distance is the position of cell
within a circle around the multicellular spheroid.
following the gradients of the applied chemoattractant. The distance between the fur-
thest cell and the radius of the multicellular spheroid is defined as the “invasive dis-
tance”, as shown in Fig. 6.14. This invasive distance has been demonstrated in a study
of the growth and invasion of a glioblastoma multiforme (GBM) in 3-dimensional col-
lagen I matrices by Kaufman et al. (2005).
Plots of data for the number of cells that have reached a distance 70 pixels from
the centre of lattice show almost similar patterns as the data for simulations with layer
of cells, as shown in Fig. 6.15. For data of invasion assay with rate of degradation of
β -catenin low (k2 = 0.95) the curve shows exponential increase of the number of cells
that have reached distance 70 pixels or have been removed from the simulations (purple
line). For simulation with k2 = 1.0 and k2 = 1.02 the rates of cells that have been
removed are fewer than simulation with k2 = 0.95, suggesting less invasive tumours.
Our simulation results have verified in vitro and in vivo experiments, that the level
of invasiveness of tumour cells can be assessed from the extent of the loss of cell-cell
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Figure 6.15: Plots showing the number of cells removed from multicellular spheroid simu-
lations using different values of k2.
adhesion. We can see in our simulations that high level of invasiveness is achieved by
down-regulation of cell-cell adhesion, that is by decreasing the values of k2. We use
k2 = 0.95 to simulate more invasive scenario and k2 = 1.0 for less invasive scenario as
shown by the bottom right and bottom left figures in Fig. 6.16, respectively. This then
must be followed by up-regulation of cell-matrix adhesion, another component that is
required for successful invasion. This “discrete analogy” can be related to the results in
the previous chapter. We have learnt in Chapter 5 the inverse relation between cell-cell
and cell-matrix adhesion, that is in order to invade and migrate through the surrounding
tissue, cell-cell adhesion should be sufficiently low and cell-matrix adhesion should be
sufficiently high.
In their experiments, Kaufman et al. (2005) showed the effects of increasing col-
lagen concentration on the level of invasiveness of GBM cells, which is similar to
increasing cell-matrix adhesion. GBM that has been implanted in a high collagen con-
centration shows growth pattern of malignant tumour with invasive cells that gradually
accumulate from the centre of multicellular spheroid invading outwardly everywhere,
as shown in top right figure of Fig 6.16. While GBM that has been implanted in a
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low collagen concentration shows relatively few invasive cells that tend to be invading
along distinct branches, as shown by the top left figure.
Figure 6.16: Plots showing the growth patterns of experimental data of multicellular
spheroids grown in low collagen concentration (top left figure) for less invasive pattern and
in high collagen concentration (top right figure) for more invasive pattern (Kaufman et al.,
2005) and our computational simulation results (bottom right figure with k2 = 0.95 and bot-
tom left figure with k2 = 1.0). The simulation results were taken at 900 MCS. Top right and
left figures are reprinted from Biophysical Journal, 89/1, L. Kaufman, C. Brangwynne, K.
Kasza, E. Filippidi, V. Gordon, T. Deisboeck, and D. Weitz, Glioma expansion in collagen
I matrices: analyzing collagen concentration-dependent growth and motility patterns, 635–
650, Copyright (2005), with permission from Elsevier [OR APPLICABLE SOCIETY COPY-
RIGHT OWNER].
Although we cannot directly compare our simulation results (bottom right and left
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figures) with the experimental results of Kaufman et al. (2005) (top right and left fig-
ures), the patterns of invasion from decreasing cell-cell adhesion (our simulation re-
sults) show similarities with the patterns of invasion from increasing cell-matrix ad-
hesion (experimental results). We note that GBM is a sarcoma and likely not use
E-cadherin/β -catenin signalling as it is not originated from epithelial tissues. Instead,
sarcomas along with other types of brain tumours, express N-cadherin that also medi-
ate calcium-dependent intercellular adhesion. Nevertheless, another paper by Ramis-
Conde et al. (2009) developed another multiscale model of transendothelial migration
(TEM) involving N-cadherin in which the pathway that they developed is not far dif-
ferent than the pathway using E-cadherin, based on their literature study. Hence, there
may be possibility that the kinetics of intracellular proteins of GBM similar to the
kinetics we have described here.
6.5 Discussion and Conclusions
In this chapter we have developed a multiscale model of cancer growth and invasion
using CC3D and Bionetsolver to study the role of intracellular dynamics of E-cadherin
and β -catenin based on a mathematical model by Ramis-Conde et al. (2008). We used
CC3D, a lattice-based simulation environment, for modelling on the cellular level and
Bionetsolver, a programming library, for modelling on the subcellular (or intracellular)
level. The integration of CC3D and Bionetsolver modelling mechanisms enables us to
study cell behaviours that are driven by the dynamics inside of the cells. It allows us to
tune the level of details in intracellular level, without switching simulation framework,
and examine the effects of changing the level of details on a cellular level.
In the multiscale model presented here, we examined the invasive behaviours of
cancer cells by modifying key parameters that are responsible for cell adhesion. Exper-
imental studies have suggested that nuclear β -catenin upregulation may characterise
invasive cell populations in many types of cancer (Brabletz et al., 2001; Ng et al.,
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2005; Suzuki et al., 2008; Uchino et al., 2010). In our model it is possible to tune
parameters that regulate the concentration of free β -catenin (also by implication nu-
clear β -catenin) to study cancer invasiveness in silico. Two key parameters that were
considered by Ramis-Conde et al. (2008), as shown in the pathway (6.11), were the
parameter k+ which influences the association rate of β -catenin with the proteasome
and the parameter k2 which is the rate of β -catenin degradation.
A sufficiently high value for k+ can maintain cell-cell adhesion and also tumour
compactness because it keeps the β -catenin concentration of all cells below a thresh-
old value. However, when k+ is decreased to a sufficiently low value, free β -catenin
accumulates in the cytoplasm as a result of a decreased β -catenin-proteasome complex.
This leads to EMT events, where loss of cell-cell adhesion leads to cells managing to
break off from the primary tumour body to migrate through and invade the surrounding
tissue.
Varying parameter k2, which is the rate of β -catenin degradation, gives characteris-
tics of studying invasive potential on invasion assay. Sufficiently low k2 results in cells
that are more invasive than the cells with sufficiently high k2. Our simulation results
from varying k2 are qualitatively comparable with experimental data for the study of
multicellular tumour spheroids (Kaufman et al., 2005).
While we were able to qualitatively reproduce results from Ramis-Conde et al.
(2008), there were noticeable discrepancies that are likely due to fundamental differ-
ences in the two simulation methodologies. In the implementation of the GGH model
into CC3D-Bionetsolver, the detachment waves of β -catenin in epithelial layers can-
not be controlled to appear from a single cell in a layer and propagate radially outward
in a regular manner, as shown in Figures 5 and 6 of the paper by Ramis-Conde et al.
(2008). Instead, by reducing k+ from 1.5 to 1.0 in our GGH model, the detachment
waves in an epithelial layer of cells are triggered by many cells which then propagate
outward irregularly. See Fig. 6.17 for comparison.
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Figure 6.17: Comparison showing the difference in β -catenin detachment wave simula-
tions between centre based model of Ramis-Conde et al. (2008) (left figure) and our CC3D-
Bionetsolver results (right figure). Left figure is reprinted from Biophysical Journal, 95, I.
Ramis-Conde, D. Drasdo, A.R.A. Anderson, and M.A.J. Chaplain, Modeling the influence
of the E-cadherin-β -catenin pathway in cancer cell invasion: a multiscale approach, 155–
165, Copyright (2008), with permission from Elsevier [OR APPLICABLE SOCIETY COPY-
RIGHT OWNER].
Another discrepancy, is that the stochastic nature of the GGH model produces fluc-
tuations of the concentrations of intracellular variables in response to fluctuations in
contact area between cells. This can be seen from the plots shown in Figs. 6.8 and
6.9. It should be noted that the issue of differences between simulation methodologies
is distinct from the question of how well the simulation results collectively reflect or
correspond to actual experimental observations. Nevertheless, there are primary con-
tributions that we have made from our multiscale implementation study, which include
the following: (1) It brings to light fundamental differences that exist between two
major individual cell-based modelling methodologies, the centre-based model and the
GGH model, within the context of cancer biology, and (2) it provides an introduction
to CC3D-Bionetsolver, a recently developed multiscale framework for multicellular
simulation.
Having seen that the CC3D-Bionetsolver can be used for multiscale modelling of
cancer cell invasion to study the effects and roles of cell adhesion (including cell-cell
and cell-matrix adhesion), it is our aim in the near future to augment the multiscale
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model of cancer invasion by incorporating intracellular pathways that describe interac-
tions between the cells and the matrix.
Chapter 7
Intracellular Modelling of Cell-matrix
Adhesion
7.1 Introduction
Adhesive interactions between cancer cells and their surroundings, i.e., the extracellu-
lar matrix, are vital for metastatic spread. The adhesive interactions are required for
migration through the basement membrane and extracellular matrix surrounding the
tumour after detachment from the primary tumour mass, and for penetration of the
circulating tumour cells into the tissue of the target organ at the secondary site.
In the interactions between cell and matrix, termed cell-matrix adhesion, the in-
tracellular compartment of the cell is connected with the extracellular environment
through cell surface receptors. Inside the cell, cell surface receptors are indirectly
linked to the actin cytoskeletal network that is dynamically remodelled. Outside the
cell, cell surface receptors bind with extracellular matrix components such as fibronectin.
The reorganisation of the actin cytoskeleton combined with binding of cell surface re-
ceptors to matrix components provides a mechanical linkage between cell and matrix,
to produce the force or traction necessary for cell adhesion, spreading and migration.
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Cancer cells migrate in various ways, according to cell type and degree of differ-
entiation. The molecular mechanisms underlying the migration of cancer cells through
the tissues are similar to the mechanisms used by normal, non-neoplastic cells for
migration during physiological processes, such as wound healing, embryonic morpho-
genesis, immune cell trafficking, etc. The principles of cell migration were initially
investigated in non-neoplastic fibroblasts, keratinocytes and myoblasts, but additional
studies on tumour cells show that the same basic strategies are retained (Friedl and
Wolf, 2003).
Cell migration is an integrated process that requires the continuous, coordinated
formation and disassembly of adhesions. Migration can be viewed as a cyclical pro-
cess. Based on studies, it is commonly agreed that the basic migratory cycle includes
the following processes (Palecek et al., 1998; Machesky and Hall, 1997; Nishizaka
et al., 2000; Webb et al., 2002; Ananthakrishnan and Ehrlicher, 2007):
• Extension of a protrusion. Polymerisation of the actin cytoskeletal network
drives the initial extension of the plasma membrane at the cell front;
• Formation of stable contacts near the leading edge of the protrusion. The in-
teraction of the cell surface receptors with the extracellular matrix stabilises the
adhesions by recruiting signalling and cytoskeletal proteins;
• Cytoskeletal contraction, that generates a tractional force;
• Translocation of the cell body forward. The small, nascent adhesions may trans-
mit strong forces, and serve as traction points for the propulsive forces that move
the cell body forward; and
• Release of adhesions and retraction at the cell rear. This completes the migratory
cycle allowing net translocation of the cell in the direction of movement.
The major groups of cell surface receptors for mediating cell-matrix adhesion are
known as integrins, named for their role in integrating the intracellular cytoskeleton
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with the extracellular matrix (Ojaniemi and Vuori, 1997). Integrins provide a bi-
directional signalling for mechanochemical information across the cell membrane, that
is, two-way signalling occurs from outside-to-inside and from inside-to-outside. This
signalling functioning provides a major mechanism for connecting the intracellular
compartment (which is the cytoskeleton) and the extracellular compartment (extracel-
lular matrix components or glycoproteins, such as fibronectin).
Over the last twenty years there have been attempts to mathematically model the
interaction between cells and surfaces representing the extracellular matrix, such as by
Hammer and Lauffenburger (1987) who modelled cell adhesion to surfaces mediated
by specific binding between molecules on the cell surface and complementary ligand
molecules on the receiving surface. The binding depends on various quantities such
as receptor number, binding affinity between receptor and ligand, bond formation rate,
receptor diffusivity, distractive fluid forces, and contact area. Palecek et al. (1999)
modelled the interactions between integrins, the cytoskeleton, and the matrix for cell
retraction and dissociation mechanisms at the cell rear. DiMilla et al. (1991) modelled
the dependence of cell speed on adhesion-receptor/ligand binding and cell mechanical
properties. Their model incorporated cytoskeletal force generation, cell polarization,
and dynamic adhesion for cell movement.
In this chapter we model a cell-matrix adhesion pathway describing interactions
between fibronectin, integrins and actin reorganisation. Binding of fibronectin with
integrins triggers a clustering of protein complexes, which then activates and phos-
phorylates regulatory proteins that are involved in actin reorganisation causing actin
polymerisation and stress fibre assembly. Rearrangement of actin filaments with inte-
grin/fibronectin complexes near adhesion sites and interaction with fibrillar fibronectin
produces the force necessary for cell migration, accounting for cell-matrix adhesion.
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7.2 Structural Components of Cell-matrix Adhesion
To model the mechanisms of cell adhesion to extracellular matrix, we consider three
major components that are needed to generate traction used by cells to perform migra-
tion through the matrix. These components are the cell surface receptors integrins, the
matrix glycoprotein fibronectin, and the actin cytoskeleton.
Integrins comprise a large family of transmembrane glycoproteins that mainly func-
tion to mediate cell-matrix adhesion. Integrins are composed of two subunits, α and
β , and each αβ combination has its own binding specificity and signalling properties
(Giancotti and Ruoslahti, 1999). To date, there are 18α and 8β subunits which com-
bine with each other to form a family of 24 distinct heterodimeric integrins that have
been identified in humans (Hynes, 2002; Takada et al., 2007). Heterodimeric integrins
are expressed on the cell membrane to link the actin cytoskeleton to the extracellular
matrix. Three different β1 integrins, which are α4β1, α5β1, and α8β1, have been found
which bind to fibronectin. Another large subfamily of integrins is composed of het-
erodimers sharing the αV subunit, also receptors for fibronectin, αVβ1, αVβ3, αVβ5,
αVβ6, and αVβ8 (Koistinen and Heino, 2002).
The cytoplasmic tails of integrins are generally short with roughly 50 amino acids
in length, except for integrin β4 that has∼ 1000 amino acids. The cytoplasmic tails are
also devoid of enzymatic features. Hence, integrin cytoplasmic domains form multi-
molecular complexes with proteins involved in cell signalling and adapter proteins
that connect the integrin to the actin cytoskeletal system, cytoplasmic kinases, and
transmembrane growth factor receptors (Giancotti and Ruoslahti, 1999; Berrier and
Yamada, 2007). The cytoskeleton organisation is performed after accumulation of
cytoskeletal proteins like tensin, α-actinin, talin, vinculin, and focal adhesion kinase
(FAK).
Migrating cells bind to fibronectin by means of discrete integrin clusterings at the
leading or protruding edge. Integrin clustering can be a result of integrin binding
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with fibronectin which then promotes the localisation of adaptor proteins linking to
the cytoskeleton (Giancotti and Ruoslahti, 1999; Berrier and Yamada, 2007) or the
clustering of integrins can cause binding of the leading edge of the cell with fibronectin.
A study on integrin clusterings in motile fibroblasts by Regen and Horwitz (1992)
showed that integrin clusterings grow at the leading edge and shrink at the cell rear
over time, in the sense that they fluctuate in size, density, and shape over a period of
minutes. As cells move, integrin clusterings that bind with fibronectin (often referred
to as focal contacts or focal adhesion sites) appear at the leading edge and diminish in
number toward the cell centre, while at the cell rear there is only a small number of
clusterings that abruptly break as the cell body advances forward. Experiments carried
out by Cluzel et al. (2005) demonstrated that integrin activation is a prerequisite for
clustering events. They observed that integrin clusterings in the periphery of the cell
occur within minutes, starts about after 3 minutes.
Integrin binding with matrix can also affect integrin activation, where integrin bind-
ing to fibronectin changes the conformational state of integrin, from inactive to active
(Garcı´a et al., 1998; Garcı´a and Boettiger, 1999; Berrier and Yamada, 2007). Integrin
activation is a prerequisite for clustering, hence activated integrins preferentially lo-
calise to the leading edge, where new adhesions form. In our model, we assume that
integrin activation is triggered by binding of integrin to fibronectin, which then leads
to clustering of integrin/fibronectin complexes.
The clustering of integrin/fibronectin complexes at the focal adhesion sites regu-
lates downstream signalling pathways that induce an accumulation of signalling and
adaptor proteins near the cytoplasmic domains of integrins. There are more than 50
cytoplasmic proteins present in the cell-matrix adhesion structure. The downstream
signals coordinate reorganisation of the cytoskeleton as a result of actin polymerisa-
tion. The cytoskeleton is a highly dynamic part of a cell. It consists of numerous
cytoskeletal actin filaments (F-actin) that constantly grow at their barbed end through
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polymerisation of monomeric actin (G-actin) and shrink at the pointed end through
actin depolymerisation. This process is referred to as “treadmilling”, which is a steady
state flux of filaments (Pollard and Mooseker, 1981; Wehrle-Haller and Imhof, 2003).
The reorganisation of the actin cytoskeleton is the primary mechanism of cell motil-
ity and is essential for most types of cell migration. During cell migration, the actin
cytoskeleton is dynamically remodelled, and this reorganisation produces the force
necessary for cell migration. The reorganisation of actin filaments into larger stress
fibres, in turn, causes more integrin clusterings, thus enhancing the matrix binding
and organisation by integrins in a positive feedback system (Giancotti and Ruoslahti,
1999). Evidence accumulated from a variety of cell types has shown that the actin
filaments assembled near the leading edge are also transported rearward or in a direc-
tion opposite to the movement of the cell. This phenomenon is known as retrograde
flow. There is a balance between the actin cytoskeleton assembly and the retrograde
flow that govern and control cell movement (Abraham et al., 1999; Mallavarapu and
Mitchison, 1999; Wiseman et al., 2004; Guo and Wang, 2007).
The structure and composition of the extracellular matrix is also very important
for cancer cell invasion. One of the key components of the extracellular matrix which
plays a major role in cell-matrix adhesion is fibronectin. Two forms of fibronectin exist.
One form, plasma or soluble fibronectin, is a major plasma protein and found at con-
centration of 300µg/ml in human blood. An early study by Tamkun and Hynes (1983)
showed that hepatocytes of rats and hamster synthesised and secreted fibronectin as a
soluble dimeric protein. In humans, soluble fibronectin is synthesised predominantly in
the liver by hepatocytes in dimeric form. Another form, known as cellular fibronectin,
is found at the surfaces of many different cell types, where it forms insoluble fibrillar
matrices (Pankov and Yamada, 2002). A major fraction of the cellular fibronectin in
the extracellular matrix has been found to be derived from plasma fibronectin (Moretti
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et al., 2007). The assembly of fibronectin matrix or insoluble fibrillar matrix is a cell-
mediated process. It is thought that the binding of integrin to fibronectin promotes
fibrillar matrix formation through interactions with other cell-association fibronectin
dimers. As fibrillar matrices form on the outside of the cell, cytoplasmic domains of in-
tegrins organise cytoplasmic proteins (signalling and adaptor proteins) into functional
complexes linking to the cytoskeleton. The whole process of binding of cytoskeleton
to integrins and fibronectin is essential for fibrillar matrices formation and propagation
(Wierzbicka-Patynowski and Schwarzbauer, 2003). The insoluble fibrillar matrices,
along with other components of extracellular matrix, provide structural support for
cellular functions such as cell adhesion, migration, and tissue organisation. For mi-
grating cells, binding onto a rigid surface helps generate tractional forces necessary
for moving the cell body forward. Since the assembly of fibronectin into a fibrillar
matrix is a complex process, we assume, for our model, that the fibrillar matrices are
formed by binding of the clustering of integrin/fibronectin complex bound with soluble
fibronectin. The more fibronectin or fibrillar matrices formed, the more rigid the extra-
cellular matrix becomes. The rigidity of extracellular matrix causes the strengthening
of the integrin-cytoskeleton linkages (Choquet et al., 1997). Hence it generates posi-
tive feedback for cytoskeleton organisation inside of the cell. The adhesion forces are
the final step produced from the kinetics and mechanics of the structural components
of cell-matrix adhesion.
7.3 Mathematical Model Derivation
Based on the kinetics of the major components of cell-matrix adhesion summarised in
section 7.2, we assume the following steps for our cell-matrix adhesion pathway:
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1. Binding of integrin [R] to plasma or soluble fibronectin [Fp] to form an inte-
grin/fibronectin complex [FR], with reversible reactions:
R+Fp
k1
GGGGGBF GG
k2
FR
2. The clustering of integrin/fibronectin complex results from the binding of inte-
grin with fibronectin at the cell membrane. Here we adopt a simple clustering
reaction as in Fussenegger et al. (2000), which is assumed to be irreversible, with
rate k3:
FR
k3
GGGGGA F˜R
3. Clustering triggers recruitment and localisation of cytoplasmic proteins, hence
activation and phosphorylation of regulating proteins. This then activates actin
polymerisation and actin reorganisation Ap at the leading edge that pushes the
membrane forward in finger-like structures (filopodia) and can also be in sheet-
like structures (lamellipodia), with rate k4:
F˜R
k4
GGGGGA Ap
To account for processes that reduce actin filaments at the leading edge such as
treadmilling and retrograde flow, we assume a natural decay with constant rate
m.
4. Rearrangement of actin filaments with clusters of the integrin/fibronectin com-
plex near focal contact sites:
Ap+ F˜R
k5
GGGGGBF GG
k6
Ap.F˜R
5. Meanwhile, surrounding the cell in the extracellular domain, the formation of
the fibrillar fibronectin network occurs with a rate k7:
F˜R+Fp
k7
GGGGGA F×
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The formation of the fibrillar fibronectin network increases matrix rigidity, which
in turn, gives a positive feedback with rate k8 to the strengthening of the integrin/fibronectin-
cytoskeleton linkage Ap.F˜R.
6. Binding of the integrin/fibronectin-cytoskeleton linkage Ap.F˜R to the fibrillar
network yields an adhesion force, measured by its strength, required for cell
movement:
F×+Ap.F˜R
k9
GGGGGBF GG
k10
F×.Ap.F˜R
The complex F×.Ap.F˜R ruptures during cell detachment at the cell rear. Hence
the reaction is reversible.
7. An increasing force adds a positive feedback to the clustering of complex with
rate k11.
These intracellular interactions are summarised in a schematic diagram shown in
Fig. 7.1.
Figure 7.1: A schematic diagram of the kinetics for cell-matrix adhesion process involving
integrin, fibronectin, and actin.
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By letting
[R] = x1
[Fp] = x2
[FR] = x3
[F˜R] = x4
[Ap] = x5
[Ap.F˜R] = x6
[F×] = x7
[F×.Ap.F˜R] = x8
and applying the law of mass action, we obtain the system of ODEs:
dx1
dt
= k2x3− k1x1x2 , (7.1a)
dx2
dt
= k2x3− k1x1x2− k7x2x4 , (7.1b)
dx3
dt
= k1x1x2− k2x3− k3x3 , (7.1c)
dx4
dt
= k3x3− k4x4+ k6x6− k5x4x5− k7x2x4+ k11x8 , (7.1d)
dx5
dt
= k4x4+ k6x6− k5x4x5−mx5 , (7.1e)
dx6
dt
= k5x4x5+ k8x7− k6x6− k9x6x7+ k10x8 , (7.1f)
dx7
dt
= k7x2x4− k8x7+ k10x8− k9x6x7 , (7.1g)
dx8
dt
= k9x6x7− k10x8− k11x8 . (7.1h)
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We introduce dimensionless variables
x∗1 =
x1
xR
, x∗2 =
x2
xF
, x∗5 =
x5
xR
,
where xR is the reference concentration of integrin and xF is the reference density of
plasma fibronectin. To set the reference for density of integrin/fibronectin complex,
we follow Garcı´a and Boettiger (1999), that under conditions of excess ligand (of
fibronectin) the steady state density/concentration of integrin/fibronectin complex is
proportional to
xFR = KaxRxF ,
where Ka =
k1
k2
is the equilibrium affinity constant for binding of integrins with fi-
bronectin. We use it for the other dimensionless variables:
x∗3 =
x3
xFR
, x∗4 =
x4
xFR
, x∗6 =
x6
xFR
, x∗7 =
x7
xFR
, and x∗8 =
x8
xFR
.
We nondimensionalise time as
t∗ =
t
T
where T is an appropriate reference time and we obtain the nondimensional parame-
ters:
k∗1 = xFRk1T , k
∗
2 = k2T , k
∗
3 = k3T , k
∗
4 = k4T , k
∗
5 = xFRk5T , k
∗
6 = k6T
k∗7 = xFRk7T , k
∗
8 = k8T k
∗
9 = xFRk9T , k
∗
10 = k10T , k
∗
11 = k11T , m
∗=mT .
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Inserting the dimensionless variables and parameters above into the system of
equations (7.1) and after dropping the stars for notational convenience, the nondimen-
sional model for cell-matrix adhesion is
dx1
dt
= αk2x3− 1β k1x1x2 , (7.2a)
dx2
dt
= βk2x3− 1α k1x1x2− k7x2x4 , (7.2b)
dx3
dt
=
1
αβ
k1x1x2− k2x3− k3x3 , (7.2c)
dx4
dt
= k3x3− k4x4+ k6x6− 1α k5x4x5−
1
β
k7x2x4+ k11x8 , (7.2d)
dx5
dt
= αk4x4+αk6x6− k5x4x5−mx5 , (7.2e)
dx6
dt
=
1
α
k5x4x5+ k8x7− k6x6− k9x6x7+ k10x8 , (7.2f)
dx7
dt
=
1
β
k7x2x4− k8x7+ k10x8− k9x6x7 , (7.2g)
dx8
dt
= k9x6x7− k10x8− k11x8 , (7.2h)
where
α =
k1xF
k2
and β =
k1xR
k2
.
For migrating cells, adhesion of cells to matrix occurs instantaneously in order to
prevent the formation of mature focal adhesions which are bigger in size and hold cells
from moving.
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7.4 Computational Simulation Results
In this section we present the results of computational simulations from the system (7.2).
To obtain dimensionless parameter values, we use parameters listed in Table 7.1 for
reference.
Table 7.1: Parameter values for the intracellular simulations
Parameter Definition Range/Value Reference
xR Receptor density 108−1012cm−2 Palecek et al. (1999)
xF Ligand density 106−1013cm−2 Palecek et al. (1999)
k1
k2
Receptor-ligand equilibrium constant 10−8−10−6M−1 Palecek et al. (1999)
k2 Reverse receptor-ligand reaction rate 5×10−4s−1 Chen et al. (1999)
k3 Rate of integrin clustering 6.3×10−3s−1 Wehrle-Haller (2007)
k5
k6
Receptor-cytoskeleton equilibrium constant 10−8−10−6M−1 Palecek et al. (1999)
k7 Rate of fibrillar matrix formation 0.01141 min−1 Monaghan et al. (2004)
T Time integrin clusterings start at focal contacts 1 hour Kawakami et al. (2001)
For parameter values that could not be found in the literature, we use estimated
values. Dimensionless parameter values used in the simulations are summarised as
follows:
k1 = 1.8 , k2 = 1.8 , k3 = 20 , k4 = 1.1 , k5 = 0.36
k6 = 0.36 , k7 = 2.7 , k8 = 0.01 , k9 = 5 , k10 = 0.001 ,
k11 = 0.001 α = 1.0 β = 0.1 , m = 0.005 .
Initially we assume that there is a 0.6 fraction of free integrins on the cell mem-
brane, a 0.45 fraction of soluble fibronectin and a small amount (0.03 fraction) of
fibronectin matrix outside the surface of the cell. As a cell must have a cytoskeleton to
support its shape, we assume there is a 0.3 fraction of actin filaments near the leading
edge. The rest of the variables are initially zero.
194
The first result from the cell-matrix adhesion pathway that we show here is the
adhesion force or adhesion strength produced from complex interactions between the
cell surface receptor integrins as mediators, the cytoskeletal network inside of the cells
and fibronectin with the fibrillar network outside of the cell. Using the dimensionless
parameters given above, the computational simulations show that the generated adhe-
sion strength shows an initial exponential increase, until it reaches a steady state or a
constant strength, as shown on the right plot of Fig. 7.2. This result qualitatively agrees
with the experimental data by Gallant et al. (2005) that measured fibroblast adhesion
strengthening on fibronectin, as in the left plot of Fig. 7.2.
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Figure 7.2: Plots showing a comparison between experimental data showing increase and
steady state of adhesion force by Gallant et al. (2005) and our simulation result of generated
force (right figure) from cell-matrix adhesion model (7.2) equation (7.2h).
Both experimental data and our simulation result show that the adhesion force or
strength increases rapidly at early times and reaches a steady state value by 4 hours for
experimental data and around dimensionless time 3 for our simulation. Experiments
by Gallant et al. (2005) show the dependency of adhesion strength on fibronectin den-
sity, where a lower density of fibronectin yields a smaller constant adhesion strength
(open circles) and a higher fibronectin density gives a bigger constant adhesion strength
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(closed circles). For our cell-matrix adhesion model, the adhesion strength shows de-
pendency both on integrin and soluble fibronectin densities. In Fig. 7.3 we plot ad-
hesion strengths over time by varying the initial value of integrin x1(0) and soluble
fibronectin x2(0) concentrations as shown on the left figure (for varying/increasing
x1(0)) and right figure (for varying/increasing x2(0)). The initial value of concentra-
tions is increased from x1(0) = 0.1 (bottom curves), x1(0) = 0.3, x1(0) = 0.6, and
x1(0) = 0.9 (top curves) for both x1(0) and x2(0). Taking both x1(0) = 0.9 and
x2(0) = 0.9, the time taken for the adhesion strength to reach a constant value is fast,
around 2 dimensionless time units, and the constant adhesion strengths are also the
same, about 0.25 for both initial densities of integrin and fibronectin 0.9. With the low-
est initial densities x1(0)= 0.1 and x2(0)= 0.1, the time taken for the adhesion strength
to reach a constant value is longer, around 6 dimensionless time units and the constant
values of adhesion strengths are different for each integrin and fibronectin, where with
x1(0) = 0.1 the constant adhesion strength is around 0.16 and with x2(0) = 0.1 the
constant adhesion strength is around 0.195.
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Figure 7.3: Plots showing increasing constant adhesion strength values by increasing initial
concentration of integrins x1(0) (left figure) and initial concentration of soluble fibronectin
x2(0) (right figure) from 0.1, 0.3, 0.6, and 0.9.
Butler et al. (2006) developed an in vitro assay to visualise and quantify actin poly-
merisation from purified αvβ3 integrin complexes that cluster at the protruding parts
of the cells as shown on the left plot of Fig. 7.4. The experimental data show the
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rates of actin assembly/polymerisation from different cells stimulated and unstimu-
lated with Arg-Gly-Asp-ligand-induced β3 tyrosine phosphorylation, where the black
curve shows the rate of actin polymerisation by cells of wild type stimulated with Arg-
Gly-Asp-ligand-induced β3 tyrosine phosphorylation, the blue curve from unstimu-
lated cells, the red curve for stimulated and expressing Y747-759F β3 cells, and the
orange curves for unstimulated expressing Y747-759F β3 cells. The rate of actin poly-
merisation from experimental data shows a tendency of a rapid increase at early times
until it reaches a constant value, the same pattern as the experimental data for adhe-
sion strength. Our computational simulation result for x5 from the model (7.2) which
accounts for actin polymerisation followed by actin reorganisation near the leading
edge as well as actin depolymerisation and retrograde flow for balance, also shows the
same exponential increase until reaching a constant rate, as shown by the right plot of
Fig. 7.4.
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Figure 7.4: Plots showing different rates of actin polymerisation from experimental data by
Butler et al. (2006) (left figure) and simulation result of actin polymerisation from cell-matrix
adhesion model of equation (7.2e) (right figure). Left figure is reprinted from Current Biology,
16/3, B. Butler, C. Gao, A.T. Mersich, S.D. Blystone, Purified integrin adhesion complexes ex-
hibit actin-polymerization activity, 242–251, Copyright (2006), with permission from Elsevier
[OR APPLICABLE SOCIETY COPYRIGHT OWNER].
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Other processes that are of experimental interest are the rate of change of solu-
ble fibronectin and the rate of change of formation of insoluble cellular fibronectin or
fibrillar fibronectin network (matrix) outside of the cell. We compare our simulation
results for both kinetics with the experimental data of Sechler et al. (1996), as shown
in Fig. 7.5. The left plot, which is the experimental data, shows the fast formation of
insoluble fibronectin (open circles) from a certain type of soluble fibronectin (closed
circles) (FN∆III1−7) that rapidly decreases. Both concentrations of soluble and in-
soluble fibronectin eventually reach contant values. The simulation results, shown by
the right plot, from equations (7.2b) for soluble fibronectin concentration and (7.2g)
for insoluble fibronectin concentration exhibit the same rate of reactions, which are an
exponential decrease for soluble fibronectin and an exponential increase for insoluble
fibronectin. The concentrations of both reach a constant steady state.
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Figure 7. Rate of incorpora- 
tion of pFN, FNA-B-,  and 
FNAIII~_7 into DOC-insolu- 
ble matrix. Quantitative im- 
munoblot analysis was per- 
formed on DOC-soluble and 
-insoluble cell extracts iso- 
lated from CHOet5 cells in- 
cubated with each of the 
three FNs over the indicated 
periods of time as described 
under Materials and Meth- 
ods. Values are expressed in 
terms of percentage of total cell-associated FN (DOC-soluble plus insoluble) at each time point. In each case, DOC-soluble material 
(closed circles) is converted into DOC-insoluble matrix (open circles). 
sequence. Differences in the rate of its assembly suggest 
that the deleted region plays a regulatory role during fibril 
formation. 
Within the first seven type I I I  repeats reside a major 
FN-binding site in the Il l l  module and two low affinity 
heparin-binding regions in repeat 1111 and repeats 1114_6 
(Hynes, 1990). The FN-binding site appears to be cryptic 
(Morla and Ruoslahti, 1992; Hocking et al., 1994) but, 
when exposed, it is able to interact with the first five type I 
repeats (Aguirre et al., 1994; Hocking et al., 1994). F N -  
FN interactions involving I l l l  or other as yet unidentified 
sites within repeats 1111_ 7 could play a role in regulating 
matrix assembly. We have postulated that intramolecular 
interactions between FN-binding sites in 11_5 and 1111 do- 
mains could hold soluble FN dimers in a compact form 
that is inactive for assembly (Aguirre et al., 1994). Confor- 
mational transitions in FN upon binding to the cell surface 
could disrupt the intramolecular interactions, activating 
FN by making the binding sites in 11-5 and Il l l  available for 
association with adjacent FN dimers. Removal  of one of 
the binding sites, as in FNAIIII_7, might yield a constitu- 
tively active molecule that behaves differently during the 
first stages of assembly. Our  data fit well with this model. 
FNAIIII_7 becomes DOC-insoluble significantly faster than 
full-length FN after binding to ct5131 on the cell surface. 
The increased rate of accumulation suggests that FNAIII1_7 
is already in an activated state. 
Figure 8. Characterization of DOC-insoluble matrix. (A) CHOa5 
cells were incubated with medium containing 50 ixg/ml FNAIIII_7 
or rat pFN for 48 h. DOC-insoluble material was isolated and 
equal amounts of total protein were analyzed by SDS-PAGE un- 
der nonreduced conditions. FN was detected with IC3 antibody 
and chemiluminescence reagents. High molecular weight multi- 
mers (solid arrows) and dimeric FN (open arrows) are indicated. 
(B) CHOet5 cells were incubated with medium containing 25 p~g/ 
ml FNAIIII_7 or rat pFN and 0, 50, or 100 ~g/ml 70 kD fragment 
for 16 h. DOC-insoluble material was isolated and FN detected 
under reduced conditions as described above. Position of 180 kD 
molecular mass standard is indicated by dash. 
Figure 9. Inhibition of fibril formation with the 70-kD amino-ter- 
minal fragment. CHOa5 cells were incubated with 50 wg/ml rat 
pFN (A and B) or FNAIIII_7 (C and D) for 16 h followed by stain- 
ing for immunofluorescence. In B and D, ~1 mg/ml 70 kD frag- 
ment was included in the incubation.7 
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Figure 7.5: Plots showing the computational results of our model for kinetics of soluble
fibronectin and the formation of insoluble fibronectin matrix (right figure) are comparable with
experimental data by Sechler et al. (1996) (left figure).
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7.5 Conclusions and Discussion
In this chapter we have presented a model of the key biochemical processes involved in
cell-matrix adhesion that accounts for reactions between integrins, soluble fibronectin,
the integrin/fibronectin complex, clustering of the integrin/fibronectin complex, actin
polymerisation and reorganisation, the cytoskeletal complex, insoluble fibronectin (fib-
rillar network), and adhesion strength from the combination of the clustering inte-
grin/fibronectin complex with the cytoskeletal network and attachment to insoluble
fibronectin outside the cell, using a system of ordinary differential equations (7.2). We
formulated the mathematical model from a proposed cell-matrix adhesion pathway that
was derived based on the key events as reported in the literature.
Despite some parameters used in the simulations are only estimated values because
not all parameters are available experimentally or in literature, our model shows good
qualitative agreement with the experimental data, such as for adhesion strength plots
shown in Figs. 7.2 and 7.3 and for kinetics of soluble fibronectin and formation of
matrix fibronectin as shown in Fig. 7.5.
For migrating cells, the adhesion force generated from interactions of proteins lo-
cally is used for one cycle of movement which includes extending protrusions and
moving their body forward. One cycle of cell movement takes around 30 minutes
to 1 hour to occur, depending on many other variables such as a sufficient rigidity
of surface/matrix for the smooth movement, an available gradient of chemoattractant,
etc. The dynamics of key cell-adhesion components such as integrins, the cytoskeletal
network and fibronectin, are also instantaneous. After one cycle of movement is com-
pleted, the whole pathway is restarted from the beginning to perform another cycle of
movement. In order to prove this conjecture and to see whether our cell-matrix adhe-
sion pathway works adequately, it is our aim for future work to apply the intracellular
cell-matrix adhesion model into a multiscale cellular model together with the cell-cell
adhesion model we have presented in Chapter 6.
Chapter 8
Conclusions and Future Work
In this thesis we have presented mathematical models of cancer cell invasion of tissue
looking at the role of cell adhesion using two different mathematical approaches: (i) a
continuum approach and (ii) a multiscale individual cell-based approach, or from a bi-
ological perspective the approaches refer to the tissue level and a combination between
the subcellular and the cellular levels, respectively. With the continuum approach, we
focused on a model of the urokinase plasminogen activation (uPA) system and the role
of cell adhesion in cancer invasion, while with the individual cell-based approach we
took a closer look at adhesion at a subcellular level and investigated the dynamics and
interactions of proteins that control the complex phenomena.
For the uPA system model that is presented in Chapter 4 we performed a linear sta-
bility analysis and computational simulations of the model which was first proposed
earlier by Chaplain and Lolas (2005). Our main contribution and finding is the obser-
vation of a very rich (“dynamic”) spatio-temporal heterogeneity of the solutions. The
linear stability analysis and computational simulations suggest that this may be due
to a taxis-driven instability of the spatially homogeneous, positive steady state of the
model. We showed that by varying key parameters of the model, the qualitative char-
acter of the solution, either of travelling-wave-like form or heterogeneous dynamics,
can be changed. The prevalent character of the solution for a given parameter set can
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be predicted by examining dispersion relations derived from a linear stability analysis
of the system. We acknowledged that the model should be extended to a more compre-
hensive mechanism of invasion by including cell adhesion in the model. Cell adhesion
has been shown experimentally, in vivo and in vitro, to be critical in cancer progres-
sion, from local invasion where the cancer originates to the dissemination of cancer to
distant anatomical sites or metastasis
In Chapter 5 the original uPA system model, which consists of 5 PDEs, is devel-
oped and extended by including nonlocal terms to model the cell-cell and cell-matrix
interactions, based on the work of Armstrong et al. (2006) and resulting in a system
of integro-differential equations (Gerisch and Chaplain, 2008; Sherratt et al., 2009;
Painter et al., 2010). We used the uPA model presented in Chapter 4 as a base model
and extended it with adhesion properties by incorporating an adhesive movement term
in the equation for cancer cell density. The adhesive movement term is nonlocal (in
space), it comprehensively accounts for adhesion between cell and cell, or cell-cell
adhesion, and adhesion between cell and extracellular matrix, or cell-matrix adhesion.
This new adhesive movement term, or nonlocal term, replaces the original haptotactic
term used in the uPA model for the directed movement of cells in response to gradients
of matrix components. The extended model, or nonlocal model, is biologically more
realistic and allows us to more accurately model local invasion by cancer cells of tissue
where malignant tumour cells or cancer cells must detach from the main tumour body,
degrade surrounding tissue and migrate through the tissue.
Using a multiscale individual cell-based approach, we also studied the role of the
intracellular dynamics of E-cadherin and β -catenin based on a mathematical model
developed by Ramis-Conde et al. (2008), presented in Chapter 6. We used CC3D, a
lattice-based simulation environment, for modelling on the cellular level and Bionet-
solver, an ODE programming library, for modelling on the subcellular (or intracellular)
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level. The integration of CC3D and Bionetsolver led to a multiscale model which en-
abled us to study cell behaviours that are driven by the dynamics of key proteins inside
the cells. We examined invasive behaviours of cancer cells by modifying key parame-
ters that are responsible for cell adhesion, i.e., E-cadherin and β -catenin. The novelty
of this work is the integration of Bionetsolver with CC3D, leading to a multiscale
framework for multicellular simulation. Our CC3D-Bionetsolver framework, which is
a lattice-based modelling approach, proposes a different methodology than that used
by Ramis-Conde et al. (2008), which is off-lattice modelling. In many respects, the
two methodologies have the same overall goal, that is to mimic behaviours and inter-
actions of biological cells. Although the mathematical foundations and computational
implementations of the two are very different, the results of the computational simula-
tions of both modelling approaches are compatible with each other, suggesting that we
can formulate in a natural way complex multicell, multiscale systems. The ability to
easily reproduce results of one modelling approach using an alternative approach is es-
sential from a model cross-validation stand point and also helps to identify modelling
artefacts specific to a given computational implementation. The primary aim of this
study was to demonstrate cross-validation of a published model using the open-source
simulation environment, CompuCell3D-Bionetsolver.
Finally in Chapter 7 we presented an intracellular pathway for the interactions be-
tween cell and matrix. We developed a model of cell-matrix adhesion that accounts
for reactions between the cell surface receptor integrins, the matrix glycoprotein fi-
bronectin, and the actin cytoskeleton. Each represents components for an intermediate
compartment, the extracellular compartment, and the intracellular compartment, re-
spectively. The model consists of a system of ODEs for integrins, soluble fibronectin,
integrin/fibronectin complex, clustering of integrin/fibronectin complex, actin poly-
merisation and reorganisation, cytoskeletal complex, insoluble fibronectin (fibrillar
network), and adhesion strength from combination of clustering integrin/fibronectin
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complex with cytoskeletal network and attachment with insoluble fibronectin outside
of the cell.
In vivo and in vitro experiments or “biological modelling” have demonstrated the
significant role cell adhesion plays in cancer invasion. Using mathematical modelling
we have also been able to show the importance of cell adhesion and a broad range of
invasion patterns that resulted from our computational simulations. Varying the cell
adhesion properties can affect the spatio-temporal behaviour of cancer cell invasion.
Since the quality of any modelling process needs to be validated, we have shown that
the results of our computational simulations are in qualitative good agreement with
experimental data, both from the continuum and the individual cell-based approach. It
will be part of our future work to get modelling and simulation results that are compa-
rable not only qualitatively but also quantitatively with experimental data.
Similarities of the challenges in modelling from the two approaches include: (i) the
choice of assumptions that we have to make to provide as simple model as possible but
also to cover broad aspects relevant in biology; (ii) including as many experimentally
determined parameters as possible; and (iii) running the simulations in an efficient and
fast way. For the latter, running the simulations of continuum models in 2-dimensional
space takes as much time as running multiscale individual cell-based models. The main
difference lies in the size of the system we want to model. With a continuum approach
it is appropriate to model systems with large number of cells, of the order of 106 or
higher. On the other hand, computation becomes very expensive for modelling systems
with numbers of cells larger than 103 for multiscale individual cell-based models.
The ability to model different phenotypes of varying degrees of malignancy as well
as cell-cell and cell-matrix adhesion at a continuum level and an individual cell level,
offers a fruitful future for a deeper understanding of the processes involved in cancer
cell invasion and of their relative importance to each other. Therefore for the continuum
model, we aim at performing nonlinear stability analysis for future work. Because of
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the nonlinearity of the system, the precise patterns that evolve are governed by the
full nonlinear system. Therefore a nonlinear stability analysis perhaps could give us
more insight into the developed model. As for our individual cell-based model, our
next work is to incorporate the cell-matrix adhesion pathway into the multiscale model
together with the cell-cell adhesion pathway that has already been developed.
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